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Abstract: ATP dependent chromatin re-modeling factors have previously been shown 
to play a pivotal role in the regulation of gene expression in several model organisms, 
including yeast, fruit fly and human. When encountered with a nutrient depleted 
environment Dictyostelium discoideum enter a process of multicellular development 
which requires the correct temporal and spatial expression of a large subset of genes. 
Here it is shown that two of these ATP dependent chromatin re-modelling factors, 
1NO80 and CHDC, are required for the correct expression of developmental genes of 
Dictyostelium discoideum and subsequent multicellular morphogenesis. These factors 
are identified as having a key role in the earlier stage of aggregation and cellular 
chemotaxis towards the developmental chemoattractant cAMP. Genetic disruption of 
genes encoding major subunits of these complexes, arp8 and chdC, both result in a 
decreased ability to form correct fruiting bodies, also showing a marked decrease in 
chemotactic ability. In each case, these defects are seen to occur through different 
mechanisms, indicating the role of multiple pathways in the regulation of 
Dictyostelium chemotaxis. Interestingly, both mutant cell lines are also responsive to 
the neuropsychiatric treatment drug lithium and are shown to affect elements of the 
inositol signaling pathway.
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Chapter 1:
Introduction
Summary: The primary aims of this project were to investigate the roles of ATP 
dependent re-modeling factors during the starvation response of the social amoeba 
Dictyostelium discoideum. We investigated the roles of these complexes, to gain a 
better understanding of how they work, the pathways affected during this process and 
provide some insight into the roles that they play in the cells response to the mood 
stabilizing drug lithium.
Two specific chromatin re-modelers became the focus of this project; INO80 and 
CHDC. Both have been shown to be highly important in other organisms, with INO80 
being involved in regulating inositol biosynthesis in yeast and the CHDC proteins 
being implicated in a number of human developmental disorders. This research was 
designed to investigate whether these complexes affect Dictyostelium in a similar 
manner and whether they could be further characterized in a simpler developmental 
system. We also set out to identify any new roles of these re-modelers, if any, in this 
organism.
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1.1 The history of the therapeutic use of lithium and mood disorders
Bipolar disorder, or manic depression, is an extremely prevalent 
neuropsychiatric mood disorder with severe symptoms that can often have devastating 
effects on quality of life [1]. This disease can become life threatening in conjunction 
with other psychiatric conditions. Patients swing erratically between a deep 
depression and an overblown mania with no control over which phase they will be in 
at any one time. If untreated, there is a 25% chance of suicide, with an estimation of 
one million deaths worldwide per year [1,2]. Bipolar disorder has been well classified 
with behavioral models however, the underlying molecular biological systems 
controlling these symptoms remains unclear. Traditional research models for this 
disease have involved patient and rodent behavioral studies, however recently there 
has been an increase in simpler biological systems such as the social amoeba 
Dictyostelium discoideum.
The study of the mechanism of action of several mood stabilising drugs on this 
disease has long been an ongoing research interest, with the goal of improving these 
treatments. Lithium, along with valproic acid (VPA) and carbamazepine (CBZ) are 
the most commonly prescribed mood stabilising drugs in the treatment of a number of 
these disorders [2]. These treatments are all non-curative and require long term usage 
with extremely poor response rates in many cases. In all of these cases the therapeutic 
mechanism is not understood, yet establishing the molecular targets of these drugs 
will hopefully lead to a better appreciation of the principles governing the symptoms 
of bipolar disorder and the development of new and improved therapies.
Lithium was initially used as an anti-manic agent in the 19th Century. 
However, its use diminished before being re-introduced in 1949 by John Cade [3J. 
Since then it has been widely used as the best available treatment for both long and
12
short-term phases of bi-polar disorder. Whilst still being one of the most commonly 
used drugs it does still have several drawbacks. These include a large number of 
patients being unresponsive to treatment and an increasing intolerance to side effects, 
which include tremors, nausea and diarrohea [4]. This is likely to be due to lithium 
having several direct biological targets.
Several direct biological targets of lithium have been identified; Inositol 
monophosphatase (IMPase), Inositol polyphosphate 1-phosphatase (IPPase), glycogen 
synthase kinase-3 (GSK3), Fructose-1, 6-bisphosphate phosphatase (FBPase), 
Bisphosphate nucleotidase (BPNase) and Phosphoglucomutase (PGM). IMPase and 
IPPase are both involved in the inositol biosynthetic pathway and are rate limiting 
enzymes involved in the recycling and de novo synthesis of free inositol and are 
inhibited non-competitively by lithium [5]. Recycling of inositol phosphates (IP’s) 
and phosphotidylinositides (Pi’s) are essential to maintain intracellular PI mediated 
cell signaling in response to external signals. The regulation of IP’s and Pi’s have 
been implicated in the causes of bipolar disorder in the inositol depletion hypothesis 
and are discussed in the next section.
GSK3 is a serine-threonine kinase and a key regulating factor of several 
signaling pathways including the Wnt pathway and the PI-3 kinase pathway [6], 
affecting a diverse range of cellular processes. One of the most relevant to bipolar 
disorder is the inhibition of GSK3’s pro-apoptotic effects. This occurs through 
activation of several transcription factors, including the P-catenin destruction complex 
[7J. When GSK3 becomes inhibited by lithium, this leads to inhibition of the 
apoptotic pathway.
FBPase and PGM are the least studied of the direct targets of lithium and 
considered less likely to be the therapeutic target of lithium. FBPase removes the 1-
13
phosphate from fructose, 6-bisphosphate to produce fructose 6-phosphate. 
Bisphosphate nucleotidase (BPNase) removes the 3’-phosphate from 3’- 
phosphoadenosine 5’-phosphate (PAP) to form adenosine 5’-phosphate (AMP). 
Phosphoglucomutase (TOM) is involved in the processes of glycogenolysis and 
glycogenesis and catalyzes glucose 1-phosphate from glucose 6-phosphate. All are 
inhibited by lithium within the therapeutic range [2].
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Fig. 1.1 Metabolism of soluble inositol phosphates
The above diagram indicates the metabolic pathways linking the soluble inositol 
phosphates found in Dictyostelium discoideum.
Abbreviations found in the diagram; I - Inositol, P - phosphate, DAG - 
Diacylglycerol, PtI - Phosphotidylinositol, P'ase - phosphatase, PLC - phospholipase 
C, MIPP - Multiple inositol polyphosphate phosphatase.
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1.2 Inositol phosphate biosynthesis and the inositol depletion hypothesis
Inositol phosphate and the membrane lipid phosphatidylinositol are wide 
ranging, highly regulated second messenger signaling molecules (summarized in Fig. 
1.1). Through phosphorylation of the six hydroxyl moieties on the core inositol 
carbon ring a great diversity of signaling molecules are synthesized affecting a large 
number of cellular processes. Inositol phosphate signaling has been implicated as 
being one of the possible molecular mechanisms of bipolar disorder [ 12|.
Myo-inositol is produced in several ways; de novo synthesis occurs from glucose-6- 
phosphate, catalysed by myo-inositol-phosphate synthase (encoded by the gene inol) 
181, recycling of the higher order inositol phosphates and finally by uptake from the 
extra-cellular media by specific myo-inositol transport channels [9J.
In the inositol signaling pathway, free myo-inositol is first converted to PtI by 
the enzyme phosphatidylinositol synthase and further phosphorylated to PtI(4)P and 
PtI(4,5)P2 by the PI4’ kinase and PI5’ kinase respectively. PtI(4,5)P2 is a significant 
pool of cellular inositol phosphate and is the substrate for both Phospholipase C 
(PLC) and the PI3’ kinase in response to external stimuli. PLC hydrolyses PtI(4,5)P2 
to the signaling molecules I(1,4,5)P3 and diacylglycerol (DAG), both of which are 
involved in a number of cellular responses including release of Ca2+ from intracellular 
stores and the production of higher order inositol phosphates [ 10].
The inositol depletion hypothesis was the first proposed mechanism for a 
bipolar disorder treatment. Described nearly 20 years ago by Berridge et al [11] it 
attempted to explain the biological mechanism behind the treatment of manic 
depression with lithium. The hyposthesis suggested that second messenger signaling 
could be reduced by lithium’s affect on the free pool of inositol in the brain. This was 
proposed to occur via the inhibition of IMPase and IPPase, reducing the levels of free
16
inositol by breaking the inositol signaling pathway (Fig. 1.1). However conclusive 
clinical evidence either for or against this theory has been difficult to establish.
Early evidence linking lithium to this theory came in 1971 with Allison and 
Stewarts [12] work on the rat cerebral cortex indicating a 30% decrease in myo­
inositol concentration in this region following lithium treatment. Further work by the 
same group later coupled this decrease with a build up of IP!, the substrate for IMPase 
[13]. More recently, post-mortem clinical investigations have also revealed a decrease 
in the inositol levels in the fontal cortex of bipolar patients [14]. Treatment of 
Dictyostelium with lithium, or VPA, leads to a reduced cellular concentration of 
I(1,4,5)P3. This is taken as an indication of the reduction of intracellular inositol 
phosphate based signaling [15]. Investigations into dorsal root ganglion (DRG) 
neuronal growth cone movement have shown that the retardation of growth seen with 
lithium and VPA treatment can be rescued with the administration of myo-inositol to 
the DRGs [16].
However, there is some inconclusive evidence that is not in concurrence with 
what we would expect if the inositol depletion hypothesis were true. It has been 
observed that not only myo-inositol (the biologically active isomer) but also epi- 
inositol can inhibit observed lithium pillocarbine induced seizures in rats [17]. Also 
knocking out both impal and impa2, encoding IMPase, in yeast does not lead to a 
depletion of inositol levels, as would be have been expected [18], arguing against an 
inhibition of IMPase leading to inositol depletion.
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13 Dictyostelium as a model organism
Dictyostelium discoideum, commonly known as a social amoeba, is a soil 
dwelling eukaryote native to North America, discovered in the 1930’s by Kenneth 
Raper [19]. In 2000 Dictyostelium was included in an NIH list of 10 non-mammalian 
model organisms cementing its place in current biomedical research. The organism is 
well placed for this role, being more complex than some lower organisms such as the 
two yeast species, yet being simpler and more genetically malleable than higher 
organisms such as round worm and fruit fly.
Dictyostelium can be subjected to high levels of genetic manipulation and 
coupled with the recent sequencing of the genome has produced an incredibly 
versatile tool for studying cellular processes in a modem research environment. The 
genome consists of 6 chromosomes plus an extra chromosomal palindromic element 
comprised of ribosomal RNA. The highly AT rich genome is known to encode 
~12,500 genes with a total size of 34Mb [20]. Dictyostelium occurs along a branch 
towards the base of metazoan evolution and when compared to yeast, shares a greater 
number of genes homologous to higher organisms, making them a very good genetic 
model. The haploid genome of this organism provides an ability to easily manipulate 
the genetic material producing knock out and epitope tagging knock-in cell lines by 
homologous recombination and ectopic over-expresser strains by transformation with 
extra-chromosomal plasmids among other current biochemical techniques.
The organism displays a number of unique characteristics that make it suitable 
for the study of a number of biological processes. When there is an ample supply of 
bacterial food, or supplemented media, in their environment these free-living 
organisms grow and feed as individuals and divide by binary fission. However, when 
the food supply is diminished a change occurs. The cells begin aggregating, by a
18
process of chemotaxis. Chemotaxis is the movement of the organism towards a 
chemical attractant. They then undergo a strict regime of differentiation and 
development. This produces a multi-cellular organism, of about 105 cells, going 
through several developmental stages (outlined in Fig. 1.2). The final structure 
consists of a single spore laden head, a stalk and a basal disc anchoring it to the 
substratum. This fruiting body will then stay in this form until conditions become 
favorable again, whereupon the spore cells will germinate to form new amoebae. This 
switch between uni- and multi-cellular organism reflects many of the characteristics 
observed during differentiation and development in higher organisms. This provides a 
unique opportunity to study development and cellular differentiation in a genetically 
simpler system. This is extremely relevant to this thesis as ATP dependent chromatin 
remodeling has been suggested to have evolved to accommodate the changes inherent 
in a switch from uni- to multi-cellularity [21].
Complex cellular processes described in higher metazoans have also been 
observed in Dictyostelium. These include cell movement, chemotaxis, phagocytosis, 
pattern formation and signal transduction pathways, which all play roles in 
Dictyostelium development [22, 23]. In fact Dictyostelium has proven to be the most 
widely investigated model organism for cellular chemotaxis, providing many insights 
into other systems such as neutrophils and leukocytes. Particularly relevant to this 
project Dictyostelium cells are shown to be responsive to lithium in a chemotactically 
detrimental manner [1]. Treatment of cells with therapeutic levels of lithium greatly 
reduces the directionality and speed of Dictyostelium migration and also affects the 
chemotactic index to a lesser degree (lithium treatment also reduces the ability of the 
cells to form full fruiting bodies with increasing concentrations) [24].
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Due to the organisms haploid genome, the production of mutants is relatively 
less difficult than with some other model organisms. There are several methods for 
producing mutants, one of which is restiriction enzyme-mediated integration (REMI). 
This is a powerful tool for producing a large mutant library which can then be 
screened to identify genes involved in specific biological processes. Originally 
developed in yeast this process was first utilized in Dictyostelium to identify 
developmental^ regulated genes [103]. Mutants are produced by first creating 
insertion sites in the genome by digestion with the restriction enzyme DpnII. 
Following this wild-type cells are transformed by electroporation with a plasmid 
containing complimentary (BamHl) sites and an insertional antibiotic resistance 
cassette, allowing for selection of mutants. Once the library is created by growing 
transformants in the presence of the selective antibiotic, the mutants found to contain 
an insert are then screened for a particular biological trait. The affected genes can 
subsequently be identified by IPCR. Sequences flanking the resistance cassette are 
identified by plasmid rescue and then subsequently used to search the genome 
database [104]. Subsequent replication of each mutant is usually created by 
homolgous recombination.
This process of creating gene deletion mutants by homologous recombination 
was used to produce both the arp8 null mutant and the final cell line used in this 
study: the chdC null. As the Dictyostelium genome is haploid homologous 
recombination is an extremely effective method for producing gene deletions. This 
technique was developed and first utilized by De Lozanne & Spudich in 1987 [105] to 
investigate the role of myosin in cell motility and during development. The process 
once again utilizes the insertion of an antibiotic resistance cassette into the genome. A 
linearized plasmid is created containing the resistance cassette, flanked by two
20
homologous regions to the gene of interest. This is then transformed to the 
background strain, in both of these cases AX2, and selected for by growth in the 
presence of the appropriate antibiotic.
The easy accessibility of the cells genetic, biochemical and cell biology 
coupled with high levels of genetic manipulation, robust system of development and 
chemotaxis, easy cell culture and control in the laboratory make Dictyostelium a 
particularly good model organism for studying the affects of ATP dependent 
chromatin remodeling factors on cellular development.
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Fig. 1.2 The developmental life cycle of Dictyostelium discoideum 
Electron microscope images, originally produced by MGrimson and Blanton, 
copyright M J . Grimson and R.L. Blanton, Biological Sciences Electron Microscopy 
Laboratory, Texas Tech University. The morphological stages are all clearly 
demonstrated in this image. The process of starvation induced cellular differentiation 
and development can be seen through early aggregation to form the loose mound and 
following aggregate structures resulting in first the slug and finally the fully 
culminated fruiting body.
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1.4 An introduction to cell movement by chemotaxis.
Eukaryotic chemotaxis is the process by which a cell migrates towards a 
chemoattractant source along a diffusible chemical gradient. It is seen to be essential 
in both lower and higher organisms for such basic cellular processes as finding 
nutrients, cell division, embryogenesis, wound healing and the break down of 
pathogens by neutrophils. Accurate detection of these gradients and the resulting 
cellular migratory response requires several key aspects of current cell biology. These 
include internal and external signal detection and transduction, functions of cell 
motility, cell polarity and substrate adhesion. This biological process usually follows 
a similar molecular pathway in most organisms, beginning with the binding of an 
external signaling molecule to a cell surface receptor. This is followed by the internal 
transduction of the signal via a complex set of multiple signaling pathways, resulting, 
in the re-organisation of the cell cytoskeleton components and the formation of new 
pseudopods through the generation of a gradient of cellular components.
In Dictyostelium, there are two chemoattractants that have been widely 
studied; the movement in vegetative cells towards a folate source secreted by bacteria 
in vegetative cells and the chemotaxis towards cAMP as a response to a lack of 
nutrients within the cells’ environment. In the absence of a chemical stimulus, the 
cells produce pseudopods randomly over their surface and move about the 
environment in a meandering fashion, searching for a chemical attractant to follow. 
Upon encountering a chemical signal the cells have to determine the direction of the 
source and are remarkably well adapted to this in that they are able to sense 
differences in chemo-attractant concentration of as little as 2% across the length of the 
cell [25]. This process requires a highly fine tuned system of detection of external 
signaling and localization of internal cellular response.
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One of the early key pieces of work in the field of Dictyostelium chemotaxis 
indicated PIP3 as a major signaling molecule. It was observed that PIP3-specific 
pleckstrin homology (PH) domain of the cytosolic regulator of adenylyl cyclase 
(CRAC) protein localized to the membrane in response to a directed extracellular 
cAMP stimulus [25]. This set up a whole series of further research describing a 
Dictyostelium theoretical “biological compass” which was required to direct the cells 
towards the cAMP source. These experiments supported PIP3 as the major signaling 
molecule in chemotaxis, with PI3-kinase synthesizing PIP3 at the leading edge and 
PTEN converting it back to PIP2 at the rear of the cell [26]. Cells also have a rapid 
ability to re-orientate the localization of PIP3, in response to cAMP, coinciding with a 
change in cellular orientation. PIP3 has recently been shown to be the major signaling 
target for the affects of lithium on chemotaxis in Dictyostelium [1]. However, recent 
experimental evidence has started to dispute this theory. A study where all five of the 
Dictyostelium PI-3 kinases were genetically disrupted simultaneously showed that 
although these mutants did not show any PIP3 localisation, they still retained the 
ability to chemotax towards a cAMP gradient with only marginal difference to wild- 
type [27]. This suggests that PIP3 is not the sole signaling mechanism responsible for 
the chemotactic response. Chemo-attractant gradients are usually set-up using one of 
two standard methods, these being a microinjector or a zigmond chamber (fully 
described in materials and methods chapter) [28].
It is now apparent that there are several key signaling pathways involved in 
mediating chemotaxis and that each may come into play during different stages of the 
process. Phospho-lipase A2 (PLA2) has been implicated in a study where the gene 
encoding PLA2 was either knocked out or chemically inhibited in the PI3-kinase 
mutants. These cells show a greater level of disruption to chemotaxis, but yet were not
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fully inhibited [29]. Further experiments on these pathways have investigated the 
steepness of the gradient on cells lacking the PI-3 kinase and PLA2 pathways coupled 
with a number of inhibitory drugs. The resulting data has suggested that either 
pathway can give rise to normal chemotaxis in a steep gradient, however when the 
gradient is shallow loss of either pathway results in a reduction of chemotactic ability 
[30]. Further research that has suggested that cells respond differently to differing 
gradients has shown that the PIP3 localisation to the leading edge is only seen with 
steeper gradients and additionally is distributed in a more even pattern around the cell 
membrane in shallower gradients [31,32].
Another pathway implicated in the control of gradient sensing in 
Dictyostelium and linked to PIP3 signaling, is the target of rapamycin complex 2 
(TORC2), via an interaction with PI3K. Individual genetic disruption of several key 
subunits of this complex leads to chemotactic defects in Dictyostelium. This complex 
is activated upon stimulation of the cell by cAMP whereupon it induces the 
phosphorylation of two PKB isoforms; PKBA and PKBR1 (PKBG). PKBA is 
normally found in the cytosol, but upon stimulation translocates to the membrane and 
is phosphorylated in a PI3K dependent manner, whereas PKBR1 is always found at 
the membrane [33].
Further research by van Haastert and co-workers has suggested that there are 
in fact four individual signaling pathways involved in mediating chemotaxis in 
Dictyostelium [34]. They suggest that the PIP3 and PLA2 pathways are involved in 
early chemotaxis, up to 5 hours after starvation, with these pathways becoming 
redundant towards 7 hours. They go on to show the involvement of cGMP in 
chemotaxis as cGMP null cells can no longer chemotax at 7H in the presence of both 
PI3-kinase and PLA2 pharmacological inhibitors. It is worth noting that these cells
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can chemotax if only one or the other inhibitor is administered suggesting that the 
PI3-kinase and PLA2 pathways can still mediate chemotaxis at this point but are not 
essential. The fourth pathway mentioned was initially identified by Roelofs and van 
Haastert [35] with the deletion of two genes encoding soluble guanylyl cyclases 
(sGCs) GCA gca and sgc. Knocking out these genes once again significantly affects 
chemotaxis in the presence of both PI3-kinase and PLA2 inhibitors, 7 hours into 
starvation.
All the evidence suggests that there are several different signaling mechanisms 
involved in Dictyostelium chemotaxis and that they each become involved at different 
points during starvation in accordance with increasing extracellular concentrations of 
cAMP that occur as the cells aggregate into a tighter mound structure (Fig. 1.2)
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Fig. 13 Internal and external signaling relating to cAMP synthesis and 
chemotaxis
The productions of rhythmical cAMP pulses is produced via a complex intra- and 
extra-cellular signaling relay. The process is triggered by an external cAMP stimulus 
which in turn triggers the production of intra-cellular cAMP through ACA 
stimulation. This occurs through the activation of Ras proteins which in turn activate 
PI3K resulting in an increase in PIP3 levels at the membrane. PIP3 recruits the PH- 
domain containing proteins; CRAC and PKBA which activate ACA. A second 
function of stimulation id to activate the TOR pathway which will lead to the further 
activation of ACA and the SCAR/WAVE complex, involved in cell movement 
through actin dynamics.
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1.5 cAMP signaling in Dictyostelium
The aggregation and subsequent differentiation and development of 
Dictyostelium had been noticed for some time before the chemo-attractant that 
controlled this process was identified. This chemical was identified to be cAMP in 
1967 following an investigation by Konijin et al [36]. Following this a successive 
number of papers described the role of cAMP in bninding cell surface receptors, its 
effect on cellular differentiation and the positive feedback increasing its own 
synthesis in the stimulated cell, reviewed in [37].
Under starvation conditions Dictyostelium form spontaneous signaling centers 
that start to synthesise and secrete cAMP. Neighboring cells sense this signal and start 
to chemotax towards the source whilst themselves synthesising and secreting their 
own cAMP relay signal to be passed back through the population. This sets up a 
pattern of coherent travel in response to periodic waves of cAMP release. These 
waves of chemical transmitter release can take the form of the Belousov-Zhabotiniski 
(BZ) reaction in the shape of spiraling waves traveling through the population [38]. 
Alternatively they may take the form of concentric circles emanating from the 
signaling center. The periodicity of these pulses of cAMP is ~6mins during the 
initiation of development and chemotaxis but decreases as the cells approach the 
mound stage to provide a more continuous stimulus required for cell sorting.
The signal is detected by a series of cAMP receptors. These are all members 
of a family of 7-transmembrane domain receptors coupled to heterotrimeric G- 
proteins. Termed CAR 1-4 each has a varying affinity for cAMP corresponding to its 
distinct temporal and spatial expression pattern during the development process [39, 
40, 41, 42]. CAR1 has the highest affinity, followed by CAR3 and finally CAR2 and 
CAR4 having the lowest affinity. These decreasing affinities reflect the increasing
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external concentration of cAMP during development. A study on the receptors ability 
to rescue mutations in the early receptors CAR1 and CAR3 discovered that all of the 
receptors can mediate the aggregation response in place of CAR1 suggesting a similar 
regulatory and activation mechanism for all [43]. CAR1 is also transcriptionally 
responsive to differing concentrations of cAMP by being under the control of two 
promoters. The first has a higher affinity for cAMP and is expressed earlyier during 
aggregation. The second has a lower affinity for the chemo attractant and is expressed 
later in development in response to higher external cAMP [44]. CAR2 has been 
implicated in the correct patterning of cells during mound stage differentiation. 
Expression is found exclusively in the prestalk A cells and removal of this receptor 
results in the arrest of development at the mound stage [40].
Adenylyl cyclase A (ACA) is the enzyme responsible for the production of the 
majority of the Dictyostelium cells cAMP. It is a 12 transmembrane domain protein 
with two cyclase domains sharing homology with the mammalian ACA [45]. 
Expression of the gene encoding ACA, acaA, is high during the early stages of 
development. The activation of ACA quickly follows stimulation of the cells CAR1 
receptor with extracellular cAMP and is rapidly saturated and adapts to a constant 
stimulus. Activation occurs through the dissociation of the (3y dimer from the 
heterotrimeric G-protein G2 which then binds and activates PI3-kinase which 
catalyses the phosphorylation of PIP2 to PIP3. PIP3 then recruits CRAC through the 
previously mentioned affinity for the PH domain. Cells lacking the PI3-kinases are 
deficient for signal relay and synthesis of cAMP [46]. Once at the membrane CRAC 
interacts with ACA, although the exact mechanism for this interaction is currently 
unclear. CRAC was the first gene to be discovered that was related to cAMP
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production. A genetic screen identified a mutant, synag7 that could not synthesise 
cAMP and could only aggregate when mixed with wild-type cells [47].
There are two further adenylyl cyclases in Dictyostelium: ACB and ACG. 
Both follow differing expression patterns to ACA, with ACB transcription increasing 
after 4H of starvation and remaining constant till culmination, whereas ACG 
expression is limited to fully developed fruiting bodies and is involved in germination 
[48]. ACB is thought to be involved in terminal differentiation as ACB nulls show 
normal development to the slug stage, following which they fail to produce normal 
fruiting bodies, showing unstable spore heads and elongated stalks [49]. ACG null 
cells are able to develop to produce normal fruiting bodies but display abnormalities 
in germination, with cells germinating spontaneously even under unfavorable 
conditions of high osmolarity [50].
The mechanisms for the cyclical hydrolysis of cAMP are equally important in 
such a dynamic signaling system as exists to regulate Dictyostelium chemotaxis and 
this role falls to the phosphodiesterases. There are 5 phosphodiesterases identified in 
Dictyostelium: PdsA hydrolyses both cAMP and cGMP, whereas Pde3 and PdeD are 
cGMP specific, RegA is cAMP specific and PdeE hydrolyses cAMP at a six-fold 
higher rate than cGMP [51]. The principal phosphodiesterase to be involved in early 
development and chemotaxis is PdsA, being expressed early in starving cells and 
found in both secreted and extracellular membrane bound forms. PdsA activity is 
regulated by a similarly secreted inhibitor; PDI which binds only the soluble form, 
reducing the KM for cAMP [52]. When extracellular levels of cAMP are high PdsA 
expression is enhanced, whereas when levels are low expression of PDI is promoted. 
The expression of PdsA is also highly regulated with the gene being controlled by 
three promoters, each becoming active during different stages of development, one
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being active during growth, the second for aggregation and the third during 
multicellular development [53].
A body of work, by Cox et al [54] investigating the action of these 
phosphodiesterases has suggested that they play a key role in setting up the pattern of 
cAMP release throughout the population. Their hypothesis suggests that cells start 
signaling weakly with the cAMP emanating from a signaling center in a concentric 
circle. These patterns of release do not allow for a refractory period between pulses 
and need the cells at the aggregation center to keep emitting the pulses to maintain the 
signaling. However, if the pulses of cAMP meet other pulses spreading throughout the 
population they become disrupted and start to produce spiral waves. This disruption 
allows time for the action of the phosphodiesterases to reduce cAMP levels and allow 
the cells to recover and become responsive to cAMP once again. This enables the 
cells to maintain a pattern of release and stimulation without the need for pacemaker 
cells at the center of the aggregation territory.
The cell density factor (CMF) is also involved in regulating cAMP signaling 
in Dictyostelium development through activating transcription of the slow dissociating 
form of the CAR1 receptor and by promoting the loss of ligand binding. Cells lacking 
CMF have been shown to be unable activate the CAR1 receptors even in high cAMP 
concentrations suggesting that binding of CMF will not itself elicit a response but it 
will allow for cAMP binding and induction of the second messenger responses 
leading to chemotaxis and development [55]
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1.6 Previous work on this project.
Melanie Keim-Reder, a previous student of the Harwood lab, carried out a 
restriction enzyme mediated mutagenesis (REMI) screen looking for lithium 
insensitive mutants and identified several candidates for analysis. REMI involves the 
random insertion of an antibiotic resistance cassette throughout the genome and then 
screening for mutants which are selective for specific criteria (a full description of this 
technique is covered in materials & methods section 2.3). In this case the mutants 
were screened for lithium resistance. Two of those discovered in this screen were 
termed LisA and LisG. Both of these mutants showed an ability to aggregate in the 
presence of lOmM lithium. Initial findings showed that LisA increased inol gene 
expression in a similar way to that of a prolyl oligopeptidase (PO) inhibitor, which 
was dependent on the absence of the LisG mutation [Melanie-Keim Reder PhD 
Thesis]. Inverse PCR on LisG showed that the mutant possessed a 182bp fragment 
cloned into the LisG gene. It was found in the intron between the first and second of 
four open reading frames. Whilst being resistant to lithium affects on aggregation, 
RT-PCR data has shown that the original LisG mutant still expressed the LisG gene 
[56]. Preliminary analysis of LisG’s sequence revealed a conserved split Snf2 ATPase 
domain and two downstream chromodomains suggesting that LisG could be an ATP 
dependent chromatin remodeling factor. The presence of the chromodomains 
identified LisG as being most likely to be part of the CHD family of chromatin re­
modelers. A literature search for other possible chromatin remodeling factors that may 
be involved in regulating Dictyostelium development and play a role in inositol 
biosynthesis identified the INO80 complex. This complex is another ATP dependent 
chromatin re-modeler and has a role in yeast as a modulator of inol, also being under 
regulation by higher order inositol phosphates [57].
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1.7 The basics of chromatin structure: How is DNA packaged inside the nucleus?
The most important question when addressing the issue of chromatin 
dynamics is how the cell manages to pack 2 meters of genetic material into a nucleus 
that is only micrometers in diameter. The most basic unit of this process is the 
formation of the nucleosome. DNA in eukaryotic cells is packaged into a compact 
chromatin fiber formed of regularly spaced repeating units known as nucleosomes and 
results in the DNA being compacted about sevenfold. Each nucleosome consists of 
DNA, bound to a histone complex, forming the nucleosome. Each histone complex 
consists of four different histone molecules, H2A, H2B, H3 and H4, arranged into two 
dimers of H2B-H2B and a stable H3-H4 tetramer. There are also a large number of 
histone variants that confer a range of different properties to the nucleosome and build 
specific chromatin structures [58]. The DNA is wrapped around the histone molecule 
in 1.65 super-helical turns consisting of 147 base pairs reviewed by Luger and Hansen 
[59]. However, this level of folding is still too low to accommodate the full length of 
the DNA within the nucleus. The chromatin structure is then subject to much higher 
levels of folding resulting in undefined highly compact structures.
The packaging of DNA into chromatin provides a definite barrier to the 
processes of transcription, replication, repair and recombination in cells. A highly 
specified and regulated system is required to allow these processes to proceed with 
correct gene expression at the right time.
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1.8 Accessing the DNA: An introduction to chromatin re-modeling.
The next question that arises within the scope of chromatin dynamics is how 
can this tightly packaged chromatin be accessed during key cellular operations such as 
transcription, replication or repair? The answer to this question is inherent to the 
answer to the previous question of how is chromatin packaged within the cell. When 
the DNA is held within nucleosomes and compact higher order structures, only a very 
small fraction of it is available for transcription. This is the standard structure during 
times of cell division, however, when the cell is required to execute various processes 
such as growth, DNA replication, DNA repair or recombination the correct spatial and 
temporal exposure of genes is required and this occurs through direct re-modeling of 
the chromatin.
The question of how chromatin is remodeled is answered by three processes 
that work in parallel to restructure the basic nucleosomal subunits of chromatin. 
Working together these form a dynamic system that allow the packaging and un­
packaging of the DNA elements that allow transcription. The three processes are 
DNA methylation, covalent modification of the histones or replacement with a histone 
variant and the direct remodeling of the nucleosome spacing by ATP dependent 
chromatin re-modelers.
DNA methylation is linked to several aspects of chromatin dynamics and 
epigenetics, having been seen to be involved in genetic silencing, chromatin 
organization and differentiation. The process involves the methylation of cytosine 
residues in the context of CG dinucleotides and has been typically observed in 
mammals during embryogenesis where methylation patterns are maintained 
unchanged in somatic cells [60]. It was initially thought that Dictyostelium did not 
possess a DNA methyltransferase; however, recent studies have identified a candidate
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and a number of genes possessing methylated cytosines. A drop in these levels of 
methylation have been identified in strains lacking the suggested Dictyostelium DNA 
methyltransferase and a number of developmental defects are observed [61].
The histones themselves are capable of being post-translationally covalently 
modified directly on several positions of their histone tails. This establishes correct 
nucleosomal spacing and confers epigenetically maintained developmental 
phenotypes. There are 3 types of post-translational modification (PTM) that can affect 
the histones. These are intrinsic, which affect the nucleosome directly, extrinsic, 
which affect the chromatin structure and effector-mediated, relating to changes 
brought about by interaction between PTMs and non-PTM chromatin effecting 
elements [58]. One function of effector mediated covalent modifications is the 
recruitment of ATP dependent chromatin re-modelers through a specific binding 
domain. These include PHD and CHROMO domains that are targeted to specific 
methylated lysine residues and BROMO domains that recognize acetylated histone 
tails. In Dictyostelium the inhibition of a histone deacetylase (HDAC) results in 
histone hyperacteylation and a delay in development with affected expression of a 
number of cAMP dependent genes [62]. It is apparent that histone modifications 
result in altered biological outputs yet their exact affect on cellular processes has yet 
to be fully appreciated.
The final group of chromatin modifying enzymes are the ATP dependent 
chromatin re-modelers. This group was initially discovered in yeast with the 
SWI/SNF complex which was initially classed as both a regulator of mating type 
switching (SWI) or for growth on no sucrose containing media (SNF, sucrose non- 
fermenter) [63]. There are now four recognized classes of ATP dependent re-modelers 
which are all characterized by a highly conserved ATPase domain that utilises energy
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derived from ATP hydrolysis to alter the histone DNA interactions in a multitude of 
ways. These core members of the family exist in a large number of different 
complexes in most eukaryotic organisms resulting in a great range of specificity for 
various targets. This allows organisms to regulate a large number of cellular processes 
from this core family of ATPases conferring both environment and developmental 
stage specific gene expression [64].
It is seen that not only does chromatin provide a method of compacting DNA 
into the nucleus but it also provides a highly regulated system for controlling gene 
expression through a varied series of remodeling processes.
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Fig 1.4 Methods of action of chromatin remodelling factors.
A.) DNA methyltransferases methylate cysteines on nucleosomal DNA providing a 
form of transcriptional repression. Removing this methylations allows for 
nucloesomal remodeling and transcription. B.) Modification of histone tails are yet 
another key element in regulating transcription. Here a Histone acetyl transferase 
(HAT) is shown to acetylate the histone tail, whereas a histone deacetyltransferase 
(HDAC) is seen to remove it. C.) ATP dependent chromatin remdelling factors use 
energy derived from ATP to reposition nucleosomes allowing the access of 
transcription factors and transcriptional activation or repression.
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1.9 There are four classes of chromatin re-modelers
SWI/SNF family: As mentioned above this group were first identified in yeast 
and became the most studied subfamily of ATP dependent chromatin re-modelers. 
The SWI/SNF subunit itself is characterized by its ATPase domain and an adjacent 
Bromo domain (Fig. 1.5). There appear to be 2 distinct variations on the complexes 
formed around this core subunit, the main SWI/SNF complex and the RSC complex, 
both being present in yeast, Drosophila, and humans, reviewed by Wang [65]. 
Currently there has been no research into Dictyostelium SWI/SNF re-modelers. 
However, investigation of the sequence at the online Dictyostelium resource; 
dictybase fwww .dictvbase .org). reveals that a SWI/SNF is indeed present in the 
genome.
ISWI family: The imitation SWI (ISWI) family was first identified by several 
in vitro re-modeling experiments in Drosophila. These investigations identified a 
single ISWI as the core subunit of three re-modeling complexes: NURF, ACF and 
CHRAC. Subsequent analysis has identified a second ISWI, ISW2 in other model 
organisms. The ISWI protein is characterized by the ATPase domain alongside SANT 
and SLIDE domains which have been shown to be DNA and nucleosome binding 
domains also found in many other chromatin binding proteins. The ISWIs are also 
characterized by a lack of any domains that recognize a direct covalent histone 
modification such as methylation or acetylation. The ISWI complex works by sliding 
nucleosomes along the strand of DNA allowing an ordered spacing between the 
nucleosomes, or restructuring the nucleosome pattern. ISWI also appears to have a 
function in establishing higher order chromatin structures being required to correctly 
incorporate the linker histone protein HI, reviewed by Corona and Tamkun [66]. At
present there has been no published research into the role of ISWI in Dictyostelium, 
although, there is an ISWI identified in the genome.
CHD family: Members of the Chromodomain helicase DNA binding protein 
subfamily are characterized by the SWI/SNF like ATPase domain and also by the 
presence of two N-terminal CHROMO domains. This is a large family consisting of 9 
members, divided into 3 sub-groups: CHD 1-2 in the first both containing a C-terminal 
DNA binding domain, CHD3-4 in the second both containing paired PHD zinc finger 
domains and CHD6-9 in the final group are defined by a paired BRK (Brahma and 
Kismet) domain, reviewed by Marfella and Imbalzano [67]. The first CHD protein to 
be identified in Dictyostelium was the LisG mutant; DDB_G0293012, mentioned in 
Chapter 1.4. Further sequence analysis has identified two other CHD family proteins 
in the genome, one falling into the CHD 1-2 subfamily; DDB_G0284171 and the other 
also falling within the CHD6-9 group; DDB_G0280705. The Dictyostelium genome 
does not contain any members of the CHD3-4 subfamily.
INO80 family: The INO80 subfamily consists of two very large multi-subunit 
complexes involved in transcriptional activation and repair, the INO80 complex and 
the SWR1 complex, with Dictyostelium only possessing the INO80 complex. Both the 
INO80 and SWR1 subunits are characterized by a split ATPase domain and their 
binding to two Ruv-B like proteins termed Rvbl and Rvb2. INO80 complexes have 
been identified and characterized in yeast, fruit fly, and human, reviewed by Bao and 
Shen [68].
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Fig. 15 There are 4 classes of ATP dependent chromatin remodelling factors.
A.)The domains conserved across the SWI/SNF family are the N-terminal HSA 
domain which binds ARPs and the C-terminal BROMO domain, recognising 
acetylated lysines on histone tails. B.) The ISWI family is classified by its HAND- 
SANT-SLIDE domain which is found in the c-terminus. SANT binds unmodified 
histone tails, whereas SLIDE binds nucleosomal DNA. C.) The INO80 complex is 
characterised by a split ATPase domain and a HSA and PTH domain, both binding 
other complex proteins described later. D.) The CHD family is distinguished by the 
CHROMO domains which target methylated lysines, typically marking areas of 
activated chromatin. E.) Alignment of the ATPase domain from several factors in 
several organisms.
NB: Untitled 1 = Dicty CHDC
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1.10 The INO80 complex and Actin related proteins
Ino80 was first identified in the yeast Saccaromyces cerevisiae, in a study into 
structural genes of phospholipids biosynthesis, particularly those regulated by a UAS 
element termed ICRE (inositol/choline responsive element). The ino80- mutant was 
identified in a screen for mutants defective in ICRE dependent gene activation [69] 
with mutants failing to grow in inositol free media. It was proposed that this INO80 
ATPase may play a role in chromatin re-modeling in a manner similar to that of the 
SWI2/SNF2 ATPase. This function was first shown again in yeast with the 
purification and characterization of the complex and a series of in vitro biochemical 
studies to describe the DNA dependent ATPase activity and 3’ to 5’ helicase activity 
of Ino80 [70]. Since the initial discovery INO80 has been shown to be the core 
ATPase of a large multi-subunit complex involved in chromatin remodeling present in 
human [71], yeast [69], fly [72] and now also in Dictyostelium.
Co-immuno-precipitation of the INO80 protein revealed the other subunits 
involved in the remodeling of chromatin [70] (outlined in Fig. 1.6). Two of the most 
conserved subunits found across all species are the actin related proteins Arp5 and 
Arp8. Bioinformatic analysis reveals that these proteins are also present and highly 
conserved in the Dictyostelid family [73].
Conventional Actin and the actin related proteins are members of a large, 
evolutionarily ancient and highly conserved family of proteins. The family is 
characterized by a common tertiary structure centered around an actin fold which 
contains a nucleotide binding pocket known to bind ATP. The actin related proteins 
were originally classified along their similarity to conventional actin and were termed 
Arpl through to Arpl 1 with Arpl being the most similar [74]. Arps 1-3 and 10-11 are 
all cytoplasmic and are involved in structural roles in the cytoskeleton, with the
Arp2/3 complex playing a role in cytoskeleton restructuring through interactions with 
the SCAR/WAVE complex in Dictyostelium [75]. The remainder of the Arps, are 
involved with various chromatin remodeling complexes, being found to interact with 
SWI/SNF, INO80 and SWR1 but not with ISWI or CHD complexes. Interaction with 
these complexes has been shown to occur through a specific helicase-SANT (HAS) 
domain [76]. Arps 1-6, 8 and 10 have all been identified in the Dictyostelium and 
other members of the Dictyostelid family’s genomes [73].
It is currently not fully understood whether the Arps are providing regulation 
of the catalytic activity of the ATP dependent chromatin re-modelers or if they are 
involved in maintaining the structure of the complexes, evidence exists for both cases. 
Arp5 and Arp8 are the two actin related proteins that were identified as members of 
the INO80 complex in yeast immuno precipitation experiments [70]. Arp5 and Arp8 
have been shown to have a requirement in preserving the integrity of the INO80 
complex with deletion strains having severe affects on complex assembly. Null strains 
of Arp5 and Arp8 both phenocopy the deletion of the INO80 subunit in yeast and both 
show similar changes in pho5 gene expression to an INO80 deletion [77].
The Rvb AAA+ ATPases, Rvbl and Rvb2, are another highly conserved group 
of proteins that are found consistently to be part of both the INO80 and SWR1 
complex in all organisms investigated [78]. They have both been shown to be directly 
related to the bacterial RuvB ATPase which is involved in the resolution of holliday 
junctions that occur during homologous recombination [79]. Both are shown to be 
essential for complex function in yeast as null strains appear to lose binding of Arp5, 
which has been shown to exist in a separate regulatory complex with both Rvbs [78].
The most well documented effects of the yeast INO80 complex on 
transcription have been on the inol and pho5 promotors. PH05 encodes a
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phosphatase required for the uptake of extracellular phosphates when the internal 
pools have become exhausted. Under normal conditions four nucleosomes are found 
to sit across the pho5 promotor blocking transcription. However when cells are grown 
in phosphate free media a transcription factor, Pho4p, binds a part of the promotor and 
recruits INO80 and SWI/SNF which both act to re-position the nucleosomes allowing 
access to the promoter for the cells transcriptional machinery, reviewed by Conway 
[79]. Re-modeling of the yeast inol promotor occurs in a similar way involving the 
recruitment of both INO80 and SWI/SNF. Recent ChIP studies have indicated that a 
transcription factor, Ino2p/Ino4p, binds the upstream cw-acting promoter element 
UASino which is inhibited in repressing conditions by the regulatory Opilp. Upon 
stimulation, due to a decrease in cellular inositol, Opilp dissociates from the 
Ino2p/Ino4p complex stimulating the activation of INO80 and SWI/SNF at the inol 
promotor resulting in the movement of nucleosomes to allow transcription [80].
This complex has also been shown to be involved in both activation and 
repression of genes involved in several signaling pathways beyond inositol phosphate 
signaling. Microarray data investigating the role of INO80 complex from Arabidopsis 
thaliana and yeast has indicated transcriptional regulation of up to 20% of all genes 
[79]. There has also been strong evidence to link the action of the INO80 complex 
with the repair of double strand breaks (DSBs) through histone H2A phosphorylation. 
This action of histone phosphorylation by ATM/ATR-like checkpoint kinases is one 
of the first actions that correlates with the repair response to DSBs [81]. Yeast strains 
lacking either INO80, ARP5 or ARP8 are all hypersensitive to DNA damaging agents 
and have been shown to recruit to sites of DSBs by ChIP [82].
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Fig. 1.6 The INO80 complex
A.) A diagram of the binding of INO80 to its subunits as determined in 
Saccharomyces cerevisiae adapted from a review by Conaway and Conaway [79].
1.11 The CHD family of chromatin re-modelers
The CHROMO domain was first identified in the epigenetic repressors 
Polycomb (Pc) and Heterochromatin protein 1 (HP1) of Drosophilla [83] and 
subsequently the first CHD protein was characterized in mice during a search for 
regulators of immunoglobin regulators [84]. Following on from this initial 
characterization; 9 CHD proteins have been identified across a large number of 
eukaryotic organisms, including protists, plants, insects and mammals. They have 
been shown to be involved in many processes through interaction with a large number 
of binding partners providing either transcriptional activation or repression. All 
members of the CHD family are extremely high molecular weight, ranging from 
~220kDa up to 300kDa all sharing large amounts of sequence homology.
In those early experiments the chromodomain was shown to be an ~35 amino 
acid sequence that has subsequently been expanded to encompass ~60 amino acids 
and been indicated to be highly conserved amongst family members. In recent 
structural studies, the highly conserved region has been reduced further to a conserved 
core of ~21 amino acids termed the chromobox [85]. The double chromodomain 
structure has been shown to have a specific binding recognition for a direct covalent 
tri-methylation of the lysine at position 4 of histone H3 [86] (H3K4me) a recognized 
hallmark of transcriptionally active chromatin in eukaryotes. This binding can result 
in both the formation of heterochromatin and the regulation of developmentally 
regulated homeotic genes. In the case of the CHD proteins, unlike Pc and HP1, the 
chromodomains interact to bind the modified histone tail. The functional significance 
of the DNA binding domain of the CHD proteins has yet to be elucidated, however it 
is currently understood that the mouse chromodomain preferentially binds the minor 
groove of DNA in vitro with a long A-T rich sequence preference [87].
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Of the three CHD proteins we have identified in Dictyostelium, two fall in the 
third class and share the highest sequence similarity to CHD7 and CHD8. The most 
commonly studied member of the CHD7 subfamily is the Drosophilla gene kismet, 
which has been identified to be involved in the maintenance of spatially restricted 
patterns of homeotic gene expression in the developing larvae [88]. This group is 
characterized by its BRK domains found at the N-terminus, a 41 amino acid structure 
that has also been observed to be associated with other transcription and chromatin 
associated proteins [88], yet the exact function of these domains is currently 
unknown.
There is also still very little information on the binding partners of this final 
subfamily of CHD proteins. CHD6 has been suggested to associate with RNApolII 
and has been seen to co-localise to sites of transcription in human cells [89]. Neither 
CHD7, or the Drosophilla isoform kismet have been shown to have any binding 
partners at present. In mice, CHD8 has been identified as binding the chromatin 
insulator protein CTCF [90] which has been implicated in the definition of distinctly 
regulated regions of neighboring chromatin and acting as a boundary to block the 
affect of nearby enhancers.
It was not until recently that the CHD proteins were implicated in any 
developmental processes. However the whole spectrum of ATP-dependent re­
modelers have now been characterized as playing a role in the development of higher 
organisms [91]. Specifically CHD7 has been shown to be involved in the 
development of several organs in human systems, including the gut [92], lip and 
palate [93] and also plays a role in human developmental disease. CHD7 has been 
implicated in the human CHARGE syndrome [94]. This disease is associated with 
multiple congenital abnormalities including; coloboma, heart malformation, choanal
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atresia, retardation of growth and development often specifically ear and genital 
abnormalities [95]. CHD8 has also been implicated recently as a possible molecular 
cause in another human multi abnormality disorder associated with developmental 
defects and cognitive impairment [96]. Along with implications in disease models 
CHD8 has been highlighted in regulating many diverse roles within the cell, including 
the regulation of androgen responsive transcription [97], efficient RNApol III 
transcription [98] and the suppression of p53 mediated apoptosis during early 
embryogenesis [99].
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Fig. 1.7 The CHD family
A.) Schematic diagram indicating the key domains that distinguish each of the three 
subfamilies of CHD proteins. B.) Alignment of the CHROMO box domain of the 
CHD subfamilies in Dictyostelium, Human and Yeast. Alignments were performed 
using the clustlw algorithm in the MACvector software.
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1.12 Regulation and specificity of chromatin re-modelers
To accurately regulate chromatin dynamics, in a temporally specific way, so 
as to provide the right changes in chromatin structure during the correct 
developmental stages, some form of regulation of the complexes themselves must 
occur. In chapter 1.8 the regulation of the binding and activation of INO80 and 
SWI/SNF at the inol and pho5 promotors by transcription factors has already been 
described, but what other mechanisms have been discovered? There are several other 
possible modes of regulation for these complexes. These include post-translational 
modification of the ATPase subunit itself, or one of the other subunits that form these 
large complexes, by histone modification or histone variants (mentioned in chapter 
1.6) or by interaction with a secondary messenger signaling molecules [100].
It is the final one of these processes that seems to be the most interesting in 
terms of the inositol phosphate signaling pathway and this project. Recent 
investigations into the roles of inositol phosphates as regulatory secondary 
messengers have suggested an involvement of higher IPs that may modulate the 
activation and inhibition of the INO80 complex [57]. Using an in vitro assay to assess 
the movement of reconstituted mono-nucleosomes along a strand of DNA containing 
the inol promotor they showed that IP4 and IP5 positively regulate SWI/SNF mediated 
transcription from the inol promotor whereas IP6 negatively regulates the INO80 
complex to inhibit transcription. In a similar manner recent evidence has suggested a 
role for IP7 in the negative regulation of a series of transcription factors and kinases 
involved in recruiting INO80 and SWI/SNF to the pho5 promotor [101].
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1.13 Summary and aims of project.
The developmental roles of ATP-dependent chromatin remodeling factors are 
beginning to become clear in several model organisms and it is becoming apparent 
that they are responsible for the correct expression and patterning of gene expression 
in many cell types. Failure to regulate these complexes correctly is likely to result in 
aberrant gene expression and the incorrect development and differentiation of cell 
types.
The aims of this project were to use current and up to date molecular 
biological techniques to characterize the effects of genetically ablating the genes chdc 
and arp8 in the model organism Dictyostelium discoideum. The study will focus 
particularly on starvation induced development and the chemotactic process by which 
cells aggregate in the early stages. The study will also look at the role of lithium on 
these complexes and in these processes to try to further elucidate the mechanism of 
action of this important treatment in the control of bipolar disorder.
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Chapter 2: 
Materials and methods
2.1 Bioinformatics
Identification of Dictyostelium homologue of Arp8 and identification of 
CHDC (previously LisG) was performed using the Dictybase website 
(www.Dictybase.org) [102]. The actin related proteins had previously been identified 
in Dictyostelium and the sequences were readily available on Dictybase.
CHDC had previously been identified in the thesis of Melanie Keim-Reder 
and the sequence was available to me. Further analysis utilizing the whole protein 
sequences identified a further 2 CHD family proteins in the Dictyostelium genome 
which we have termed CHDA and CHDB. Further analysis identified highly 
conserved CHROMO domains in all family members which showed significant 
homology to CHROMO domains in other species. Dictybase reference codes are 
given for all Dictyostelium genes. Alignments were constructed using the Clustal 
algorithm as part of the MacVector 7.2 software suite (Accelerys).
22  Dictyostelium cell culture
Dictyostelium cells were grown axenically in HL-5 medium (14 g/L proteose 
peptone, 7 g/L yeast extract, 13.5 g/L glucose, 0.5 g/L Na2HP04, 0.5 g/L KH2P04,pH 
6.4.) for normal culture and all antibiotic selections. Cells were also grown and 
allowed to develop on SM agar plates (10 g/L proteose peptone, 1 g/L yeast extract, 
10 g/L glucose, 1.9 g/L KH2P04, 1.3 g/L K2HP04.3H20 , 0.49 g/L MgS04, 17 g/L 
agar) on a lawn of Klebsiella aerogenes by standard methods. The arp8 null and 
LisG-REMI and CHDC null strains were all grown in the presence of 10p,g m l1 
Blasticidin. Cell lines transformed with the ecmA-gal, ecmB-gal and pspA-gal were 
grown in the presence of 40 ng ml'1 Geneticin (G418). In all cases, except where
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otherwise stated, the AX2 strain was used as wild-type and is the parent of all 
mutants. When required, cells were pelleted by centrifugation at 700g for 2 minutes.
Cells were washed in KK2 buffer (16.5 mM KH2P04, 3.8 mM K2HP04 pH 
6.2) before all starvation experiments. Then 2xl07 cells were collected and 
resuspended in 1ml KK2 before being applied to a black whatman nitrocellulose filter 
placed on top of 2 whatman filter pads soaked in KK2. The cells were left for 5 mins 
for the excess to filter through and this was then aspirated off and the cells left in a 
humid environment to develop. After the desired development time, the cells were 
washed off the filter, pelleted and the pellets frozen for future use.
2.3 Cell lines used in these studies
Several cell lines were used in the investigations into the roles of the two ATP 
dependent chromatin re-modelers. Three different lines were used in the experiments 
relating to the 1NO80 complex. These were the arp8 null line, the Arp8-GFP line and 
the IMPase-GFP {arp8 null) line. The first two cell lines were produced in the 
laboratory of Annette Muller-Taubenberger at Ludwig-Maximilian Universitat in 
Munich. The null cell was produced by homologous recombination (process 
described in Chapter 1.3) whereas the tagged cell line was produced by transforming 
wild-type AX2 cells with an extrachromosomal plasmid expressing the arp8 gene 
with a GFP tag at the C-terminus. The final cell line used in relation to the first part of 
the project was produced by transforming an IMPase-GFP expressing plasmid into the 
arp8 null cell line by electroporation (procedure described in Chapter 2.7). The 
plasmid was produced by Dr. Jason King and expresses the impAl gene with an N- 
terminus GFP tag. The plasmid is fully described in King et al, 2010 [24].
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A further two cell lines were used in the research into the CHDC re-modeler. 
These were the REMI mutant LisG (lithium sensitive mutant G) and the null cell line 
chdc null. The LisG mutant was produced by Dr Melanie Keim-Reder during her PhD 
and was made by restriction enzyme-mediated integration (REMI), which is fully 
described in Chapter 1.3. The mutant was identified in a screen for lithium sensitive 
mutants and more detail on its production is found in Chapter 5. The final mutant 
strain chdC null was produced by a technician in the Harwood lab; David Proctor who 
used homolgous recombination to knock out regions coding key domains in the chdC 
gene. More detail on this mutant is also found in Chapter 5.
2.4 RNA extraction and cDNA synthesis
Following development, total RNA was extracted using a GE kit. RNA quality 
was then checked by running ljxl on a 1% formaldehyde/agarose/ethidium bromide 
gel. Any samples lacking two clear ribosomal bands or any sign of genomic 
contamination were discarded. RNA was then quantified by measuring absorbance at 
260 and 280nm using a nanodrop spectrophotometer. Reverse transcription was done 
using lp,g total RNA using Qiagen’s Quantitect reverse transcription kit as per the 
manufacturers instructions. In all cases random primers were used. Once the reaction 
was complete all samples were diluted 1:10 to a final volume of 200/d. For all 
samples a no RT reaction was also performed and analyzed using a set of primers for 
PKBA1 to check for genomic contamination.
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2.5 RT-PCR analysis of expression
To check for expression of each gene, cDNA was analysed by RT-PCR. For 
each gene the following primer pairs were used to generate a 200-300bp specific 
product for each gene:
Ig7 Fw = TCC AAGAGGAAGAGGAGAACT GC 
Ig7 Rv = CGCT ACCTT AGG ACCGTC AT AGTT AC 
impkl Fw = GCAGGTTCAACACCATTCAAAAAATC 
impkl Rv = TCCAACACTATCCATTCCTTACCATC 
impk2 Fw = TGGTAGTTTTTTGAGTGTCAGCCC 
impk2 Rv = TGATGATGTTGTTGTTGTTGTTGTAGTG 
arp8 Fw = CCTTCTGAAGCAGTTGGCACTACCACA 
arp8 Rv =ATGGTTGTGGCACATAGGGTGGTGGA 
acaA Fw = CATTCTAGAGGCGGTATTGGC 
acaA Rv = GGAGAAAATGTCTGATTTCGCTT 
car A Fw = CCAGCCAATGAAACATCATTG 
car A Rv = AGGGAAACCACCATTGACAG 
pdsA Fw = CCATTGGGTACAACTGGTGGA 
pdsA Rv = AACTGCCCATGATGGATAGGT 
inol Fw = GACACCGTCGTCGTTATGTGGT 
inol Rv = GCAATCATATCATCGACAACATTTG 
impal Fw = GATCAAGAGGAACCAATTAAGGTTTC 
impal Rv = CCTTTTGAGTAATCTAATTGTTGTTT 
ecmB Fw = GCCAACGTTGAAAAAGCTGAA 
ecmB Rv = AC AGTTT ACT GGGGTGTG AG A 
ecmA Fw = GTACAATCACCAACAGTACCG
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ecmA Rv = GAGACCACCAATTAAACCAGAG 
cotB Fw = GATTGCGATGGTTTATCAAAAGATC 
cotB Rv = AGCAAGACAATCGTTACTATCTCT 
pspA Fw = ACATTGGCCAATCAAAATCCAGT 
pspA Rv = TTGGTGCGGGTGTGGCAG 
chdC Fw = AGTACTACTGCATCAACGACAACAAAG 
chdC Rv = TGGTGGTCTTTTTGATGTTGCTAT
PCR conditions used were 34 cycles of 95° x 30s, 56.5° x 30s and 68° x 15s. 
The reaction mix contained iQ SYBR green supermix (Bio-Rad), lOOnM of each 
primer and 5/d cDNA was used as template in all reactions. Data was collected using 
an Opticon 2 instrument (MJ Research). Each reaction was then subjected to melting 
curve analysis, to verify product quality. All samples were run in triplicate, and in at 
least 2 independent experiments. Expression analysis was carried out using the 
Biogazelle qbase software [106, 107]. This piece of software utilizes a modified 
version of the original delta-deltal Ct method [108] to allow for multiple reference 
genes and therefore a more accurate normalization and calculation of calibrated data. 
The reference genes used in all cases were rnlA (Ig7), ipmkA and ipmkB (DDB 
0203614 and DDB 0218526) which have all been shown previously to have 
unchanging expression during development.
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2.6 Extraction of genomic DNA
For use as a control PCR template. 107 cells were pelleted and washed once in 
KK2 before being dissolved in 1ml DNAzol reagent (Invitrogen). Cell debris was 
then removed by centrifugation at 15,000 x g, and DNA precipitated from the 
supernatant by the addition of 0.5 ml 100% ethanol. This was left for 5 minutes at 
room temperature before centrifugation at 15,000 x g for 5 minutes. The DNA pellet 
was then washed once in 70% ethanol and finally dissolved in 100pl 8mM NaOH. 
The pH was then adjusted to 7.0 using 3.2pl 1M HEPES buffer.
2.7 Dictyostelium transformation
Cells were transformed by electroporation as previously described [109]. 
Briefly, 107 cells, growing in log-phase were washed once in ice-cold electroporation 
buffer (50 mM sucrose in KK2) before being resuspended in a final volume of 800pl 
in an electroporation cuvette. For integrating plasmids, 20pg and for episomal 
plasmids lOpg DNA was then added and incubated on ice for 10 minutes. Cells were 
then electroporated at lkV before a further 10 minute incubation on ice. The cells 
were then transferred into a 10cm petri dish and 8pl of salt solution (0.1 M MgCl2, 0.1 
M CaCl2) added. After 20 more minutes the cells were then finally resuspended in 10 
ml HL-5 medium.
After 24 hours, transformations of knockout vectors were cloned into 6 x 96 
well plates in the presence of 10 |xg/ml blasticidin S. After approximately 2 weeks, 
multiple clones were seen and transferred into individual wells of a 24 well plate for 
screening. Transformations with episomal expression vectors were simply expanded 
in 10cm dishes and selection started 24 hours post-transformation with 20 pg/ml 
G418. Due to the extrachromosomal nature of these vectors, all clones should have
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the same copy number and have no positional affects. Therefore, sub cloning is 
unnecessary and all colonies produced were pooled. This technique was used to 
transform the IMPase-GFP over expressing plasmid into the arp8 null cells.
2.8 Western blotting
For western blotting, cells were lysed in Laemelli buffer (50 mM Tris-HCL 
pH 6.8,100 mM dithiothreitol, 2% SDS, 0.1% bromophenol blue, 10% glycerol) and 
boiled for 5 minutes to denature proteins before running on either a 10% 
polyacrylamide gel or a 12-3% Tris-Acetate gel for larger proteins. The protein from 
2 x 105 cells was loaded per lane. Western blotting was then carried out using standard 
methods, and probed with either a rabbit a-Arp5 antibody (Gift from A Mueller 
Taubenberger) or a a-CHDC antibody (developed by Open Biosystems) both used at 
1:1,000 dilution. This was followed by a secondary horse-radish peroxidase (HRP)- 
conjugated a-rabbit antibody (Sigma), used at 1:10,000 dilution. In all cases Pierce 
ECL reagent was used as HRP substrate.
2.9 Analysis of cell movement (Chemotaxis assay)
For analysis of random cell movement, 24 hours prior to analysis, cells were 
seeded at 3 x 105 /ml in FM minimal medium. On the day of the experiment, the cells 
were re-suspended and 40 pi transferred to a glass-bottomed chamber slide (Lab-Tek) 
containing 2 ml medium. Cells were then left for 30 minutes to attach and recover 
before the medium was aspirated and replaced with KK2 containing either sodium or 
lithium chloride. They were then left for 1 hour before analysis.
For chemotaxis assays, growing cells were washed once and resuspended at 5 
x 106 cells /ml in KK2. Cells were then shaken for 5 hours and subjected to 100 nM
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cAMP pulses at 6 minute intervals. LiCl treatment was included for the final hour 
only. After 5 hours a small number of cells was then allowed to adhere to a glass slide 
before being exposed to a cAMP gradient using a Zigmond chamber [110] .The 
chamber was set up with lpM cAMP (in KK2) on one site and KK2 on the other and 
left for 15 minutes before analysis.
In all experiments DIC images were taken using an Olympus 1X71 inverted 
microscope with a 20x objective (NA 0.45). As our microscope is equipped with a 
motorized stage, 8 fields of view were taken simultaneously for each sample. Images 
were captured every 10 seconds for 10 minutes. DIAS 3.4.1 software (Soli 
Technologies Inc.) was then used to analysis the images. In this analysis, for each 
frame of the movie each cell was automatically outlined and cell paths determined. At 
this stage any cell that contacts another was disregarded. The average speed, 
persistence, acceleration, direction change, roundness and chemotactic index over the 
10 minute period was calculated for each cell and in every case a minimum of 50 cells 
were measured and averaged. All experiments were repeated at least 4 times and, 
normalized to a NaCl control value as indicated. In all cases statistical analysis was 
done using an unpaired 2-tailed T-test.
2.10 Immunofluorescence
For immunofluorescence imaging, cells were seeded onto poly-L-lysine 
coated coverslips, and allowed to adhere for 30 minutes. Coverslips were then washed 
twice in PBS and fixed in 3% paraformaldehyde (in PBS) for 20 minutes. They were 
then washed three times more and permeabilised by two incubations of 15 minutes in 
1% gelatin/ 0.2% saponin. Cells were then stained with lpg/ml 4’,6-Diamidino-2- 
phenylindole dihydrochloride (DAPI). Coverslips were then washed and mounted on
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slides using Vectorshield mounting medium (Vector Labs). Images were then taken 
using a 40x oil immersion objective on a Leica TCS SP2 confocal microscope.
2.11 Dictyostelium development assay
Cells were cultured to 80% confluency before being washed in KK2 and 
resuspended in fresh KK2 at a density of 106 cells/ml. 6-well plates were prepared 
containing 1ml non-nutirent KK2 agar in each well. 1ml of cells was seeded into each 
well and allowed to adhere for 30 minutes before excess liquid was aspirated off. 
Timelapse images of cells were taken every 5 minutes, under brightfield conditions 
using Olympus 1X71 inverted microscope with a 4x objective and the simplepci 
image capture software. The availability of an automatic stage made it possible to take 
multiple fields of view and as such 9 images, creating a 3 by 3 grid, were taken for 
each sample. Images were processed using ImageJ to create a ‘montage movie’ 
consisting of all 9 fields of view.
2.12 Dictyostelium cAMP pulse assay.
Cells were cultured to 80% confluency before being washed in KK2 and re­
suspended in fresh KK2 at a density of 106 cells/ml. 6-well plates were prepared 
containing 1ml of non-nutrient KK2 agar in each well. 5ml of cells was seeded into 
each well and allowed to adhere for 30 minutes before excess liquid was aspirated off. 
Timelapse images of cells were taken every 30 seconds, under dark-field conditions 
using an Olympus 1X71 inverted microscope with a 4x objective and the simplepci 
image capture software. The availability of an automatic stage made it possible to take 
multiple fields of view and as such 9 images, creating a 3 by 3 grid, were taken for 
each sample. Images were processed using ImageJ to create a ‘montage movie’
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consisting of all 9 fields of view. Following the creation of the montage the movies 
are subject to several rounds of processing to better visulalise the cAMP pulses. The 
most important feature of this processing is the image subtraction whereby for each 
frame in the movie it is subtracted from the successive frame. This produces a movie 
whereby the subtle movement in shape that the cells exhibit between frames is more 
pronounced and visible as the characteristic waves. To highlight these waves the 
movies are further subjected to rounds of Gaussian blurring to further visually 
enhance the movement of the waves.
The biology behind this technique is that as the cells move in response to the 
cAMP pulses they change morphology to a more streamlined structure through 
reorganization of the actin cytoskeleton. It is this change in shape between responsive, 
moving and refractive that is observable using this technique. The change in structure 
results in a change in the light reflection pattern visible, depending on the state of the 
cell.
2.13 Dictyostelium affinity purification.
Arp8-GFP cells (a gift from A Mueller Taubenberger) were harvested and 
washed in KK2 before being resuspended in fresh KK2 and allowed to develop on 
black nitrocellulose filters for 8 Hours, as described in section 2.2, to achieve 
maximum expression of Arp5. Cells were washed off the filters, pelleted, re­
suspended in 5ml 1% Paraformaldahyde (in water) and incubated for 10 minutes. 
Cross-linking was quenched by the addition of glycine (to a final concentration of 
1.25mM) and a further incubation of 5 minutes. Samples were then pelleted and 
washed twice in KK2 before being lysed in 1ml lysis buffer (150mM NaCl, 50mM 
Tris, 0.1% NP-40 and 10% glycerol supplemented with a Roche complete inhibitor
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tablet). Samples were incubated on ice for 20 minutes, centrifuged at 16,000rpm and 
passed through a 0.2pM filter. 50pl of a GFP-Trap coupled to agarose beads 
(Chromotek) were added to each supernatant, these were incubated at 4°C for 1 hour. 
Beads were pelleted at 500g and washed 3 times with wash buffer (150mM NaCl, 
50mM Tris, 10% glycerol supplemented with a Roche complete inhibitor tablet) 
before being resuspended in 50pl NuPage buffer. Samples were boiled at 95° for 5 
minutes (reversing the cross-linking) and loaded onto a 4-12% Bis-Tris (Invitrogen), 
which was then subject to analysis by western blot using the aArp5 antibody.
2.14 RNA-seq and data analysis.
Recent developments in next generation, or deep, sequencing technologies 
have allowed for a more complete view of an organisms transcriptome. Studies 
utililising these techniques have increasingly changed the views of researchers as to 
the complexity of the eukaryotic transcriptome by allowing a far more detailed 
measurement of transcripts than previous techniques such as microarrays and previous 
sequencing technologies.
The technique works by harvesting poly(A)+ RNA from the cell population 
and converting this to a cDNA library. Specific adaptors are ligated to the ends of this 
cDNA library and then a short sequence read of 30bp is obtained from the sequences 
using next generation sequencing technology. This technique can be applied to a 
number of systems including Roche 454 and ABI SOLID systems however the 
Illumina platform was opted for in this study. The Illumina machine system consists 
of a flow cell with an optically clear surface to which the adaptor ligated 
DNAfragments are attached. The fragments are then extended and amplified by 
bridge PCR resulting in a high density surface with many millions of copies of the
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template. These template copies are the sequenced using a four colour sequencing by 
synthesis system producing many millions of sequence reads in the ouput (process 
outlined in Fig 2.1A). Advantages over previous transcriptomic analysis include; not 
being limited to identifying sequences corresoponding to exisiting genomic sequences 
and also a greater reduction in the background signal produced as there is no 
hybridization efficiency or cross-hybridization to take into account and no saturation 
of signal. All of which are problems with microarray technologies.
For the experiments RNA was isolated using the technique outlined in section 
2.3. 1 pig was taken and applied to the Illumina RNA-seq sample preparation kit 
(Illumina). The protocol was followed as supplied and the samples were checked 
using an Agilent Bioanalyzer for RNA integrity. An RNA integrity number of 8 was 
taken as the minimum accepted value. Once the cDNA libraries were prepared the 
samples were run on an Illumina genome analyzer II system. The resulting data was 
run through the Illumina pipeline following sequencing to remove any reads resulting 
from annealed adaptors or adaptor primers and then output in the Fastq file format for 
analysis.
One of the problems that has been associated with the RNA-seq technique is 
data analysis and in particular how to go about analyzing such large amounts of data 
in a meaningful and significant way. The objectives and ideas on the table are similar 
to those of microarray analysis, however the particulars are incredibly different. The 
first step required is the mapping of the reads to a reference genome and then from 
there upwards the data takes on increasingly more complex patterns with increasingly 
abstract layers of information. To analyze these data a piece of software from 
DNAstar called Arraystar fhttp://www.dnastar.com/t-products-arravstar.aspx) was
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used. This piece of software has algorithms both for analyzing microarray and RNA- 
seq data with the possibility of comparing the two sets of data if needs be.
Before analysis with Arraystar quality control of the data was performed using 
an algorithm found on the online resource for next-gen sequencing; Galaxy 
fhttp://usegalaxv.org). This website provides a number of online tools for the 
manipulation and validation of sequencing data and has particularly good resources 
for assessing the quality of sequencing reads.
Once the quality control has been performed the data is now input to the 
Arraystar software. Each run file is imported individually along with the reference 
genome for your organism, in this case the Dictyostelium discoideum AX4 genome 
downloaded from the NCBI website. Consultion was held with the group responsible 
for sequencing and annotating both the AX2 and AX4 sequences for Dictyostelium 
discoideum as concern was raised that our wild-type strains used were the AX2 yet 
this reference was not yet available for download. The suggestions were to allow for a 
number of mismatches when performing the alignments as the differences between 
the two strains are mainly scattered single base changes and this should allow for 
these (personnal communication from Gareth Bloomfield, garethb@mrc- 
lmb.cam.ac.uk).
After the data is imported into Arraystar the reads need to be aligned to the 
reference genome using the qseq algorithm. There are a number of alignment options 
that allow the tailoring of the analysis to the quality of the data etc. For my analysis 
the minimum mer length was set to 27 as this was just below my read length and my 
reads were of a sufficient quality to not need trimming. For mismatches a minimum of 
90% matches was set to allow for approx 3 mismatched bases in the reads, this would 
hopefully compensate for using the AX4 reference genome over AX2. Reads that
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occurred more than 100 times and also reads that mapped to more than 25 places were 
occluded to reduce the read counts identified in any regions of high homology arising 
from conserved domains found in paralogous gene families and repeat regions as well 
as placing an upward cap on the read counts of extremely highly expressed genes. 
Once the sequences are mapped to the genome a lower limit of read counts was 
determined by looking at the read counts of several genes all known to have no 
expression in wild-type during vegetative growth. The average read count for all 
genes looked at in this group was 6 so this was taken to be the number of reads 
associated with an untranscribed gene and therefore would be our baseline for all 
future analysis, with all genes with a read count below 6 being occluded.
Initial representation of the data is through another DNAstar product; 
GenVision (http://www.dnastar.com/t-products-genvision.aspx) which allows the 
visual representation of the reads against the reference sequence. Whilst showing the 
coverage of the genome this representation does not yield much meaningful data. To 
really get an idea of what is going on in these systems the data needs to be compared 
between cell types and time points. Arraystar allows the fold change comparison 
between 2 data sets and also allows you to put several constraints on this comparison 
such as minimum number of reads (taken here to be our baseline of 6) and a minimum 
fold change in gene expression. Once this has been performed the genes that fit the 
criteria, exhibiting a suitable fold change in expression, are exported to a separate 
table for Gene onotology (GO) analysis.
Gene ontology relates to a defined set of terms that describe gene product 
characteristics and annotations in an attempt to standardize the way in which genes, 
products and attributes are referred to across all species. A large number of organisms 
have had their genomes annotated in relation to the terms defined by the gene
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ontology consortium (http://www.geneontologv.orgA and this includes Dictyostelium. 
The GO annotations are imported to Arraystar and the genes exported in the fold- 
change comparison are subject to GO analysis where they are grouped depending on 
their annotations. The groupings are scored on their significance by a p-value which is 
defined as the probability that the number of genes occurring in the grouping has 
occurred by chance. Therefore a low p-value is a more significant grouping. The data 
is also scored by a z-value that represents the number of standard deviations away 
from the expected number of genes the actual value is. Using these tools it is easy to 
see which biological processes contain the largest number of genes showing a fold 
change above the threshold dictated earlier in the process. It is also possible to pick 
out individual processes and identify which genes show a difference between the two 
samples or time points. It is therefore possible, using this analysis pipeline, to identify 
the changes in gene expression in specific biological processes in which you are 
interested between 2 samples using data sets collected based on total RNA levels 
within a cell type or at a specific time point. Data representation from this point on is 
then up to the user.
66
Fig. 2.1A The initial steps of Illumina sequencing.
i.) Preparing the sample, unique adaptor sequences are ligated to the ends of the 
fragmented DNA. ii.) Attaching the DNA fragments randomly to the flow cell 
surface, iii.) Initiate bridge amplification of sequences, iv.) Double stranded DNA 
bridges are formed enzymatically, v.) The Double stranded DNA is denatured to leave 
two single stranded templates on the flow cell surface. vi.)Amplification produces 
several million clusters of template in the flow cell.
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Fig. 2.IB The final steps of Illumina sequencing.
i.) Initiation of the first sequencing cycle; 4 labelled reversible terminators are added 
alongside primers and polymerase, ii.) Laser excitation and capture of emitted signal 
identifies the first base in the sequence, iii.) The first step is repeated iv.) The second 
step is repeated, identifying the second base in the sequence, v.) The process is 
repeated until the full sequence is identified, vi.) Reads are aligned to a reference 
genome and the sequences are identified.
68
2.15 Chromatm Immuno-precipitation (ChIP)
ChIP utilizes a specific antibody and fixation techniques to immuno- 
precipitate proteins/complexes bound to DNA and subsequently identify the regions 
of DNA to which the protein/complex of interested is bound.
lxlO8 Cells were allowed to develop on multiple black nitrocellulose filters as 
described in 2.2 and harvested every 4 hours by washing off using a micro pipette. 
Cells were pooled and then washed twice in KK2 and then fixed by the addition of 
10ml 1% paraformladehyde for 10 mins. The fixing reaction was quenched with the 
addition of 2M Glycine to a final concentration of 1.25M. The pellets were washed 
twice with KK2 and then snap frozen on dry ice and stored at -80C.
ChIP was performed using the MAGnify ChIP kit (Invitrogen) following the 
manufacturers instructions. Particulars variations include; sonications were carried out 
on a Soniprep 150 sonicator, with an amplitude of 20 microns, in a 1ml volume. 6 x 
10s pulses on ice were required to shear down to ~1000bp chromatin fragments and 
15 10s pulses to shear down to ~300-400bp fragments. 10//1 was kept to assay the 
shearing of the sample by reversing cross linking over night at 65°C and run on a 1% 
agarose gel, plus checked for concentration by nanodrop. 10//1 of unsheared DNA was 
also kept before sonication for the input sample. Positive control IP was performed 
using a ChIP verified RNApolII antibody (Invitrogen), whilst a beads alone IP was 
performed along with an IP the null background as negative controls.
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Analysis of ChIP DNA was performed using RT-PCR for the inol promotor. 
Primers used were:
inol Fw = GACACCGTCGTCGTTATGTGGT 
inol Rv = GCAATCATATCATCGACAACATTTG 
PCR conditions used were 40 cycles of 95° x 30s, 56.5° x 30s and 68° x 15s. 
The reaction mix contained iQ SYBR green supermix (Bio-Rad), lOOnM of each 
primer and 5/d ChlP’ed DNA was used as template in all reactions. Data was 
collected using an Opticon 2 instrument (MJ Research). Each reaction was then 
subjected to melting curve analysis, to verify product quality. Products were also run 
on a 1% agarose gel for a final analysis.
2.16 Picogreen assay
The quantities of DNA purified by the ChIP reaction are often too small to be 
measured reliably using a spectrophotometer and so a picogreen assay was utilized. 
The kit used was the Quant-iT DS DNA assay (Invitrogen) all reactions were 
performed as per the manufacturers instructions. Standards used were 0/d, 0.5/d, 1/d, 
2/d, 3/d, and 4/d then each sample was run in triplicate. Reads were made on a 
Fluostar Optima fluorimeter and all read data exported to excel. Standard curves were 
made and the concentration of unknowns calculated from these.
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2.17 ChlP-seq and data analysis
The results from the RNA-seq show the genome wide changes in transcription 
between two samples. However, there is no way of knowing if, in the case of my 
research, the effects are directly due to knocking out the chromatin re-modeler or if 
they are a secondary affect caused by another transcriptional change that was initially 
due to the removal of the re-modeler. ChlP-sequencing (ChlP-seq) provides a method 
of identifying the specific DNA binding sites of these complexes utilizing DNA 
precipitated by the ChIP method described in 2.15. This gives the ability to identify 
changes in promoter binding between developmental time points, when combined 
with RNA-seq data this should provide a comprehensive view of the roles of these 
complexes during development.
The ChlP’ed DNA needs to be sonicated down to approximately 300-400bp 
before IP, then once the DNA is eluted it is ligated to adaptors in a similar process to 
that used to create the cDNA libraries for the RNA-seq experiments (Fig 2.1A). 
Samples were prepared for use on the Illumina genome analyzer using the Illumina 
ChlP-seq adaptor ligation kit (Illumina). All reactions were carried out with lOng 
ChIP purified DNA starting material and following the manufacturers instructions. 
Once prepared, the samples were checked using an Agilent Bioanalyzer for fragment 
size and DNA purity. Following quality control the samples were run on an Illumina 
genome analyzer II system. As with the RNA-seq experiment, the resulting data was 
run through the Illumina pipeline following sequencing to remove any reads resulting 
from annealed adaptors or adaptor primers and then output in the Fastq file format for 
analysis.
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Data analysis is once again very similar to RNA-seq analysis in the initial 
stages. Once the reads have been mapped a two sided analysis needs to be performed 
to account for the background that is inherent in ChlP-seq data. A control sample is 
needed for this and is usually a no antibody IP or, as in this case, performing the IP on 
the null cell line. This analysis was performed using the analysis software CLC 
genomics workbench, provided by CLCbio.
72
Chapter 3:
Arp8 and the INO80 complex are involved in 
regulating genes involved with starvation induced 
development in Dictyostelium discoideum.
Summary: Starvation induced development in Dictyostelium discoideum relies on the 
cells ability to accurately detect and relay the cAMP signal throughout the population. 
This involves detecting the abundance of nutrients in the environment, the size of the 
population and the correct temporal expression of the cAMP producing, detecting and 
regulatory machinery. Here the mutation in the actin related protein Arp8 is seen to 
have an affect on the correct timing of development. This is seen to occur through an 
affect on the expression of specific genes involved in the production and propagation 
of the cAMP signal. Next generation sequencing data provides further evidence to 
suggest that the null cells are delayed in their ability to enter development through the 
mis-regulation of several genes involved in initiating this process.
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3.1 Arp8 expression
To investigate the role of the INO80 complex in Dictyostelium discoideum we 
targeted the subunit Arp8. Arp8 had previously been shown to be a key member of the 
complex in yeast and knocking out this protein phenocopied the knock out of the 
INO80 ATPase subunit [73].
Arp8, being a member of the chromatin binding complex INO80 should be 
expected to localize to the nucleus. To test for this localization, a strain of AX2 was 
produced expressing a GFP tagged Arp8 (a gift from the laboratory of Annette 
Mueller Taubenberger, situated in the Institute for cell biology, Faculty of medicine, 
Ludwig-Maximilian universitat in Munich) and fluorescence microscopy was used to 
image the GFP fluorescence. The GFP tag is situated at the C-terminus of the Arp8 
protein. This was coupled with DAPI staining of the nucleus and the two are shown to 
co-localize in the cell (Fig. 3.1B-C). This indicates that, just as expected the Arp8 
protein expression is situated mainly, but not exclusively, in the nucleus of the cell.
Developmental timing is a key aspect of the starvation process in 
Dictyostelium. If the INO80 complex were to be involved in regulating this process it 
is possible that the expression of the complex components themselves could be 
developmentally regulated, including arp8. This idea was assessed using qRT-PCR on 
cells isolated every 4 hours following the initiation of starvation. Fig. 3.1 A shows that 
the expression of arp8 increases gradually during the first 12 hours of development, 
decreasing again for the final 12 hours. These data are in agreement with RNA-seq 
data published online at the dictyexpress website (www.ailab.si/dictyexpress). This 
expression pattern seen here suggests a role for arp8 in modulation of genes involved 
in early development and aggregation leading us to primarily investigate these stages.
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Fig. 3.1 Arp8 expression patters.
A.) Expression of arp8 in wild-type cells is seen to increase over the first 12 hours of 
development, decreasing for the latter 12 hours. Total mRNA was analysed by RT- 
PCR and normalised to Ig7, IPMK1 and IPMK2. B.) Arp8-GFP expression is seen to 
co-localise with C.) nuclear staining with DAPI. Images were taken at 40X 
magnification.
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3.2 Arp8 null mutants show a delay in the onset of development
To further investigate the role of arp8 in Dictyostelium discoideum we also 
received an arp8 null cell line, a further gift from the laboratory of Annette Mueller 
Taubenberger, situated in the Institute for cell biology, Faculty of medicine, Ludwig- 
Maximilian universitat in Munich. The deletion was created by inserting a blasticidin 
resistance cassette, by homologous recombination, into the coding region for the arp8 
gene. This resistance was then used to screen for clones that contained the deletion, 
which were then subsequently screened by PCR.
When starved of nutrients, wild-type Dictyostelium undergo a process of 
development, culminating in a multi-cellular organism capable of surviving periods of 
low nutrients. During this process a number of distinct morphological states are 
observed and occur under a common timing (Fig. 3.2A). Using brightfield time-lapse 
microscopy these stages become clearly visible. Any defects in the timing of 
development, or the structure of the fruiting bodies produced becomes apparent. After 
around 8 hours the cells can be observed to have aggregated to form a loose mound of 
around 105 cells. Continuing on from this stage, from between 10 and 12 hours the 
cells have started to push up away from the surface forming what is colloquially 
known as the “mexican hat” structure. Over the next four hours this “mexican hat” 
has toppled over and a slug like structure is formed, capable of phototaxing towards a 
light source. As 20 hours after starvation approaches the slug ceases its movement, 
draws in its tail and starts to rise once again from the surface finally culminating in a 
head of living spores supported by a stalk of dead cells after approximately 22-24 
hours. The data presented in Fig. 3.2A indicate that the control wild-type cells follow 
this specific developmental pattern.
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The arp8 null mutants exhibit a distinct delay in this developmental process 
that ranges from around 5 hours onwards. Not all cells enter development at the same 
time, some taking as long as 15-20 hours to initiate. These data describe cells showing 
a 5-6 hour delay in starting aggregation. Each morphological structure following this, 
loose mound, slug and full culminant, all show a similarly timed delay in formation. 
This suggests that the process does not accommodate and catch up once it has started 
and that the delay is persistent. It is notable that there is also a greatly reduced, 
number and size of, aggregation territories for the arp8 null mutant and a large 
number of cells are left outside this area. However, these cells then start to rearrange 
and organize themselves into later rounds of aggregation and development. This 
possibly leads to the varied delay in the development of the cells. When at full 
culmination the fruiting bodies show little morphological difference to wild-type with 
the major observation being a slightly decreased size of spore head. It is worth noting 
that whilst there is a significant phenotype in developing arp8 mutants, there was no 
observed phenotype during vegetative growth.
The fact that the developmental delay is not uniform across the population 
suggests that the delay is not due to a fixed factor missing from the cells as this would 
be likely to produce a universally timed delay. One likely suggestion is the lack, or 
low abundance, of an external signaling molecule that needs to build up to a 
significant threshold before being responsible for initiating the development process. 
There are a number of likely candidates including cAMP and the conditioned 
mediating factor (CMF) which is responsible for sensing cell density [55] and 
involved in the initiation of cAMP signaling. Our second possible hypothesis is that 
the signal recognition machinery may be defective and the cells simply cannot tell 
that the signal is there until a threshold has been reached.
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Fig. 3.2 Arp8 null cells have a delayed development phenotype
Development of cells on non nutrient agar. A.) Over the course of 24H the wild-type 
cells aggregate and differentiate to form multi-cellular fruiting bodies seen in the final 
image. B.) arp8 null cells take a minimum of 5H longer to initiate aggregation, having 
fewer and smaller aggregation territories. Once it has begun development follows a 
normal timeline and with no noticeable other phenotype. Both experiments were 
repeated at least three times.
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33  arp8 null cells exhibit a defect in cAMP signalling
Dictyostelium aggregation is brought about via rhythmic cAMP pulses, which 
spread throughout the population, emanating from spontaneously formed aggregation 
centers. These occur with an initial period of approximately 6 minutes, in a series of 
spiraling waves that spread throughout the population. These waves decrease in 
period, but increase in intensity as development progresses resulting in a faster pattern 
of release. Using darkfield time-lapse microscopy cellular response to these waves of 
cAMP can be visualized and any changes in signaling can be recorded.
Wild-type cells exhibit the characteristic pattern of spiral waves of cAMP 
moving throughout the population (Fig.3.3A). These initiate after around 4 hours, 
coincidentally with the onset of aggregation. They originate at the aggregation center, 
with the waves propagating outwards from this point. The pulses maintain throughout 
aggregation, being directed down the streams of cells moving towards the mound. 
arp8 null mutant cells exhibit no cAMP signaling until approximately 10 hours after 
starvation (Fig. 3.3B). This is consistent with the late development phenotype of this 
mutant and indicates that the delay in initiation of aggregation may in fact be due to 
an inability to properly initiate the cAMP signal. This could be due to a lack of cAMP 
synthesis, secretion or detection, or could be due to a lack of another signaling 
molecule. When the cells eventually start to signal, the waves take the form of 
concentric circles as opposed to spirals, a condition that has previously been attributed 
to a lack of PDI an inhibitor of the secreted phosphodiesterase [54]. Cells lacking PDI 
can only produce concentric circle patterns as an increase in the inhibition of PDEs 
will increase cAMP levels and reduce the cells ability to recover from stimulation. 
This suggests that the delay in initiation of cAMP signals could be due to a defect in 
expression of the cAMP signaling genes in early development.
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Fig. 33 Arp8 null cells have delayed production of cAMP pulses
Single frame still images extracted from supplementary movies ax2cAMPpulse.avi 
and arp8nullcAMPpulse.avi. A.) Wild-type cells show the characteristic spiral pattern 
of cAMP pulses moving through the population. These pulses initiate after approx 4H.
B.) arp8 null cells do not show this characteristic pulsing pattern once signalling has 
initiated, approx 5 hours after wild-type. The pattern seen is more erratic and 
produces a concentric circle pattern. Both experiments were repeated at least three 
times.
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3.4 Null cells exhibit a delayed expression of the cAMP signalling genes during 
development
Three key components of the cellular machinery responsible for the 
production and propagation of the cAMP signal are the cAMP receptor CAR1, the 
adenylyl cyclase, ACA, and the phosphodiesterase PDE. Having all been shown to be 
essential for sensing the cAMP signal and efficient chemotaxis, these represent good 
initial candidates for genes that may be mis-regulated in the arp8 null cells [51,111].
Expression of all three genes shows a similar pattern to each other in wild-type 
cells (Fig. 3.4). They all have a relatively low expression during vegetative growth 
which increases rapidly during the aggregation phase towards 12 hours. Upon 
reaching the mound stage the expression starts to fall once again as their role in the 
process of development has been played. These data are in agreement with previous 
investigations into the roles of these genes and also currently available RNA-seq data 
www .ailab.si/dictvexpress .
The null cells also all show a similar pattern of expression for car A, acaA, and 
pdsA (Fig 3.4). However, this pattern is one of a severe delay and a retardation of the 
levels of transcription of these genes, with the peak occurring much later at 
approximately 16 hours after the onset of starvation. This delayed expression 
correlates with the observed delayed development phenotype and the delayed 
production of cAMP signals previously observed. It is now apparent that the delay is 
most likely due to an inability to signal to one another that starvation has begun and 
the process of aggregation needs to begin. However, this does no show whether this 
mis-regulation of these genes is down to a direct affect of the loss of arp8 or as an 
artifact of the loss on another external factor.
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Fig. 3.4 Expression profiles of genes involved in cAMP signaling.
Analysis of the mRNA levels present in wild type or arp8 null cells by QRT-PCR. All 
expression is normalized to AX2 OH which is given a 100% expression value. All 
genes analyzed show a similar expression pattern in wild-type cells, with an increase 
over the first 4 hours. arp8 null cells also follow a similar pattern across all genes 
examined, with a delayed and reduced peak of transcription.
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3.5 Mixing the cell population can rescue the delay phenotype
To test the theory that the delay in aggregation and cAMP pulsing is due to an 
external signaling factor; arp8 null cells were mixed with decreasing amounts of wild 
type cells. If this delay is indeed due to the null mutants lacking an extra-cellular 
signaling molecule, mixing the cells with wild-type should return this molecule to the 
environment and rescue the phenotype. If it is down to the affect of the INO80 
complex on the genes responsible for producing the signal it should not.
Mixing as few as 1% wild-type cells with arp8 null cells and allowing them to 
develop on nitrocellulose filters rescues the delay in development (Fig. 3.5A). The 
combined population develop along a similar developmental time frame as the wild- 
type cells alone. They produce chimeric fruiting bodies indistinguishable from wild- 
type alone. This does suggests that the phenotype may well be due to the loss of 
another external signaling molecule, rather than a direct affect on cAMP producing 
genes and an inability to produce, or detect, the signal.
In a similar experiment, the cells were again allowed to develop, this time on 
KK2 agar and were imaged using darkfield time-lapse microscopy to identify any 
rescue of cAMP signalling. These cells showed an almost wild-type timing of the 
initiation of cAMP pulsing (Fig. 3.5B). However, the pattern of the pulses produced 
was still that of a concentric circle rather than the spiral patterns observed in wild- 
type. It could be, in this case, that the cAMP producing genes have been rescued in 
their expression yet others responsible for cAMP degradation, i.e the 
phosphodiesterases, have not.
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Fig. 3.5 Mixing null cells with wild-type forms chimeras that are capable of 
developing normally.
A.) Development of mutant arp8 null cells mixed with 10% wild-type cells on 
nitrocellulose filters. The cells develop under the normal time frame of 24 hours. All 
image are at 4X magnification. B.) Still frame images taken from the supplementary 
movies; 10%mixcAMPpulse.avi, ax2cAMPpulse.avi and arp8nullcAMPpulse.avi. 
The third image depicts the correct temporal production of cAMP pulses, however, 
the patterns are still concentric circles, not spirals.
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3.6 Stimulating the null cells with cAMP rescues the expression of the cAMP 
signalling genes
The mixing experiments have shown that an external signalling factor is likely 
to be missing, or under expressed, in the null mutants, which has been returned by the 
wild-type strain mixed throughout the population. One possibility is that the null cells 
are incapable of producing the initial bursts of cAMP which in turn trigger the 
positive feedback loop leading to the up-regulation of the genes involved in signaling. 
To test the hypothesis the null cells were stimulated for 5 hours with cAMP, just as 
they were for the chemotaxis experiments. qRT-PCR was utilized to look for any 
difference in expression of car A, acaA and pdsA between the stimulated wild-type 
and arp8 null cells. Observations indicate that there is no difference in expression 
between these two populations, indicating that the expression of these genes has been 
rescued by addition of cAMP stimulation. It has been proposed that initial stimulation 
of CAR1 by cAMP regulates a positive feedback loop, whereby the transient 
accumulation of intracellular cAMP drives the secretion of cAMP to the extra-cellular 
matrix and subsequent propagation of the signal throughout the population [112]. This 
occurs through the increased expression of the CAR1 receptor at the membrane, 
driven by an increase in extra-cellular cAMP signal coupled with an increase in CMF 
expression as a result of increased cell density [42, 55]. This strongly indicates that a 
lack of initial extra cellular cAMP signalling in the arp8 null cells could be 
responsible for the lack of gene expression, subsequently leading to a loss of cAMP 
secretion and the delay in aggregation.
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Fig. 3.6 Supplying null cells with cAMP returns the expression of cAMP 
synthetic genes.
All cells were pulsed for 5 hours with luM  cAMP and total mRNA was extracted. 
Total mRNA levels present in wild type or arp8 null cells was analyzed by QRT- 
PCR. All expression is normalized to AX2 OH which is given a 100% expression 
value. There is no difference between expression levels for any of the cAMP synthetic 
genes analyzed.
86
3.7 RNA-seq data reveals the genes which are affected by Arp8 during vegetative 
growth.
RNA-seq was employed in an attempt to identify the global transcriptional 
changes between wild-type and arp8 null cells during development and thus indicate 
the processes regulated by this chromatin re-modeler. From previous experiments it 
was expected that genes involved in the regulation of the onset of development, 
cAMP signaling and chemotaxis would be mis-regulated. However, this analysis 
would provide an insight into other biological systems which are mis-expressed in the 
null cells. Time points were taken at 0 and 8 hours for both wild-type and null cells. 8 
hours is the point of maximum expression of arp8 and other members of the INO80 
complex and therefore would be expected to be the point of greatest impact on 
transcription.
Quality control scores, from the Galaxy resource website, were extremely 
good for all data sets with none of the samples requiring any trimming. The data 
provided was then aligned to the Dictyostelium Ax4 reference genome sequence using 
the DNAstar Array star Qseq algorithms (full description in materials & methods). 
Following the alignment of the reads, the fold difference between samples was 
calculated using the Arraystar software. To gain the best understanding of what 
processes are affected when the arp8 gene is knocked out comparisons were drawn 
between the wild-type and null cells between time points; i.e. comparing AX2 OH to 
arp8mx\\ OH and AX2 8 to arp8n\x\\ 8H. This would give a comprehensive view of the 
genes influenced by the INO80 complex at each time-point. For each time point the 
data was normalized to the base level of 6 read counts, through the Array stars inbuilt 
filters. This base level was previously decided to be the level for un-expressed genes 
(see chapter 2).
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To make sure that we are looking at real changes in gene expression a base 
limit of 2-fold change in gene expression was taken either way. Any changes below 
this were discarded through Arraystars filtering system. Looking at the total numbers 
of genes affected it is immediately apparent that there are far less affected by the 
knock out of arp8 during vegetative growth than later on in development (Fig. 3.7A 
and B). A total of 3163 genes are affected after 8H of starvation compared to a total of 
921 during vegetative growth. There are a larger number of genes that are down- 
regulated by the knock out of arp8 at both time points, with nearly twice as many 
genes showing a decrease in expression (Table 1). To analyze such a large amount of 
data initially proved daunting. However, a decision was made to initially scan the data 
looking for genes that were known, from the literature, to be involved in development 
before following this up with a comprehensive gene ontology analysis (to be 
described later).
At OH the first noticeable genes to be negatively affected are several of the 
Discoidin encoding genes; dscC 1+2, dscD 1+2, dscA 1+2 and the discoidin 2 gene 
dscE (Table 2). Discoidin is one of the most studied families in Dictyostelium biology 
and is involved in the initiation of the starvation response, initially being expressed 
when cell density increases and continues to be expressed through early development 
[113]. Observing these genes down-regulated with such a delayed development 
phenotype as is seen in the arp8 null cells stands to reason as Discoidin is involved in 
the progression of this process and considered one of the main biological markers of 
development within the field.
Two other notable genes are found within the group of genes which exhibit the 
largest drop in expression. These are; ImcA and smlA. The first of these is also known 
as V4, a gene involved in the transition from growth to development [114] .The protein
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is normally expressed during vegetative growth and is found to deactivate upon the 
onset of development. Similarly to arp8 null cells, cells deficient in V4 fail to 
aggregate and are incapable of initiating the cAMP response, lacking the receptor and 
phosphodiesterase. smlA encodes a protein responsible for the regulation or 
processing of a secreted factor involved in regulating size of aggregates; countin [115, 
116]. Countin is the major subunit of the counting factor (CF) complex that is 
involved in regulating the size of aggregates. The smlA gene is expressed normally 
during vegetative growth and early development, with smlA- cells exhibiting a 
reduced aggregation size and territory phenotype. The fact that smlA expression is 
reduced in arp8 nulls could account for the reduced aggregation territories observed 
(Fig. 3.2).
A second gene is seen near the top of the list of over-expressed genes and this 
is the gene ctnB which encodes the protein countin2 a homologue to the countin 
discussed above [117]. Mixing experiments have shown that both countin proteins are 
required for normal aggregation sizes, with ctnB- strains forming smaller aggregates 
but ctnA-lctnB- chimeras developing normally. Over expression of ctnB could be a 
response to the reduced expression of smlA which would cause an over-repression of 
the countin 1 protein.
The final genes identified in the list are both only down regulated a much 
smaller amount but are both instrumental in the growth -  development transition. 
They are in fact two of the growth development transition genes; gdtl and gdt2. These 
genes were identified as repressing the function of discoidin [118, 119] and all 
containing a putative protein kinase domain, gdtl lacks a catalytic domain and so 
therefore may not function as the kinase it has been predicted to. It is once again 
found mainly in vegetative cells and rapidly disappears upon the onset of
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development. A lack of gdtl and or gdt2 leads to a rapid onset of development, which 
would not happen in this case due to the absence of discoidin.
Following on and looking at those genes which are up-regulated during 
vegetative growth identifies a number of genes that are known to be involved in 
influencing development. The most notable of the group include; ImcB, 3B-1+2 and 
cinC.
Interestingly one of the most over-expressed genes found in this group is ImcB 
the homolog to ImcA one of the most highly under-expressed genes in the arp8 null 
cells. My only explanation for this is that they are both regulated by different control 
mechanisms and that the expression of ImcB increases to compensate for the drop in 
ImcA.
Both of the homologs of the prespore specific protein 3B are seen to be over­
expressed in this gene set. This gene is normally expressed later in development [120] 
and so goes against the general theory we are building here that Arp8 and INO80 
control early developmental gene expression. However, it does serve to show that 
these factors are incredibly diverse and play a large number of cellular roles, 
activating and repressing different genes at all stages of development.
Another interesting gene that appears to be up-regulated in these cells is cinC. 
This is the Dictyostelium homolog of elongation factor 2 EF-2 and is normally only 
found in vegetative cells [121]. The fact that it appears at 8 hours into development 
lends further evidence to the suggestion that these cells are experiencing a delay in the 
onset of the developmental process.
The genes identified here all suggest that the arp8 null cells would exhibit a 
delay in the onset of starvation induced development (barring 3B-1+2), the phenotype 
which they do indeed exhibit.
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Fig. 3.7 Arp8 knock out affects a greater number of genes 8 hours into 
starvation.
Scatter plots indicating the fold change in gene expression comparing A.) Wild-type 
and null cells during vegetative growth and B.) wild-type and null cells after 8 hours 
of starvation. Points above the line represent an increase in expression, those below 
exhibit a decrease. A much larger number of genes, both up and down regulated, is 
seen on the 8 hour plot, suggesting that the INO90 complex plays a greater role at this 
time point.
A X 2 8H
A X 2 0H
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Time point Total genes down- 
regulated
Total genes up- 
regulated
Total genes 
affected
0 hours 593 328 921
8 hours 2221 942 3163
Table 3.1 Summary of genes affected by arp8 knock out.
After excluding all results with an expression reading less than 6 the total number of 
genes affected by the knock out of arp8 are summarized above. Once again it is 
observed that there are almost 3 times more genes affected after 8 hours of starvation 
indicating that the INO80 complex plays a more significant role at this point of 
development.
Time point Dictybase ID/gene name Fold change up-regulated
0 hours ImcB 39.3
0 Hours ctnB 10.96
0 Hours 3B-1 (and 3B-2) 6.98
0 Hours cinC 7.75
Table 3.2 Genes up-regulated during vegetative growth.
A small subset of the genes up-regulated in the arp8 null cells compared to wild-type 
during vegetative growth. These genes are all possible candidates for contributing to 
the delayed phenotype observed in the null cells.
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Time point Dictybase ID/gene name Fold change down-regulated
0 hours dscC 44.18
0 hours dscD 39.85
0 hours dscA 35.13
0 hours dscE 11.43
0 hours smlA 8.73
0 hours ImcA 64.02
0 hours gdt2 2.40
0 hours gdtl 2.39
Table 33  Genes down-regulated during vegetative growth.
A small number of the genes that are seen to be down-regulated in the arp8 null cells 
compared to wild-type during vegetative growth. All of these genes could be 
potentially responsible for the delayed phenotype observed in the null cells, either 
working individually or in concert.
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3.8 RNA-seq data reveals the genes which are affected by Arp8 during early 
Dictyostelium development.
Moving on to look at the 8 hour time point, as mentioned earlier, there are a 
much larger number of genes that have been affected by the knockout, with a total of 
2221 genes exhibiting a 2-fold or more decrease in expression and 942 showing an 
increase of 2-fold or more. These data indicate that the INO80 complex is more 
heavily involved in the activation of genes but also does play a repressive role too.
The largest group of genes that stand out of the list of 2-fold down regulated genes, 
that also exhibit the largest decrease in expression are those of the growth factor; pre- 
spore cell inducing factor (PsiA). Four members of this gene family exhibit a larger 
than 250-fold drop in expression in the arp8 null cells. PsiA is a secreted glycoprotein 
that is involved in controlling the differentiation of both prestalk and prespore genes 
in developing populations [122] and is maximally expressed at the loose mound stage 
which explains why there is a such a large difference in expression as these cells are 
approaching this point at 8 hours into development. Looking for other genes also 
known to be involved in the control of prespore and prestalk differentiation several 
other key genes are seen to be down regulated. This includes the prestalk specific 
marker genes ecmA and ecmB plus the key prespore specific marker genes pspA and 
cotB [123, 124, 125]. All of these genes are down-regulated by several hundred fold 
in some cases showing a further clear delay in a set of genes involved in later 
development. Another major group of genes down-regulated in this mutant, which 
have already been validated in this thesis by rt-pcr, are those involved in cAMP 
production. All three of acaA, car A and pdsA exhibit a reduction in transcription as do 
pdeE and carB, another phosphodiesterase and cAMP receptor respectively, that are 
involved in the production of the chemotactic signal and initiation of development.
When analyzing the up-regulated genes with a 2-fold change in expression or 
higher the gene with the largest change is a histactophillin, hat A, a gene which’s actin 
binding product is a membrane anchoring protein, tethering actin to the membrane 
[126], with mutants having a defect in spore fruition. A second histactophillin, hat A, 
is also highly up-regulated suggesting a later role for the INO80 complex in 
regulating genes involved in spore viability during fruiting.
The next pair of genes noticeable in the list are the conditioned mediating 
factor (CMF) receptor genes cmfA and cmfB. These genes products are involved in the 
initiation of development by activating transcription of the slow dissociating isoform 
of the CAR1 receptor [55]. At this point the null cells are beginning to enter 
development and so will be starting to secrete CMF in response to this, which will in 
turn activate the full cAMP signaling cascade (described in chapter 1). Several of the 
Discoidin genes are also up-regulated at this point in the null cells. These genes, as 
mentioned above, are expressed in response to the initiation of starvation and the 
secretion of CMF. So as CMF is expressed at this point in the null cells, so also is 
Discoidin, which is leading the cells into the full development cycle.
The final large group of genes that is apparent from the gene list is a large 
selection of the ribosomal proteins. The fact that these genes are still being expressed 
so highly suggests that there is still a high level of translation occurring which would 
be synonymous with cells that are growing vegetatively, lending more genetic 
evidence to the idea that the null cells are developmentally delayed. All of the 
evidence from these genes identified by RNA-seq lends further evidence to the idea 
that the INO80 complex is involved in regulating early starvation induced 
development in Dictyostelium discoidin.
Time point Dictybase ID/gene name Fold change up-regulated
8 hours hatA 231.88
8 hours cmfB 98.39
8 hours hatB 90.03
8 hours dscA 20.65
8 hours dscC 8.45
8 hours cmfA 7.54
8 hours dscD 6.96
8 hours rpsl2 121.63
8 hours rpll5 102.46
8 hours rpll3 91.35
8 hours rpl88 91.33
8 hours rpl26 86.85
8 hours rpl4 80.55
8 hours rpl21 69.81
8 hours rpll2 69.87
Table 3.4 Genes up-regulated involved in development
This selection of up-regulated genes represents those that were immediately obvious 
as potential effectors of the delayed development phenotype, or changes that have 
occurred as a result of this after 12 hours of starvation.
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Time point Dictybase ID/gene name Fold change down-regulated
8 hours expl8 3458.8
8 hours psiA 2319.5
8 hours cotC 1871.7
8 hours pspA 674.4
8 hours psiM 592.2
8 hours cotB 525.0
8 hours ecmD 522.3
8 hours psiC 431.1
8 hours ecmA 351.8
8 hours psiS 257.0
8 hours pspB 228.0
8 hours pspD 184.0
8 hours cotA 122.0
8 hours acaA 100.0
8 hours cotD 70.0
8 hours carB 69.9
8 hours pdeE 49.0
8 hours carA 19.0
8 hours ecmB 10.0
Table 3.5 Genes down-regulated involved in development
A selection of genes down-regulated 8 hours into development that are likely to be 
associated with the delayed development phenotype, either possibly contributing to or 
being a direct result of the phenotype.
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3.9 Summary
• Arp8 is a member of the INO80 chromatin re-modeling complex.
• In yeast INO80 is involved in regulating inositol biosynthesis by controlling 
expression of inol.
• arp8 null cells exhibit a delay in the onset of development.
• This delay is due to an initial inability to produce correct cAMP signaling.
• The genes responsible for producing this signaling are delayed in their 
expression, starting to be expressed approximately 12 hours late.
• Expression of these genes can be rescued by pulsing the cells with cAMP and 
the developmental delay phenotype can be rescued by mixing the cells with 
wild type.
• RNA-seq data reveals a large number of other genes involved in regulating 
development which are mis-expressed in arp8 null cells.
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Chapter 4:
Arp8 and the INO80 complex regulate Dictyostelium
chemotaxis
Sumary: One of the key fundamental characteristics of Dictyostelium development is 
the ability of the cells to respond to concentrations of chemoattractant over several 
orders of magnitude. Here a mutation in a member of the large multi-subunit ATP 
dependent INO80 chromatin remodeling complex is identified. arp8 null mutants 
reduce the concentration range under which the cells are able to chemotax. PIP3 is a 
key signaling molecule in this process, having been show to translocate to the site of 
chemoattractant stimulation in steep gradients. Here it is shown that Arp8 is involved 
in maintaining the correct levels of PIP3 production via suppression of 2 genes 
involved in inositol biosynthesis, inol and impal.
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4.1 Chemotaxis is impaired in a cAMP concentration dependent manner
Starving Dictyostelium amoeba aggregate by chemotaxis towards a cAMP 
source. Cells response to cAMP is adaptable to the concentration of the 
chemoattractant experienced at different developmental stages. During the onset of 
chemotaxis the cells are subjected to very low concentrations in the nanoMolar range, 
rising up to those greater than l^M later on in the mound. The ways in which cells 
respond to varying steepness of gradient in this process can be investigated in a 
zigmond chamber [28]. This chamber sets up a shallow gradient of cAMP upon which 
cells are allowed to chemotax. This process is recorded using time lapse microscopy. 
Cells pulsed with 1//M cAMP for 5 hours are in a chemotactically competent state and 
wild type cells in this condition are capable of migrating up a shallow cAMP gradient 
in a zygmond chamber ranging from lOnM to \ jM  (Fig. 4.1A). The cells were all 
able to chemotax with a high chemotactic index (Cl), however, in lower 
concentrations (lOnM) of cAMP, at the source of the zigmond chamber, both the 
speed and directionality of the cells were reduced. These data suggest that cells are 
able to chemotax in extremely low and high gradients of cAMP switching from high 
to low sensitivity with a preference for more persistant movement when a stronger 
gradient is encountered. This system would enable the cells to preferentially move 
towards larger aggregation centers, directing the cells towards the mound. In early 
chemotaxis this switch from high to low sensitivity may be regulated by the switch 
between the two car A promoters. The early promoter producing a more sensitive 
receptor than the late [44].
arp8 null cells have a severe defect in their ability to chemotax and respond 
over a much smaller range of cAMP concentrations. In steeper gradients, where there 
is a much greater concentration in the source of the chamber to that in the sink, the
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majority of the null cells freeze and round up, not displaying any chemotaxis at all. In 
fact when arp8 null cells are conditioned by pulsing and placed in a zigmond 
chamber, with a 1//M source, only 44% of cells respond to the stimulus. Those that do 
respond, do so with severely diminished Cl, directionality and speed (Fig. 4.IB). 
However, leaving the null cells for longer in the cAMP gradient sees a greater number 
of cells start to respond to the stimulus. After 1 hour 71% of cells have started to 
respond to the gradient with a Cl, directionality and speed comparable to that of wild- 
type (Table 1). This is an interesting and previously unreported phenotype and could 
have a number of explanations. It is possible that the cells may be over producing a 
signal which decreases with time, or alternatively it is possible that the breakdown of 
cAMP in the chamber is rapid enough to create a shallower gradient which the cells 
are then able to sense.
Investigating these hypothesis the experiments are repeated using sequentially 
shallower gradients of cAMP, with cAMP sources once again ranging from lOnM up 
to \pM. If the cells start to respond due to a breakdown of extra-cellular cAMP then 
they should start to exhibit a greater response with an increasingly shallower gradient. 
This is seen to be the case. As cAMP concentration at the source is decreased the 
ability of the cells to sense the gradient was increased, with a higher percentage of 
cells responding. The cells that regained their ability to sense the gradient did so with 
an increasingly better Cl, directionality and speed (Table 1). These data suggest that 
the Arp8 null mutants are capable of responding to a much smaller range of cAMP 
concentrations than wild-type a phenomenon suggested but not described before. 
These data show that Dictyostelium cells respond to a cAMP over a large order of 
magnitude which is controlled at least in part by the action of the INO80 complex and 
Arp8 as arp8 null cells can not respond over the same concentration range.
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A Towards .  cAMP
source
Arp8 null 
250nM 
cAMP
Arp8 null 
500nM 
cAMP
Arp8 null 
1 hour in 
gradient
Arp8
nullAX2
AX2 84 0.94±0.14 0.79±0.21 9.20±3.77
arp8 
null iuM 
cAMP
44 0.60±0.56 0.46±0.19 4.75±1.92
arp8
null 5(X)nM 
cAMP
57 0.87±0.30 0.42±0.19 5.33±1.78
arp8
null 250nM 
cAMP
70 0.94±0.56 0.67±0.23 9.I8±4.16
arp8
null 1 hour in
cAMP
gradient
71 0.92±0.15 0.61 ±0.23 8.72±3.73
Fig. 4.1 arp8 nulls also show decreased chemotaxis.
A.) Traces taken from 3D-DIAS software that outline the movement of 20 randomly 
selected cells taken from a pool collected over 3 days. arp8 nulls display decreased 
ability to chemotax which can be rescued by lowering the cAMP concentration at the 
sink, or by leaving the cells longer in the gradient. B.) The values for Cl, 
directionality and speed as calculated by 3D-DIAS.
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4.2 Impaired chemotaxis could be due to a build up of PiP3 on the membrane
In a search for the internal signaling molecule potentially over-produced in 
this system we initially looked to PIP3 as this has been shown previously to be 
required for early chemotaxis. To re-cap, PIP3 was shown to be an important indicator 
of Dictyostelium chemotaxis in a field-shaping piece of work by Parent et al, 1998. 
This study suggested that a localized cAMP stimulus outside the cell resulted in a 
localized translocation of the PIP3 dependent PH domain of CRAC to the membrane, 
through the action of PI3-kinase. Our hypothesis for the stalled chemotaxis phenotype 
observed in arp8 null cells is that high levels of external cAMP could lead to an over 
production of PIP3 at the membrane which in turn could lead to an inability to detect 
the external cAMP signal as the whole system has become flooded by the internal 
signal, raising internal noise levels. The GFP tagged PH domain of CRAC, used by 
Parent et al, is utilsed to indicate this translocation in cAMP pulsed cells and as a 
predictor of PIP3 localisation.
In chemotactically competent wild-type cells, global stimulation with IpM  
cAMP causes a characteristic rapid translocation of PH-CRAC-GFP onto the entire 
plasma membrane (Fig. 4.2A). When looking at similarly treated null cells it is 
apparent immediately that there is a significant difference as PH-CRAC-GFP is 
already situated on the plasma membrane even before stimulation with cAMP. Once 
the cells have been stimulated no further translocation takes place. These data would 
be in agreement with the notion of too much PIP3 on the membrane resulting in a loss 
of sensitivity to cAMP. These cells would appear to be sensing a cAMP gradient in all 
directions resulting in an increased signal to noise ratio and therefore it is unsurprising 
that they round up and do not move as a stimulus in all directions is as bad as no 
stimulus at all for directional chemotaxis.
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To corroborate this evidence we also looked at the phosphorylation of a 
protein kinase B (PKB) homologue PkbA. PkbA only becomes active when it is 
phosphorylated at the membrane in a PI3 kinase dependent manner. This translocation 
to the membrane has previously been shown to be dependent on a PH domain which 
binds membrane associated PIP3 [33]. In the wild-type cells the phosphorylated form 
of PkbA (p-PkbA) was seen to increase after 10s, peaked at 20s and then decreased 
over the remainder of the observed minute (Fig. 4.2B). The null cells exhibit a basal 
level of p-PkbA prior to stimulation with cAMP which then rises to peak much higher 
than the wild-type level after 20s and takes longer than the observed minute to 
diminish (Fig. 4.2B). These data also suggest that pulsing the cells with cAMP places 
the cells in a state whereby they have higher basal levels of PIP3 at the membrane that 
then prevents them from properly sensing a steep gradient of cAMP and therefore 
from chemotaxing.
In summary an excess of PIP3 on the membrane of arp8 null cells may lead to 
an increase in noise in the internal signaling system which would result in cells being 
unable to respond to higher concentrations of cAMP as the receptors would become 
completely saturated all around the membrane much quicker due to the excess in the 
signal resulting in a higher signal to noise ratio through which the signal would not be 
detected.
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Fig. 4.2 arp8 null cells show an increased build up of PIP3 on the membrane.
A.) Western blot analysis of the phosphorylation of PKBA and PKBG in both wild- 
type and mutant cell lines following stimulation with luM cAMP. The percentage 
change was calculated by normalising all samples to the highest wild-type peak at 10s 
and taking this value as 100%. Actin was used as a loading control. B.) Translocation 
of the PIP3 specific marker; PH-CRAC-GFP to the plasma membrane following 
stimulation with luM cAMP. Images were taken at 60X magnification on a Olympus 
1X71 inverted microscope. C.) Graphical representation of the intensity of the 
translocation calculated by measuring the ratio between cytosolic and extra-cellular 
fluorescence over time.
4.3 Transcription of PiP3 regulating genes inol and impAl is attenuated in arp8 
null cells.
The genes impal and inol are involved in the bio-synthesis of inositol 
phosphates within the cell, inol encodes the gene myo-inositol synthase, involved in 
de-novo inositol monophosphate synthesis, whereas impAl encodes inositol 
monophosphate a gene involved in the recycling of inositol phosphates by hydrolising 
inositol monphosphate to free inositol, inol expression has been shown to be affected 
by the knock out of arp8 in yeast [77] and impal has been implicated in the regulation 
of PIP3 signaling as it regulates the levels of free inositol. If the expression of either of 
these genes were to be regulated by Arp8 in Dictyostelium then this could lead to a 
change in PIP3 signaling though an increase in synthesized PIP2 levels.
Looking at the expression of both of these genes by qRT-PCR, we observe an 
increase in expression in cells undergoing vegetative growth. This increase is 
maintained over the first half of development with there being approximately a 20% 
increase consistently throughout the first 12 hours (Fig. 4.3A). These data suggest that 
the INO80 complex and Arp8 are involved in repression of these inositol biosynthetic 
genes and in keeping the levels of PIP2 production low during early aggregation. The 
over-production of these genes, in the case of the null cells, results in a higher level of 
de novo synthesis of inositol with an ensuing increase in PIP2 levels leading to higher 
levels of PIP3 produced by the PI3 kinases.
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Fig. 4.3 Inositol biosynthetic genes are directly regulated by the INO80 complex
A.) Analysis of the mRNA levels present in wild type or arp8 null cells by QRT-PCR. 
All expression is normalized to AX2 OH which is given a 100% expression value.
Both genes analyzed show a similar expression pattern in wild-type cells, dropping 
off over the early stages of development. Null cell expression remains consistently 
higher than wild-type throughout development. B.) ChIP with the ARP5 antibody 
shows that the INO80 complex interacts directly with the inol and impAl promotors. 
1- anti Arp5, 2 - just beads, 3 - anti RNApolII 4 - Genomic DNA control. C.) Western 
blot of Arp8-GFP expressing wild type and arp8 null extracts Immuno-precipitated 
with the ARP5 antibody and probed with a GFP antibody. An approximately 120kDa 
band indicates that Arp8-GFP co-IP's with Arp5
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4.4 ChIP verifies that INO80 acts directly on the inol and impAl promotors
To verify whether the INO80 complex interacts directly with the inol and 
impAl promotors ChIP was performed and these promotors verified by PCR with 
primers specific to these loci.
An aArp5 antibody was used for the immunoprecipitation (a further gift from 
the laboratory of Annette Mueller Taubenberger, situated in the Institute for cell 
biology, Faculty of medicine, Ludwig-Maximilian universitat in Munich), as there 
was no available antibody to any of the other Dictyostelium INO80 complex subunits. 
Arp5 has previously been shown to be essential for complex function in yeast [77] 
and therefore an assumption was made that immunoprecipitating (IP) with this 
antibody should also target the same promoters as performing the IP with an Arp8 
antibody (Fig. 4.3C).
The aArp5 antibody was first checked for specificity using western blot of 
wild-type cells developed to 8H. 8H is the time of maximum expression of arp8 
(Chapter 3, Fig. 3.1) and also has been seen to be the point of maximum expression 
for INO80 in previous RNA-seq experiments (Dictyexpress). There are 3 bands 
picked up by the antibody (Fig. 4.3C). The 79 kDa band is Arp5 and the lowest band 
is extremely likely to be actin, with the final band possibly representing one of the 
other Actin related proteins. To control for the lack of specificity and that one of the 
other proteins observed may be binding the promoters of interest ChIP was also 
performed on chromatin isolated from arp8 null cells. Any positive hits that occur in 
both samples should then be either resulting from one of the other proteins pulled 
down by the antibody or background from non-specific binding to the beads used.
Before continuing it was necessary to validate the above assumption that 
performing an IP with the Arp5 antibody will identify Arp8 bound proteins and DNA.
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An IP of the GFP tagged Arp8 strain was performed at 8 hours into starvation, with 
the Arp5 antibody. This was subsequently then western blotted and probed with the 
GFP antibody to show that an IP with Arp5 will also immunoprecipitate Arp8. Two 
bands were seen on the blot, with the 98 kDa band being Arp8-GFP and the other 
lower band likely to be degradation product (Fig. 4.3C).
For these ChIP experiments chromatin was sonicated down to ~1000bp and 
analysis of the ChIP isolated DNA was by PCR using primers specific to 100-200bp 
regions of the genes inol and impAl (sequences in chapter 2). Specific bands are 
observed for both inol and impal in the wild-type samples (Fig. 4.3B), but not in the 
null cells indicating a direct interaction between the INO80 complex and both of these 
promoters. These bands are lost in the null mutants indicating that Arp8 is essential 
for binding to these promoters. Control samples of RNApolII isolated DNA and 
genomic DNA confirm the bands are not due to primer dimers.
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4.5 Treating null cells with Lithium improves chemotaxis
Lithium has been shown to have an inhibitory role on the enzyme IMPase [2]. 
It has been indicated as having a therapeutic role in the management of bipolar 
disorder in humans [3], with the inositol depletion hypothesis suggesting that this may 
modulate the levels of inositol in the brain [12]. Previous work investigating the 
effects of lithium treatment on Dictyostelium show that it produces an inhibitory 
affect on chemotaxis [1]. This is suggested to occur by reducing the pool of PIP2 
available for PIP3 signaling. If the arp8 null cell chemotactic phenotype that has been 
observed in this study were due to the increased expression of impal and subsequent 
increase in PIP3, treatment with lithium should inhibit the enzymatic activity of 
IMPase resulting in the restoration of the cells chemotactic ability.
75% of cells treated with 2mM LiCl respond to the cAMP gradient compared 
to the 44% of cells that were untreated. These cells do this with an improved Cl, 
directionality and speed (Fig. 4.4). These data indicate that treatment with low 
concentrations of LiCl will sufficiently inhibit IMPase enough that the PIP2 levels 
decrease to a point where the cells’ can detect the cAMP gradient. Higher 
concentrations of lithium begin to reduce the cells ability to chemotax again. This 
could be due to higher concentration affecting one of the other targets of lithium in 
the cell which can have an affect on chemotaxis, such as GSK3 [2].
To further test this theory a plasmid that over-expresses IMPase was 
transformed into the arp8 null cells, using the electroporation method outlined in the 
materials and methods. These cells would be expected to produce sufficiently large 
amounts of IMPase to raise the levels of PIP3 to an extent where lithium rescue will 
not be possible. Untreated arp8nu\\ (IMPase-GFP) cells have even worse chemotactic 
ability than null cells alone, with only 31% of cells sensing the gradient at all. When
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with 2mM Lithium there is no effect on the cells and if anything they behave worse 
than the untreated cells. These data indicate that it is indeed likely to be an elevation 
of IMPase that results in the arp8 null chemotactic phenotype. Having its effect 
through elevated PIP3 signaling, resulting in an inability to sense the cAMP gradient.
I l l
A Towards cAMP
Wild
typa
ArpB null Arp8 null 
(IMPaae-GFP) (IMPase-GFP)
ArpB null 
2mM NaCI
ArpB null 
2mM LiCl
2mM NaCI 2mM LiCl
Wild-type 84 0.94±0.14 0.79*0.21 9.20*3.77
arpH null 
2mM NaCI
44 0 .6 0 i0 .5 6 0.46*0.19 4.75*1.92
arpH null 
2mM LiCl
74 0.87*0.34 0.68*0.25 8.78*3.98
arp/i null 
(Impase-GFP) 
2mM NaCI
31 0.67*0.54 0.39*0.17 4.84*1.72
arpH null 
(IMPase-GFP) 
2mM LiCl
29 0.57*0 .77 0.27*0.09 3.34*0.89
Fig. 4.4 Treatment with Lithium also improves null cell chemotaxis.
A.) Traces taken from 3D-DIAS software that outline the movement of 20 randomly 
selected cells taken from a pool collected over 3 days. Treatment with low doses of 
LiCl, within therapeutic levels, leads to an improvement in chemotactic ability. 
Raising the internal levels of PIP2 through over-expression of IMPase works to 
counter the effects of LiCl and removes the ability to rescue the cells. B.) The values 
for Cl, directionality and speed as calculated by 3D-DIAS.
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4.6 Analysis of RNA-seq data reveals a number of genes affected that are 
involved in chemotaxis.
Inspecting the RNA-seq data for genes involved in chemotaxis identifies a 
number of candidates that are mis-expressed in the null cells. Firstly looking at inol 
and impAl the two genes identified by my qRT-PCR study indicates that once again 
these two genes are over-expressed in the null cells (Table 4.1). This lends further 
weight to the theory that the over-expression of these two genes, in these cells, 
contributes to the delay seen in initiating chemotaxis when presented with a cAMP 
signal. Two further up-regulated genes are two of the PI3kinase class of protein 
kinases pikF encoding PI3K4 and pikH encoding PI3K6. The first has been shown to 
be one of the PI3kinases involved in phosphorylating PIP2 to PIP3 in response to 
cAMP stimulation. The second, PI3K6, is unlikely to be involved in chemotaxis as it 
has been shown to not localize to the cell cortex upon cAMP stimulation [127]. An 
over production of this PI3K may also lead to an increase in the unstimulated levels of 
PIP3 at the membrane. Conversely to this, when looking for chemotaxis associated 
genes that have been down-regulated in the arp8 null cells it is seen that a further two 
of the PI3kinases have reduced expression compared to wild-type. Both pikB and 
pikD show a reduction in expression. This could be the cells making an attempt to 
internally regulate the over production of PIP3 and reduce the levels. 
pldA encodes a phospholipaseD which has been shown to be essential for actin 
relocalisation in both endocytosis and motility, as inhibition of this molecule reduces 
both. Also the production of PIP2 by the PI(4,5)kinase has been shown to be regulated 
by the synthesis of the PLD product phosphatic acid (PtdOH). The reduction in 
expression of pldA could also contribute to both the chemotactic and developmental 
defects observed in the arp8 null cells.
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The enzyme prolyl-oligopeptidase (PO) has previously been implicated in 
Dictyostelium chemotaxis by work from our lab [24], with PO being identified as a 
modulator of the sensitivity of cells to lithium treatment and a negative regulator of 
IP3 synthesis. The gene encoding PO, dpoA, is seen to be downregulated in the null 
cells after 8 hours of starvation. This suggests a possible further attempt by the cells to 
reduce over-produced PIP3 levels by limiting the amount of IP3 entering the system 
and thereby reducing the amount of substrate for IMPase. Another gene that has 
reduced expression in the null cells after 8 hours is dd5Pl, one of the 5’phosphatases 
also involved in the recycling of the inositol phosphates. A decrease in this enzyme 
would also be limiting in the cells ability to turn around the inositol phosphates and 
could result in a reduction of PIP2 levels.
The RNA-seq data has provided more evidence to suggest that a number of 
genes are mis-expressed in the arp8 null cells resulting in the over-production of the 
signaling molecule PIP3 resulting in an increase in the noise in the system which has 
decreased the cells ability to sense the direction from which a cAMP signal has 
emanated.
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Time point Dictybase ID/gene name Fold change up-regulated
8 hours inol 54.21
8 hours impAl 14.97
8 hours pikF 7.36
8 hours pikH 6.247
Table 4.1 Genes up-regulated involved in chemotaxis
Several genes known to be involved in Dictyostelium chemotaxis are observed to be 
up-regulated in the arp8 null cells, which could result in the over-production of PIP2 
and subsequently PIP3 at the membrane, increasing noise in the system and reducing 
the cells ability to detect a cAMP signal.
Time point Dictybase ID/gene name Fold change down-regulated
8 hours pldA 10.6
8 hours dpoA 5.7
8 hours dd5Pl 2.7
8 hours pikB 2.65
8 hours pikD 2.3
Table 4.2 Genes down-regulated involved in chemotaxis
A number of genes previously shown to be involved in Dictyostelium chemotaxis are 
seen to be down-regulated in the arp8 null cells. In two of the cases this could 
contribute to the over-production of PIP2 and subsequently PIP3 at the membrane. 
However the others may be an attempt by the cell to return these levels to normal and 
resume chemotaxis.
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4.7 Summary
• Chemotaxis is the process by which Dictyostelium aggregate under starvation 
conditions. The signaling molecule is cAMP.
• Onset of chemotaxis is delayed in arp8 null cells.
• This delay is rescued either by allowing time for the cAMP concentration to 
decrease, starting with a lower concentration of signal or treatment with 
lithium.
• These data go to show that Dictyostelium cells are able respond to a cAMP 
over a large order of magnitude. This adaptive response is controlled in part by 
the INO80 complex.
• The delay is caused by an over exaggerated response to cAMP resulting in the 
over-production of the signaling molecule PIP3 at the membrane. This 
increases the noise in the system reducing the cells ability to detect the 
external signal.
• Treatment with lithium decreases this noise by inhibiting the enzyme IMPase 
and breaking the cycle of PIP2 synthesis, therefore reducing PIP3 signalling.
• RNA-seq data also indicates a number of other genes involved in the 
chemotactic process that are disrupted by the knock out of arp8.
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Chapter 5:
The mutant LisG encodes a CHD ortholog involved in 
maintaining correct Dictyostelium development
Summary: The mutant LisG was previously identified in a screen for lithium 
sensitivity. It was shown to encode a CHROMO helicase domain containing protein 
that we have designated CHDC. Null mutants of CHDC exhibit a severe 
developmental delay with full developmental arrest occurring at the loose mound 
stage. Expression of several genes; involved in the correct differentiation of both pre­
stalk and pre-spore genes are down-regulated. The CHDC null cells also show a 
complete lack of ability to signal with cAMP throughout the population, which could 
lead to the deficiency in development. Next generation sequencing reveals a number 
of genes regulated by the CHDC re-modeler.
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5.1 Introduction to CHDC (LisG null)
Initial identification of the LisG REMI mutant came from a lithium sensitivity 
screen where it was characterized as being able to develop in the presence of lOmM 
LiCl. Inverse PCR was performed to obtain the entire open reading frame and 
Dictybase searches identified a gene of ~3000aa [Keim-Reder, PhD thesis. 2006], the 
dictybase ID being DDB_G0293012. Initial Genbank searches identified a SNF2 like 
ATPase domain of the kind found in ATP dependent chromatin re-modelers with a 
60-70% similarity between the characteristic helicase specific peptide sequences. The 
search also identified 2 CHROMO domains and a DNA binding domain, which 
classified the protein as a member of the CHD family of chromatin modifiers.
Following on from this research, further searches on the Dictybase database 
have identified 2 additional CHROMO domain containing proteins which we propose 
here to also be members of the CHD family. These can be found at Dictybase ID 
DDB_G0284171 and DDB_G0280705 Both of these protein sequences also contain 
double CHROMO domains, a SNF2 like ATPase domain and DNA binding domain 
(Fig. 5.IB). We have termed the CHD proteins CHDA through to C, with LisG being 
CHDC as it shares greatest homology to the third sub-group of higher organism CHD 
proteins particularly CHD7 and CHD8.
Whilst having a lithium resistant phenotype, earlier RT-PCR analysis of LisG 
gene expression indicated that there was still transcription of at least part of the gene 
in the REMI mutant and so further efforts were taken to knock out the whole message. 
A CHDC null mutant was created by a previous technician in the Harwood lab, Dave 
Proctor. Homologous recombination was used to insert a blasticidin resistance 
cassette into the gene, removing the majority of the functional domains. The clones 
were screened for blasticidin resistance, and the was insertion confirmed by PCR.
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Fig. 5.1 LisG is a member of the CHD family of chromatin remodelers.
A.) An alignment of the CHROMO, SNF2 and helicase domians of LisG, several 
human CHDs and the yeast CHD1. All alignments were performed with the 
CLUSTLW algorithm B.) Diagram indicating the regions that have been affected in 
each of the mutant strains LisG REMI and CHDC null. The first Bsr resistance 
cassette belongs to the REMI mutant and the second indicates the insert in the CHDC 
null strain.
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5.2 CHDC null mutants exhibit severe developmental arrest which can be 
rescued by mixing with wild-type populations.
CHDC null mutant cells were allowed to develop alongside wild-type cells on 
both nitrocellulose filters and non-nutrient KK2 agar for 24 hours, to assess their 
developmental capabilities. After 24 hours the wild-type cells formed standard full 
culminant fruiting bodies whereas the null cells only managed to attain the loose 
mound stage (Fig. 5.2A). Following on from this point the CHDC nulls continued to 
develop in an aberrant manner. Once the loose mound is formed the cells do not go on 
to form the slug structure, failing to migrate away from this initial position. As the 
structures continue to develop rather than a single spore head rising from the basal 
disk there appear to be multiple spore heads emanating from a single mound with no 
evidence of a stalk structure (Fig. 5.2B). This suggests that the CHDC null mutants 
are missing either an individual, or several, factors responsible for the correct 
differentiation of cells within the mound and subsequent developmental stages. 
Multiple spore heads arising from an individual aggregate have previously been 
attributed to the over expression of the rasD gene, which has been shown to be 
enriched in prestalk cells as the developing mound moves into the slug stage [86, 89].
Utilizing time lapse microscopy to resolve the initial stages of aggregation the 
cells do not stream but rather they tend to move around in a random pattern 
(supplementary movie; CHDCnull.avi), until they start to stick together to form rather 
clumpy aggregates (Fig. 5.2C). This is unlike the Arp8 null cells where there was a 
delay in the onset of fairly normal aggregation, producing normal looking fruiting 
bodies. This suggests a different cause behind these developmental defects observed 
in the CHDC nulls.
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However, similarly to the arp8 null cell line the CHDC null developmental 
defect can also be rescued by mixing the population with as little as 5% wild-type 
cells. This mixture of cell types then develops, forming a chimeric fruiting body. 
Varying ratios of wild-type to CHDC null cells were tried ranging from 90% down to 
1%. It appears that 5% wild-type is the lower limit for the chimeras to take on any 
morphological resemblance of a normal wild-type culminant (Fig. 5.2D). At a 5% 
chimeric cell mix the fruiting bodies do take longer than wild-type alone to develop, 
needing over 35 hours plus to reach a fully developed fruiting body and do appear 
morphologically smaller than wild-type alone. The fact that they manage to form 
mature fruiting bodies with as little as 5% wild-type cells suggests that the cells are 
not simply sorting themselves into wild-type and mutant mounds and the wild-type 
develop as there are too few in the population for this to occur. As the number of 
wild-type cells in the population increases fewer of the morphological defects are seen 
and the fruiting bodies look distinctly more like the wild-type alone and the time for 
the cells to develop also decreases.
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Fig. 5.2 CHDC cells show a severe developmental defect
A.) Wild-type and CHDC null cells were allowed to develop for 24 hours on 
nitrocellulose filters. Whilst the wild-type aggregates have reached full culmination, 
the null cells have arrested at the mound stage. B.) When allowed to develop beyond 
24 hours the CHDC nulls start to develop aberrant spore heads, often with several 
emanating from a single mound.
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Fig 5.2 CHDC cells show a severe developmental defect
C.) Still images taken from time-lapse movies of the initial stages of development at 
4X magnification. No aggregation streams are observed, with the cells seeming to 
move randomly, slowly aggregating to form loose mounds. D.) Chimeric 
developments arising from 10% wild-type mixed into the CHDC population.
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5.3 Expression of CHDC increases during the period leading up to aggregation
Dictyostelium cells have been shown to utilize a cell density recognizing 
system during the initial starvation period leading up to the aggregation period of 
development. This has been reviewed by Clarke and Gomer (Clarke and Gomer, 
1995) with the process being shown to be under the control of several secreted factors 
including the pre-starvation factor (PSF) and as mentioned earlier the conditioned 
media factor (CMF). During vegetative growth cells continuously secrete PSF the 
response to which is inhibited by the presence of a source of nutrients (bacterial or 
axenic media). However, when PSF reaches the threshold of ~ lx l06 cells/ml; the 
transcriptional initiation of several genes required for early development is activated. 
As the bacterial food supply becomes depleted, the release of PSF diminishes and the 
release of CMF increases. As mentioned earlier (Chapter 3), CMF release has been 
implicated in the initiation of cAMP signaling, aggregation and development.
If CHDC is involved in the early stages of development and related to cell 
density it would be expected that expression increases as the population expanded. 
Both mRNA and protein levels were investigated for this period, using RT-PCR and 
western blot respectively. mRNA and protein extract were taken from the same 
cultures prepared from axenically growing wild-type cells of increasing cell density, 
ranging from 5X105 to 5xl06. A 150% increase in mRNA expression is seen between 
5x10s and lxlO6 cells/ml (Fig. 5.3A) which stabilizes from this point onwards. 
Probing protein extracts with an anti-CHDC antibody also sees a similar increase in 
induction during the same time-period (Fig. 5.3B). These data suggest that CHDC 
induction is coincidental with the initiation of starvation induced development, in 
response to an increased population and decreased food source.
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Fig. 5.3 CHDC expression increases with cell density.
A.) qRT-PCR data indicating the increase in CHDC mRNA as cell density increases.
B.) Expression of CHDC protein also increases with cell density. Intensity values 
were calculated using imagej and normalised against the background on the gel. The 
top band of 346kDA is CHDC the lower bands represent protein degradation, whereas 
the smaller bands between wells are spill over due to the large volume needed to be 
loaded.
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5.4 CHDC nulls show decreased expression of both pre-spore and pre-stalk genes
To further investigate the underlying biological affects that the genetic 
ablation of CHDC has on Dictyostelium development we decided to look at the 
expression of several well documented prestalk and prespore specific genes. ecmA 
and ecmB mRNA levels were assayed by RT-PCR to examine the affects on prestalk 
specific genes [123], whilst pspA and cotB genes were investigated to identify the 
affects on prespore expression [124, 125].
Looking first at wild-type expression we see no expression of the prestalk 
genes during the first 12 hours of development with both then increasing dramatically 
beyond this point (Fig. 5.4A and B). The prespore gene cotB has a more gradual 
increase from around 4 hours into development (Fig. 5.4C). These expression patterns 
were largely in agreement with those observed in RNA-sequencing experiments 
performed by the Shaulsky lab and published online at the Dictyexpress website.
Now looking at the expression of the prestalk genes in the CHDC null mutant 
we see that there is a greatly reduced expression throughout the whole time frame of 
normal Dictyostelium development for both ecmA and ecmB although ecmA does 
show ~10 fold increase in expression over wild-type for the first 8 hours of 
development (Fig. 5.4A and B). However, the pattern of expression in the null cell 
line follows that of the wild-type cells, yet on a scale several orders of magnitude less, 
ranging from ~5 fold to ~25 fold less. Similarly, the expression patterns of the 
prespore genes pspA and cotB are both similarly decreased, once again also following 
similar developmental expression pattern (Fig. 5.4C). Judging from these data it can 
be decided that CHDC plays an important role in the regulation of both prespore and 
prestalk genes during normal Dictyostelium development in wild-type cells, whether 
this role is direct or not can not be elucidated from this experiment.
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Fig. 5.4 Expression profiles of genes marking pre-stalk and pre-spore cells
Analysis of the mRNA levels present in wild type or chdC null cells by QRT-PCR. 
All expression is normalized to AX2 OH which is given a 100% expression value. All 
genes analyzed show a similar expression pattern with there being a large decrease in 
transcription in both pre-spore and pre-stalk genes.
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5.5 CHDC null cells show a deficiency in cAMP signaling during aggregation
The dark-field time lapse microscopy technique was utilised once again to 
visualize the cAMP signaling throughout the population of cells. To recap, as the cells 
move through the population towards the cAMP source they change morphology 
which creates a change in the light reflective pattern visible through the microscope 
appearing as spiral waves and concentric circles of movement through the population. 
The CHDC null cells do not appear to produce any manner of consistent cAMP 
movement patterns through the population. There do appear to be random bursts that 
appear sporadically and do serve to partially direct the cells towards an aggregation 
center (Fig. 5.5). Once the cells have managed to aggregate into a loose mound there 
do appear to be intense pulses of cAMP throughout the structure. However, this does 
not appear to be satisfactory to progress beyond this structure.
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B.
C.
Fig. 5.5 There are distinct deficiencies in CHDC null cell cAMP signalling.
Single frame still images extracted from supplementary movies ax2cAMPpulse.avi, 
CHDCcAMPpulse.avi, and 10%mixCHDCcAMPpulse.avi A.) Wild-type cells show 
the characteristic spiral pattern of cAMP pulses moving through the population. These 
pulses initiate after approx 4H. B.) chdC null cells do not show this any characteristic 
pulsing patterns once signaling has initiated. Signaling appears to be constrained 
within the confines of the lose mound and not beyond. C.) When the population of 
null cells is mixed with as little as 10% wild-type cells then some cAMP signaling 
does return. An arm of a spiral is visible in the center of the image
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5.6 RNA-seq reveals more insight into the changes in gene expression brought 
about by CHDC during development
RNA-seq was again employed to assess the global changes in transcription 
seen between wild-type and CHDC null cells. This will give a better understanding of 
the processes regulated by this chromatin re-modeler during starvation induced 
development. The time points chosen for analysis with this mutant were 0 hours 
(vegetative growth) and 12 hours into development as this was roughly the time that 
the aggregating cells have reached the loose mound stage and development arrests. 
Therefore it should be possible to elucidate at least some of the genes and or 
processes that are mis-expressed and involved in producing this phenotype.
The experiments were carried out and the data analyzed along the same 
pathway as was used to investigate the arp8 null mutant in chapter 3. Galaxy quality 
control scores were all good and indicated no need to trim the sequences. The 
Illumina reads were aligned to the Dictyostelium discoideum AX4 genome and 
subsequent calculations were all carried out using the Arraystar software. Direct 
comparisons were made between AX2 and chdC null at both vegetative stage and 12 
hours into development to give the most complete view of the changes in expression 
between the mutant and wild-type. For each time point the data was normalized to the 
base level of 6 read counts, through the Arraystars inbuilt filters. This base level was 
previously decided to be the level for un-expressed genes (see chapter 2). To ensure 
that we are looking at real changes in gene expression a base limit of 2-fold change in 
gene expression was taken either up or down. Changes below this were discarded 
through Arraystars filtering system. When addressing the total numbers of genes 
affected, it is observed that there are many less affected by the knock out of chdC 
during vegetative growth than later on in development (Fig. 5.6 plus Table 5.1).
Looking through the data for notable genes that are up-regulated in chdC null 
at OH identifies a small number which may be at least in part responsible, or involved 
in, the developmental arrest phenotype observed.
gmsA encodes the gamete and mating specific protein. This is one of several 
proteins involved in sexual cell fusion and the recognition of different mating types. 
Knock outs of gmsA have been shown to be incapable of undergoing sexual 
development [128]. Expression of this gene could be increased to encourage sexual 
development in these cells as they cannot develop normally. This is could occur if this 
re-modeler worked to inhibit the expression of sexual development genes but is more 
likely an indirect affect of knocking out chdc.
Conversely to what is seen with the arp8 null, the gene dscA, encoding 
discoidin, is seen to be up-regulated. Discoidin is expressed during early development 
and is involved in the initiation of the starvation response [113]. This would make you 
expect the cells to enter development early if anything yet they develop along a 
normal time frame to wild-type cells during the aggregation phase, suggests that this 
process is not under the control of discoidin alone.
3B-1 (and 3B-2) is a prespore specific gene, once again normally expressed 
later in development [120]. Expression of this gene was also seen to be higher in the 
arp8 null cells where it was in opposition to the general pattern of developmental 
gene expression.
Looking for genes that are down-regulated in the chdC null during vegetative 
growth yields some extremely interesting results. One of the genes with the largest 
difference in expression between wild-type and mutant cells is yelA. This gene 
encodes an elongation initiation factor; eIF-4, involved in the regulation of terminal 
differentiation. Knocking out this gene has been shown to give a phenotype almost
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identical to that of the arrested development phenotype of the chdC null mutant. This 
is that they produce loose yellow colored mounds, where development arrests and 
they also have been shown to produce aberrant cAMP wave patterns [129]. It is 
highly likely that the developmental phenotype observed in the null cells is directly 
due to the down-regulation of this elongation initiation factor. However, there may 
also be other factors involved in producing this phenotype and also other affects of the 
knock out of chdC on the cells that are less strikingly apparent.
A number of factors associated with the countin complex were also seen to be 
down-regulated in these cells. The countin complex is involved in sensing and 
regulating the size of aggregates. cJ60, cf45, cfaA and cfaB are all decreased in 
expression suggesting these cells may have a decreased ability to create normal sized 
aggregations and therefore produce incorrect mound sizes [115]. This does in fact 
occur with chdC null mounds appearing highly varied in size.
Similarly to the arp8 null cells gdtl is again seen to be down-regulated in the 
chdC null strain. The growth development transition factor 1 expression is down three 
fold in these mutants. This protein is responsible for regulating the entry into the 
developmental cycle and is seen to directly repress the function of discoidin [118].
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Fig. 5.6 CHDC knock out affects a greater number of genes following 12 hours of 
starvation.
Scatter plots indicating the fold change in gene expression comparing A.) Wild-type 
and null cells during vegetative growth and B.) wild-type and null cells after 12 hours 
of starvation. Points above the line represent an increase in expression, those below 
exhibit a decrease. A much larger number of genes, both up and down regulated, is 
seen on the 12 hour plot, suggesting that the CHDC re-modeler plays a more 
significant role through development
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Time point Total genes down- 
regulated
Total genes up- 
regulated
Total genes 
affected
0 hours 562 264 826
12 hours 2140 995 3135
Table 5.1 Summary of genes affected by chdC knock out.
After excluding all results with an expression count reading less than 6 the total 
number of genes affected by the knock out of chdC are summarized above. Once 
again it is observed that there are nearly four times as many genes affected after 12 
hours of starvation indicating that the CHDC re-modeler plays an extremely 
significant role at this point of development.
Time point Dictybase ID/gene 
name
Fold change up- 
regulated
Found in ChlP- 
seq data?
0 hours gmsA 10 +
0 Hours dscA 6 -
0 Hours 3B-1 (and 3B-2) 5 +
Table 5.2 Genes up-regulated during vegetative growth.
A small subset of the genes up-regulated in the chdC null cells compared to wild-type 
during vegetative growth. These genes are all possible candidates for contributing 
early to the arrested development phenotype observed.
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Time point Dictybase ID/gene 
name
Fold change down- 
regulated
Found in ChlP-seq 
data?
0 hours yelA 8 +
0 hours cf60 4 +
0 hours cf45 4 +
0 hours cfaA 3 +
0 hours cfaB 3 +
0 hours gdtl 3 +
Table 5.3 Genes down-regulated during vegetative growth.
A small number of the genes that are seen to be down-regulated in the chdC null cells 
compared to wild-type during vegetative growth. All of these genes could be 
potentially responsible for contributing to the arrested development phenotype 
observed in the null cells.
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5.7 RNA-seq data reveals the genes which are affected by CHDC at the loose 
mound stage during Dictyostelium development
Similarly to the arp8 null mutant there are a much larger number of genes 
affected by knocking out chdC later in development. 12 hours after starvation both 
wild-type and the mutant have reached a loose mound stage and this is where 
development arrests for the null cells. Looking at the total number of gene affected by 
the knock out nearly four times as many genes are mis-expressed, being either up- or 
down-regulated in the null cells at 12 hours compared to those affected during 
vegetative growth.
The gene encoding the eIF-4 initiation factor is still seen to be down-regulated 
by 8 fold suggesting that this decrease in expression is consistent through 
development. As the change in expression of this gene is identified as a likely 
candidate for causing the developmental arrest and disrupted cAMP signaling 
patterns, this lends further weight to this hypothesis.
There are also a large number of down-regulated genes involved in the 
differentiation of pre-spore and pre-stalk cells which is unsurprising as these cells 
arrest at the mound stage and do not ever manage to form the spore or stalk structures. 
These include the genes identified as being down-regulated by qRT-PCR: ecmA, 
ecmB, pspA and cotB. Further genes found in these families are also see to be down- 
regulated, including; cotC, cot A, cotD, pspB and pspD (Table 3). The fourth cAMP 
receptor to be developmentally expresses; CAR4 is encoded by the gene carD [42]. 
This particular receptor is involved in the final stages of culmination. In these null 
mutant cells the expression is seen to be decreased at the time of developmental 
arrest. Conversely to what was seen in vegetative chdC null cells the pre-spore 
specific genes 3B1 and 3B2 are down-regulated. These genes have been seen to
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increase in expression through development in wild-type cells, yet in these mutants 
have the opposite expression pattern [120]. All of these genes being down-regulated 
could be due to a direct affect of knocking out chdC but also may result from an 
indirect knock on effect occurring when the direct targets are down-regulated.
One gene group which may affect the transcription of these genes is the pre 
spore initiation factor (PSI) family. Several of these genes are down-regulated in the 
null cells including; psiC, psiR and psiJ. These genes are seen to have maximal 
expression at the loose mound stage in wild-type cells. They have been reported to 
control the differentiation of both pre-spore and pre-stalk cells [122].
Another entire gene family that is down-regulated in these cells is the 
structural maintenance of chromosome family. This family of proteins is involved in 
the maintenance and dynamic restructuring of chromosomal conformation during the 
cell cycle. They have been identified as playing roles in sister chromatid cohesion, 
chromosome condensation, DNA recombination and repair, and gene dosage 
compensation, reviewed in [130]. They play a major role in both mitotic and meiotic 
cell division and mis-expression are thought to be involved in a number of human 
diseases. The decrease in expression of these genes may be a direct effect of the 
knock out of chdC, however it is also likely that this may a secondary effect of the 
developmental arrest whereby cell division is no longer required and so machinery 
involved in this process down-regulates. Further evidence supporting this theory 
comes from the observation that the gene encoding the proliferating cell nuclear 
antigen (PCNA); pcna is also transcriptionally reduced at this developmental time- 
point. PCNA is responsible for clamping the DNA polymerase complex to the DNA 
allowing for efficient transcription. Nuclear DNA synthesis has previously been 
shown to occur during later developmental stages, using a GFP fused PCNA protein
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with cells undergoing DNA synthesis in the final stages decreasing to less than 1% 
[131]. A decrease in pcna expression at 12 hours in the chdC null cells along with the 
decrease in the smcl-6 gene family indicates that DNA synthesis has been reduced 
and is in concordance with the idea that these cells have preparing to enter the 
sporulation stage early, missing out the developmental stages between there and the 
mound stage.
Whilst there are half as many genes up-regulated as down, there are a large 
number which play a role in development. Similarly to the arp8 null mutant a number 
of the genes involved in the production of ribosomes exhibit increased transcriptional 
activation over the wild-type.
Interestingly one of the genes with the highest level of increased expression 
over wild-type is gdcA a GP64 and disintegrin like protein, which in other species 
falls within the category of the ADAM proteins (A Disintegrin And Melloproteinase). 
These are a family of secreted and transmembrane proteins that play a significant role 
in regulating cell migration, adhesion, signaling and proteolysis through their function 
of “shedding” cell surface molecules [132]. GP64 has been identified in 
Polysphondilium pallidum where it was shown to be a cell surface receptor that was 
maximally expressed during vegetative growth this then decreases during 
development [133]. It is possible that, in vegetative wild-type Dictyostelium, this 
protein is regulating the production of development specific cell surface proteins. 
Once development is entered its expression decreases allowing for the correct 
expression of cell surface receptors and subsequent chemotaxis and adhesion. In the 
chdC null cells if this protein were up-regulated these cell surface proteins would still 
be being “shed” and would lead to incorrect development.
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Contrary to what is seen during vegetative growth, where proteins associated 
with the counting factor (CF) complex are down-regulated, the gene ctnA, encoding 
Countin, is over-expressed 12 hours into development. The CF complex in this case 
could be having a similar effect to treating the cells with recombinant or semi-purified 
countin where motility is increased but cell-cell adhesion is decreased [134].
Looking through the list of genes mis-expressed in the chdC null there are a 
large number of candidates for those responsible for producing the arrested 
development phenotype. It is unlikely to be one of these genes in particular that is 
creating this effect but more a number of them working in concert. Also, it is possible 
that a large number of them are not directly affected but are an artifact caused through 
the direct mis-expression of other genes. To address this problem and to identify 
which genes are directly bound by the CHDC enzyme a ChlP-sequencing experiment 
was designed.
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Time point Dictybase ID/gene 
name
Fold change down- 
regulated
Found in ChlP-seq 
data?
12 hours psiC 25397 +
12 hours cotC 11736 +
12 hours cotA 3324 +
12 hours pspB 2414 +
12 hours pspD 2348 -
12 hours cotD 1365 +
12 hours cotB 1211 +
12 hours ecmA 673 +
12 hours psiR 574 +
12 hours psiJ 258 +
12 hours ecmB 72 +
12 hours carD 32 +
12 hours 3B-1 (3B-2) 13 +
12 hours yelA 8 +
12 hours smcl 5 +
12 hours smc2 4 +
12 hours smc3 7 +
12 hours smc4 7 +
12 hours smc5 3 +
12 hours smc6 3 +
12 hours pcna 5 +
Table 5.4 development associated genes down-regulated 12 hours into starvation.
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Time point Dictybase ID/gene 
name
Fold change up- 
regulated
Found in ChlP-seq 
data?
12 hours rps24 45 -
12 hours rpll5 38 +
12 hours rps2 30 +
12 hours rpsl7 29 -
12 hours rplll 28 -
12 hours rpl4 28 -
12 hours rpsl5 25 +
12 hours rps7 25 +
12 hours rpl3 25 -
12 hours rpl38 21 -
12 hours gdcA 246 +
12 hours ctnA 41 +
12 hours nap1 30 -
Table 5.5 development associated genes up-regulated 12 hours into starvation
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5.8 ChlP-seq data reveals the pattern of re-modeler binding throughout 
development.
A ChlP-sequencing investigation was designed to assess the binding of the 
CHDC re-modeler throughout the first 12 hours of starvation induced development. 
This would hopefully provide some insight as to the direct interactions of this 
complex across the genome and development. ChIP experiments were performed as 
described in Chapter 2 using the anti-CHDC antibody raised against the N-terminal 
region of the CHDC protein. As this antibody was not seen to bind completely cleanly 
to CHDC (Fig. 5.3), with a number of other bands sometimes being observed on 
western blots, the ChIP experiments were also performed on the chdC null mutants 
for each time point to provide a suitable negative control. We finally ended up 
sequencing 9 samples: wild-type 0, 4, 8 and 12 hours, plus chdC null 0, 4, 8, and 12 
hours and also a no IP input sample. Once ChIP DNA was prepared it was assayed for 
specificity using PCR with primers designed towards the inol gene. Finally samples 
were adaptor ligated using the Illumina ChlP-seq adaptor ligation kit following the 
standard protocol, with minor modifications described in Chapter 2. The samples 
were sequenced using an Illumina Genome analyser II sequencer, courtesy of Dr. 
Alan Kimmel at the NIH, the data was output using the 1.6.47.1 pipeline.
Data analysis was performed using the CLC genomics workbench software 
provided by CLCbio. First the reads are imported into the software, along with the 
Dictyostelium discoideum AX4 reference genome and the reads are then mapped onto 
this reference genome, once again allowing for up to 3 mismatches during this 
process. Once aligned the sequence was run through CLC genomics work bench peak 
finder to identify regions of sequence enrichment and therefore regions where the 
CHDC re-modeler is likely to be bound. This process incorporates the ability to
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supply a negative control method to account for any background reading and for this 
the alignments for the chdC null runs were used. The software produced a list of 
genes for each of the developmental time points and these were then exported and 
examined using Microsoft Excel.
Once the gene lists were created for each time point it became apparent that 
there were a very similar number of genes bound across development, all being in the 
region of 8000 and varying by less than ~500 genes. This made me think of the 
possibility that the re-modeling factor stays persistently bound to the same genes and 
that expression is modulated by other factors binding or modifying the enzyme. To 
assess this possibility the VLOOKUP function of Excel was utilised. This process 
simply compares data in one cell to lists found in others, looking to see if that data 
occurs again within the set. Using this system it is shown that 5743 (approx 75%) of 
the genes are found in all four of the gene sets across the first 12 hours of 
development (Fig. 5.7). This is a very high percentage and suggests that a large 
number of genes are indeed persistently bound by this factor. Further investigations 
may be made into this in future as to the binding partners of CHDC along the genome. 
It has been shown in other organisms that CHD8 (homolog of CHDC) associates with 
the factor CTCF [90] which in turn has been shown to co-localise with cohesion 
[135]. In a similar report cohesions have been shown to reside at the same locus 
throughout cell division and also guide transcription by targeting factors such as 
CTCF and CHD8, it could be possible that a similar system is at work in 
Dictyostelium.
Using this data it is also possible to identify the genes that were mis-expressed 
in the RNA-seq data and were directly bound by the CHDC factor. Once again the 
VLOOKUP process available in Excel was employed to identify these. Once all of the
143
genes were identified the FIND function was utilised to search for the genes identified 
earlier as possibly being involved in producing the chdC null phenotype.
Fig.s 5.8 - 5.11 graphically represent the number of mis-regulated genes 
directly bound by the CHDC re-modeler during vegetative growth and at 12 hours 
into development. A large number of the genes affected by knocking out chdC are 
seen to be directly bound by the factor. The other genes are assumed to be indirectly 
affected and a knock on affect of the mis-regulation of the directly affected genes. 
The final column in Tables 5.2 -  5.5 represents whether the gene was also identified 
in the ChlP-seq data or not.
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Fig. 5.7 A large portion of genes are consistently bound throughout development
The Venn diagram describes the number of genes bound by the CHDC re-modeler at 
each developmental stage investigated. The total number of genes appears to be quite 
consistent across development, with approximately 75% of the genes being bound at 
all stages. Values were calculated from ChlP-seq data produced by CLC genomics 
workbench and sorted using the VLOOKUP function in Microsoft Excel 2003.
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Fig. 5.8 A large percentage of the genes down-regulated during vegetative growth 
are bound by the CHDC re-modeler
The Venn diagram describes the number of genes down-regulated in the chdC null 
mutant during vegetative growth and that are also bound by the CHDC re-modeler in 
wild-type cells. Values were calculated from ChlP-seq data produced by CLC 
genomics workbench, RNA-seq data produced by DNA star Array star and sorted 
using the VLOOKUP function in Microsoft Excel 2003.
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Fig. 5.9 A large percentage of the genes up-regulated during vegetative growth 
are bound by the CHDC re-modeler
The Venn diagram describes the number of genes up-regulated in the chdC null 
mutant during vegetative growth and that are also bound by the CHDC re-modeler in 
wild-type cells. Values were calculated from ChlP-seq data produced by CLC 
genomics workbench, RNA-seq data produced by DNAstar Arraystar and sorted 
using the VLOOKUP function in Microsoft Excel 2003.
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67% of down-regulated genes
Fig. 5.10 A large percentage of the genes down-regulated after 12 hours of 
starvation are also bound by the CHDC re-modeler
The Venn diagram describes the number of genes down-regulated in the chdC null 
mutant 12 hours after initiation of development and that are also bound by the CHDC 
re-modeler in wild-type cells at this time point. Values were calculated from ChlP-seq 
data produced by CLC genomics workbench, RNA-seq data produced by DNAstar 
Arraystar and sorted using the VLOOKUP function in Microsoft Excel 2003.
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seq
59%
Fig. 5.11 A much lower percentage of the genes up-regulated after 12 hours of 
starvation are also bound by the CHDC re-modeler
The Venn diagram describes the number of genes up-regulated in the chdC null 
mutant 12 hours after initiation of development and that are also bound by the CHDC 
re-modeler in wild-type cells at this time point. Values were calculated from ChlP-seq 
data produced by CLC genomics workbench, RNA-seq data produced by DNAstar 
Arraystar and sorted using the VLOOKUP function in Microsoft Excel 2003.
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RNA-
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5.9 Summary
• Lithium resistant mutant LisG is a CHD family ortholog that shares most 
homology with the group of CHD proteins including human CHD6-9 and has 
now been termed CHDC. A full knock out of CHDC was analysed: CHDC 
null.
• Expression of CHDC in wild-type cells increases with cell density, implying a 
role in early development.
• CHDC null phenotype is a developmental arrest at the mound stage after less 
than 12 hours of development. This developmental arrest can be rescued by 
creating mixed populations with as little as 5% wild-type cells. CHDC null 
cells exhibit a severe deficiency in cAMP signaling during aggregation.
• CHDC null cells show a decreased expression of both pre-spore and pre-stalk 
genes suggesting a role in regulating genes involved in differentiation.
• RNA-seq identifies a much larger group of genes that are mis-expressed 
during development. Several of these, including the gene yelA may be directly 
responsible for the developmental phenotype.
• ChIP_seq shows that approximately 75% of the genes bound by the factor 
during development are done so consistently across this period.
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Chapter 6:
CHDC affects lithium sensitivity
Sumary: Starving Dictyostelium cells are capable of chemotaxing towards a cAMP 
signal. In wild-type cells lithium has been shown to inhibit this process, greatly 
reducing the cell’s ability to follow a cAMP gradient. Here two mutations in the same 
gene, CHDC result in two allelles each responding in two opposite ways to both a 
cAMP gradient and to lithium treatment. LisG REMI shows enhanced chemotaxis 
which is reduced when treated with lithium. CHDC null cells are severely 
chemotactically impaired and when treated with therapeutic levels of lithium are 
rescued and chemotaxis is improved.
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6.1 The LisG REMI exhibits an improved chemotaxis which provides it with 
lithium resistance.
It has been shown in earlier chapters that novel evidence exists to suggest that 
Dictyostelium are capable of responding to chemoattractants across a large order of 
magnitude and are able to attenuate their response to these varying concentrations 
through changes in gene expression leading to a switch between signaling 
mechanisms. Here in this brief final chapter another new phenomenom in this field 
will be introduced and that is for two alleles of the same chromatin re-modeler to have 
opposing phenotypes and to respond to lithium treatment in converse ways also.
These two alleles are the two CHDC mutants described in the introduction to 
chapter 5. One has an insert between the first and second open reading frame and 
produces an almost full length transcript, yet is resistant to lithium and the second is 
the CHDC null mutant which has had the entire region that contains the CHROMO 
domains, ATPase domain and the helicase domain genetically ablated.
These experiments were once again carried out in a zigmond chamber with 
cells that had been pulsed for 5 hours with IpiM cAMP to place them in what is 
considered to be a chemotactically competent state. In this case looking first at the 
LisG REMI mutant it is seen that they appear to be more chemotactically competent 
than wild-type cells. They move with a better Cl and with a quicker speed towards the 
cAMP source (Fig. 6.1).
When wild-type cells are treated with 2mM lithium, within the therapeutic 
dose, they are seen to both inhibit development and disrupted chemotaxis. The affects 
on chemotaxis are to cause a reduction of speed and directionalty resulting in the cells 
inability to correctly sense the gradient and therefore not develop properly [1].
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Several mutants have been identified which are resistant to this affect of lithium on 
chemotaxis and these are of express interest to us.
One such mutant is LisG REMI, and when you look at the affects of lithium 
on chemotaxis it is noticeable that lithium does cause a marked reduction in the cells 
chemotactic ability (Fig. 6.1). However, it is not a large enough reduction to drop this 
ability much below that of wild-type cells. This could in principle be explained by the 
LisG REMI cells having a faster speed and Cl already counteracting the effect of 
lithium on the cells. This would suggest that one of the internal signaling pathways is 
over stimulated in these cells, which is then reduced along the same mechanisms that 
cause the defects in wild-type chemotaxis. This would lead to the cells appearing to 
have a resistance to lithium, when in fact they do not. They actually have acquired a 
buffer against its effects.
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Towards
cAMP
source
AX2
B.
LisG
REMI
Sample Chemotactic index (C l) Directionality Speed
A X 2 0.9±0.17 0.81±0.17 9.6±4.4
LisG REMI 0.74±0.52 0.62±0.28 12.65±4.57
LisG REM I + 7mM LiCI 0.66±0.17 0.56±0.30 6.4±3.07
Fig. 6.1 The LisG REMI mutant is protected against the effects of lithium
A.) Traces taken from 3D-DIAS software that outline the movement of 20 randomly 
selected cells taken from a pool collected over 3 days. LisG REMI cells display 
increased chemotactic speed which is reduced upon addition of lithium. B.) The 
values for Cl, directionality and speed as calculated by 3D-DIAS.
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LisG REMIn 
+7mM LiCI
6.2 The CHDC null mutant shows an opposite response to both chemoattractant 
and lithium treatment.
Looking at the CHDC null cell traces there is an obvious large difference 
between the two mutants. The REMI cells are capable of chemotaxing extremely 
efficiently up the cAMP gradient with comparable directionality and Cl to wild-type 
cells whereas the null cells show a severely decreased ability to move towards the 
cAMP source. They move erratically with a reduction in speed and almost no ability 
to sense the gradient whatsoever, randomly changing direction constantly (Fig. 6.2). 
Both the Cl and directionality are reduced significantly. This movement is not like 
migrating vegetative cells looking for food. It is as if the pathways that trigger 
development have been activated yet the directional sensing mechanisms have been 
impaired.
Conversely the CHDC null cells are rescued by treatment with the same dose 
of lithium as inhibits chemotaxis in wild-type and LisG REMI cells. There is a large 
improvement in their sensing of the gradient, with increases in directionality, Cl and 
speed. This is in stark contrast to the other allele: LisG REMI. This suggests that in 
each case there is a different system being affects. In this case it is likely that the loss 
of the chromatin re-modeler has affected one or more signaling systems resulting in 
the cells inability to sense the gradient, which is once again improved by inhibiting 
one of the molecular targets of lithium.
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A Towards .  cAMP 
source
CHDC
null
CHDC null 
7mM LiCIAX2
B.
Sample Chemotactic index (Cl) Directionality Speed
AX2 0.9±0.17 0.81±0.17 9.6±4.4
CHDC null 0.74±0.52 0.62±0.28 12.65±4.57
CHDC null + 7mM LiCI 0.66±0.17 0.56±0.30 6.4±3.07
Fig. 6.2 The CHDC null mutant shows greatly impaired chemotaxis that is 
rescued by lithium treatment.
A.) Traces taken from 3D-DIAS software that outline the movement of 20 randomly 
selected cells taken from a pool collected over 3 days. chdC nulls display decreased 
ability to chemotax which is rescued when treated with 7mM LiCI as opposed to the 
REMI cells. B.) The values for Cl, directionality and speed as calculated by 3DD1AS.
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6.3 The chemotactic response to lithium is possibly controlled, at least in part, by 
the relative expression of the inositol biosynthetic genes inol and im pAl.
Previous investigations into the genetic affects associated with the LisG REMI 
mutant identified an increase in the expression of the gene encoding myo-inositol 
synthase; inol [56] during vegetative growth. Further work showed that over 
expression of both inol and another gene involved in the biosynthesis of inositol, 
impAl encoding IMPase, conferred upon wild-type cells the ability to both chemotax 
and fully develop in the presence of therapeutic levels of lithium [24]. The role of 
these genes in relation to Dictyostelium chemotaxis has been discussed in previous 
publications from our lab [136]. When more closely examining the results reported in 
the King et al paper [24] it is seen that in fact the cells over-expressing inol and 
impAl move with a considerable increase in speed, similar to that which is seen with 
the LisG REMI mutant. As this mutant has been shown to have increased inol 
expression it seemed that the expression of these genes may play a significant role in 
the control of Dictyostelium chemotaxis. However, earlier in chapter 4 my work with 
the arp8 null cells has suggested that over-expressing inol and impAl will inhibit 
chemotaxis through over production of PIP3 so there may be another process at work 
in the case of LisG REMI mutant It could also be possible that the entire system is 
up-regulated rather than just these two genes.
Looking at the expression levels of both inol and impAl in the CHDC null 
mutant (Fig. 6.3) it is observed that whilst there is a large increase in the expression of 
impal during vegetative growth this does then decrease during the first few hours of 
development staying low for the duration of development. Interestingly the expression 
of inol is decreased during vegetative growth, the opposite to what was found at this
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A -  C 125*i Ax2 inol 
CHDC null inol
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Time through development
Ax2 impal 
CHDC null impal
B. in o l
Time through development
impA1
1 2 3 4 1 2 3 4
Fig. 6.3 Both inol and impAl show different expression patterns in the CHDC 
null cells
A.) Analysis of the mRNA levels present in wild type or CHDC null cells by QRT- 
PCR. All expression is normalized to AX2 OH which is given a 100% expression 
value. impAl whilst initially higher, shows a similar expression pattern in both wild- 
type and null cells, dropping off over the early stages of development. Null cell 
expression of inol is converse to wild-type with expression increasing over the first 
12 hours as opposed to dropping. B.) ChIP with our anti CHDC antibody indicates 
that the CHDC chromatin re-modeler directly interacts with both the inol and impAl 
promotors. 1- anti CHDC, 2 - just beads, 3 - anti RNApolII 4 - Genomic DNA 
control.
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stage in the LisG REMI mutant. The expression during vegetative growth is reduced 
to ~50% of the levels found in wild-type cells and appears to rise during 
developmental onset, with a peak occurring at around 12 hours into development.
ChlP-PCR, performed on DNA IP’ed from cells growing vegetatively, 
indicate that the CHDC factor directly binds both the inol and impAl promotors (Fig. 
6.3). This is consolidated by expression increases identified in the RNA-seq data. 
Analysis of the expression of inol indicates a rise from a non significant difference 
during vegetative growth to a 27 fold increase over wild-type levels at 12H into 
starvation (Table 6.1). impal expression is seen to be increased 2 fold in vegetative 
cells whereas there is no difference at 12 hours. This is in stark contrast to what is 
observed in wild-type cells where inol expression mirrors that of impAl and starts 
high, slowly decreasing across the first four hours of starvation to ~20% of that seen 
during vegetative growth. Theoretically this increase in inol could result in the 
production of an excess of inositol monophosphate which may competitively inhibit 
the action of IMPase which would be decreasing during this time. Such an inhibition 
would result in a decrease in PIP2 production and subsequently a lack of PIP3 for 
signaling in response to chemotaxis. This would result in a lack of directional sensing 
in the cells causing them to move more erratically.
A cell over-producing inositol monophosphate would be more sensitive to the 
effects of lithium. Lithium, which acts as a non-competitive inhibitor of both IMPase 
and IPPase [2] could break this cycle prior to IMPase decreasing the free inositol 
levels, along the same lines as the inositol depletion theory. This would dampen the 
whole system raising the PIP2 concentration to near wild-type levels and restoring 
chemotaxis.
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6.4 Genes involved in chemotaxis identified by RNA-sequencing.
The RNA-seq data, produced in Chapter 5, includes a number of genes 
previously shown to be involved in the control of chemotaxis towards a cAMP source, 
in both the up- and down-regulated lists. As I mentioned above both inol and impAl 
are mis-expressed in the chdC null. Further to these, at 12 hours after starvation, the 
5’ phosphatase 3 gene dd5P3 is down-regulated 3 fold. This phosphatase is also 
involved in the regulation of the inositol phosphates, exerting its de-phosphorylation 
action at several points in the pathway, specifically at the point of I(1,4,5)P3 to 
I(1,4)P2 [137, 24]. A decrease in the production of this phosphatase would deplete the 
cellular levels of I(1,4,5)P3. Recent data suggests that increased I(1,4,5)P3 can reduce 
PTEN expression providing a second feedback loop which would function alongside 
the up-regulation of pic and inol to modulate PIP3 signaling (personal communication 
from Regina Teo).
The second down-regulated gene is gcA which encodes the Guanylyl Cyclase that has 
been reported to play a key role in regulating chemotaxis [138]. Guanylyl cyclase 
produces the signaling molecule cGMP which has been implicated the correct 
formation of myosin fibers at the rear of the chemotaxing cell, which are involved in 
the retraction of the uropod [139]. Knocking out this gene in wild-type cells causes a 
severe disruption to chemotaxis and its down-regulation in these cells may be 
contributing to the chemotactic deficiency observed. The defect is characterized by 
the production of pseudopods over the whole surface of the cell, a behavior also 
exhibited by the chdC null cells which is clearly seen when watching the 
supplementary chemotaxis movie chdCnullct.avi. This pathway has not been reported 
to be a target of lithium and so it is not to be expected that the rescue of the defect by 
lithium would be due to an affect on this observation.
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The largest number of genes identified, that are likely to be involved in the 
disrupted chemotaxis phenotype are up-regulated at 12 hours into development. It 
should be noted that most of the cells have finished chemotaxing at this point and 
these mis-expressions are only being suggested as possibly involved in this process. 
Further analysis of 4 and 8 hour time points is required to gain true insight into the 
genes affected during this process.
The first of these genes that has previously been shown to play a role in 
Dictyostelium chemotaxis is pic. This produces Phospholipase C which is involved in 
catalyzing the reaction: PIP2 to I(1,4,5)P3 and Diacylglycerol (DAG) when cells 
receive external stimuli. In the case of this mutant this may also be serving to reduce 
the free pools of PIP2 in the cells and having an adverse affect on chemotaxis by 
reducing PIP3 mediated signaling. This would also increase the amount of I(1,4,5)P3 
in the cell, possibly necessitating the requirement for more 5’ phosphatase 3 to then 
decrease this. This would also result in a feedback loop producing more inositol (1) 
phosphate which may, by my earlier theory, inhibit IMPase further.
A second gene involved in PIP3 related signaling is up-regulated and this is 
pkbA. This is the non-myristolated form of protein kinase B (PKB) is normally found 
in the cytosol but which translocates to the membrane in a PI3-kinase dependent 
manner upon stimulation of the cell with cAMP [33] resulting in activation of the 
TORC2 complex. Once again it is likely that this up-regulation is an indirect affect of 
the decrease in PIP2 levels and that more PKB is made available to maximize the 
affect of what little PIP3 synthesis may occur.
A number of genes involved in the SCAR/WAVE and Arp2/3 complexes are 
seen to be up-regulated in these cells. These complexes are both involved in the 
positive regulation of actin polymerization, with SCAR/WAVE activating Arp2/3.
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Both have also been shown to be actively involved in the chemotactic process [140, 
141, 142]. The gene pirA encodes a member of the SCAR/WAVE complex and Arp3 
is produced by arpC. Both of these are seen to be up-regulated, along with arcD and 
arcB, two actin binding proteins reported to associate with the Arp2/3 complex. 
Whilst no literature regarding the over-expression of any of these genes was available 
it could be considered that an increase in the machinery responsible for producing 
actin polymerization could indeed increase this process and when coupled with the 
previously reported increase in gcA expression lead to an increase in lateral and 
dorsally produced pseudopods.
Further related to chemotaxis, in particularly cAMP signaling, three genes 
encoding phosphodiesterases show increased expression in the null cells. These three 
are pdsA, regA and pde7. The phosphodiesterases are responsible for both the external 
and internal degradation of cAMP and are key to regulating this important signaling 
molecule during development. Earlier in this thesis the developmental expression of 
pdsA was discussed. This is reported to start low, increases over the first 4 hours then 
decreases sharply after this point to a low peak at 12 hours. This data is unavailable 
for the other two genes. A key role for these phosphodiesterases was suggested in the 
initiation of characteristic cAMP signaling patterns [54]. The hypothesis suggests that 
signaling starts weakly with the cAMP emanating from a signaling center in a tight 
concentric circle. This pattern of signal release does not allow for a refractory period 
between the pulses and the cells at the aggregation center are required to keep pulsing 
for maintenance of the signaling. When the cAMP pulses meet others spreading 
throughout the population, they become disrupted and produce characteristic spiral 
waves. This allows time for reduction of cAMP levels by the phosphodiesterases 
allowing the cells to recover and become responsive to cAMP once again. Along the
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lines of this hypothesis if the phosphodiesterases were to be increased then the signal 
would be reduced too much and cAMP pulsing would become disrupted, much like 
what is seen with the chdC null mutants (Chapter 5, Fig. 5.6, Supplementary movie 
CHDCcAMPpulse.avi). Therefore, the over-expression of the phosphodiesterases in 
the null cells may produce the disrupted cAMP signaling observed in the null cells. 
Looking at the ChlP-seq data to identify whether any of these genes are also directly 
bound by the CHDC factor the VLOOKUP and FIND functions of Microsoft Excel 
was once again employed. The final column in Tables 6.1 and 6.2 indicates whether 
the gene identified was also directly bound by the re-modeler.
Time point Dictybase ID/gene 
name
Fold change down- 
regulated
Found in ChlP-seq 
data?
12 hours dd5P3 3 -
12 hours gcA 3 +
Table 6.1 Genes down-regulated involved in chemotaxis
A small number of genes previously shown to be involved in Dictyostelium 
chemotaxis are seen to be down-regulated in the chdC null cells. In each of these 
cases there could be a contribution to the chemotactic defect observed in these cells.
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Time point Dictybase ID/gene 
name
Fold change up- 
regulated
Found in ChlP-seq 
data?
12 hours inol 27 +
12 hours impAl 2 -
12 hours pic 6 +
12 hours pkbA 17 -
12 hours pirA 5 -
12 hours arpC 4 +
12 hours arcD 2 +
12 hours arcB 2 +
12 hours pdsA 10 -
12 hours regA 5 +
12 hours pde7 3 -
Table 6.2 Genes up-regulated involved in chemotaxis
There are a much larger number of genes up-regulated related to chemotaxis. Each of 
these could play a role in the chemotactic defect observed in the chdC null cells.
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6.5 Summary
• We have two mutants for the gene CHDC
• LisG REMI has a stronger chemotactic response than wild-type cells, 
responding with a faster speed and moving more directly whereas chdC null 
responds extremely poorly to a cAMP stimulus, failing to detect the signal.
• Lithium treatment reduces the response of LisG REMI, but only reduces it 
down to wild-type response, providing the cells with lithium resistance.
• Treating the chdC null cells with lithium rescues the poor response to cAMP 
stimulus, improving all aspects of chemotaxis.
• chdC null shows over-expressed impAl levels and reduced inol expression.
• Reduced inol is the opposite to what has previously been observed in the LisG 
REMI cell line, where inol expression is increased.
• The increased chemotactic response of the REMI cells is unlikely to be a 
result of increased PIP3 levels as this has previously been shown this to inhibit 
chemotaxis rather than enhance it in the arp8 mutants.
• Genes involved in several pathways implicated in Dictyostelium chemotaxis 
and cAMP signaling are seen to be mis-expressed in chdC null cells.
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Chapter 7:
Discussion
Summary: ATP dependent chromatin re-modeling factors are involved in the 
regulation of key genes required for the correct development of Dictyostelium 
discoideum in response to starvation and also for efficient chemotaxis towards cAMP, 
the developmental chemoattractant. The primary objectives of this investigation were 
to identify the roles of two of these ATP dependent chromatin remodeling factors; 
INO80 and CHDC, during starvation induced development and to characterize their 
function in the social amoeba; Dictyostelium discoideum.
The major findings of this thesis were that both CHDC and INO80 play a significant 
role in development of these cells, with null strains being defective in this process to 
differing degrees. Both of these factors are also essential for correct chemotaxis, with 
both null mutants showing disrupted chemotaxis phenotypes. These defects are seen 
to occur through different mechanisms, indicating the role of multiple pathways in the 
regulation of Dictyostelium chemotaxis.
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7.1 The INO80 complex is involved in regulating Dictyostelium development.
Through its interaction with the Arp8 subunit it has been shown that the 
INO80 chromatin re-modeling complex plays a significant role in the starvation 
induced development of Dictyostelum discoideum. Starvation induced development in 
Dictyostelium discoideum relies on the cells ability to accurately detect and relay the 
cAMP signal throughout the population. This involves detecting the abundance of 
nutrients in the environment, the size of the population and the correct temporal 
expression of the cAMP producing, detecting and regulatory machinery
An arp8 null strain exhibits a delay in the onset of development, with 
initiation being delayed by a minimum of 4-5 hours. This delay is shown to be related 
to an inability to produce correct cAMP signals through the population, resulting in a 
lack of communication that the developmental process and aggregation should begin. 
Dark field time-lapse movies show an delay in the onset of cAMP pulsing through the 
population that is on a similar time scale to the delay in onset of aggregation. Several 
genes responsible for producing the messenger, receptor and regulators of this system 
are also temporally delayed in their expression and it is hypothesized that this delay in 
expression of cAMP synthesis is responsible for the delay in initiation of aggregation. 
These genes are carl, acaA and pdsA encoding the cAMP receptor CAR1, the 
adenylyl cyclase ACA and the phosphodiesterase PDE respectively. Losing these key 
factors from the signaling pathway would mean that the positive feedback responsible 
for initiating this process would be less effective and the developmental process 
would be delayed.
The correct timing of development and the expression of these genes can all 
be rescued by mixing in a small amount of wild-type cells into the population, 
suggesting that the arp8 null cells are lacking an external secreted factor that signals
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entry into development. This was first thought to be cAMP as pulsing the null cells 
with cAMP rescues the expression of the cAMP biosynthetic genes that are seen to 
have delayed expression in this mutant. However there is no direct evidence for this 
as many factors influence the initial release of cAMP that stimulates the positive 
feedback loop resulting in cAMP pulsing.
Next generation sequencing data provides further evidence to suggest that the 
null cells are delayed in their ability to enter development through the mis-regulation 
of several genes involved in initiating this process. A large number of genes involved 
in a diverse range of processes such as; initiation of development, sensing cell 
density, cAMP biosynthesis and growth development transition. The most 
documented of these previously being Discoidin, which is significantly down- 
regulated, along with the genes involved in the production detection and regulation of 
the cAMP signal.
It is clear from these results that the INO80 complex is involved in regulating 
the initiation of development in Dictyostelium, particularly in maintaining the correct 
expression if the cAMP signal and its propagation throughout the population.
7.2 Chemotaxing cells respond across a large order of magnitude and alter 
signaling mechanisms accordingly.
Cells advancing through the aggregation process encounter rising 
concentrations of cAMP as they approach the mound (aggregation center). The 
mechanisms by which cells maintain their behavior across concentration changes of 
several orders of magnitude have previously been unclear. It would seem sensible for 
a system to have evolved to allow for a modulation of the sensing of external cAMP 
concentration to be incorporated into the developmental process. Indeed, several
different cAMP receptors are expressed across the developmental time-frame, with 
each becoming less sensitive the later through development it is expressed [39,40, 41, 
42]. However a more sensitive system could be in place at the onset of development.
The PIP3 signaling system is a key component of the Dictyostelium 
chemotaxis process. In steep cAMP gradients there is an accumulation of this 
signaling molecule at the leading edge of the cells, which was previously thought to 
act as a biological compass directing the cells towards the source. When the INO80 
complex is disrupted by knocking out arp8 there is a severe narrowing of the range 
over which the starving cells can respond to cAMP, with the majority of cells 
appearing motionless in high gradients. When the gradient of cAMP is reduced, or 
when the cAMP is allowed to degrade to a detectable level, the cells begin to 
chemotax normally.
These data reported in this thesis go some way to suggest that PIP3 signaling is 
modulated through the production of the precursor molecule PIP2. The inositol 
biosynthetic genes inol and impAl have previously been shown to increase PIP3 
signaling through over production of PIP2 [1]. Elevated levels of PIP2 result in an 
increased signal to noise ratio in the cells meaning that they are incapable of detecting 
the external signal. This results in the cells remaining motionless in steep cAMP 
gradients.
RNA-sequencing data reveals another set of genes that are possibly linked to 
the chemotactic phenotype observed in these null cells. Along with inol and impAl 
the PI3-kinase pikF is seen to be up-regulated and may also contribute to the increase 
in PIP3 signaling through increased production from PIP2. The down-regulation of 
pldA, dpoA, dd5Pl, pikB, pikD would all also serve to modulate the levels of PIP2 in 
the cell and thus altering PIP3 signaling.
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The arp8 null cells are also lithium sensitive, responding better to a steep 
cAMP gradient in the presence of 2mM LiCI. This suggests further that the PIP3 
signal noise ratio is controlled by the inositol biosynthetic genes as IMPase (encoded 
by impAl) is inhibited by lithium which would therefore reduce the PIP2 levels in the 
cell, allowing them to sense the gradient once again.
These results all go some way to showing that chemotaxing Dictyostelium 
cells are able to control the signal to noise ratio within the PIP3 signaling system, 
enabling them to maintain the movement towards chemoattractant at high 
concentrations of cAMP.
7.3 The Dictyostelium CHD8 homolog CHDC plays a significant role during 
starvation induced development
Members of the CHROMO domain helicase DNA binding (CHD) protein 
family have been shown to modulate transcription of DNA in several model 
organisms. The family is most characterized by their SWI/SNF like ATPase domain, 
two CHROMO domains and a DNA binding motif. The lithium resistant mutant LisG 
was identified as having a mutation in a homolog of the CHD family member which 
we have now designated CHDC. However the LisG mutant was found to still express 
a transcript of the gene and so is not considered a null mutant. Full disruption of the 
CHDC gene resulted in a severe developmental phenotype resulting in developmental 
arrest at the mound stage after 24 hours.
Developmental arrest of chdC null cells suggests that this CHDC re-modeling 
factor plays an essential role in modulating genes involved in the correct culmination 
of this process. The cells not only exhibit developmental arrest, but also a non 
standard aggregation pattern where the cells appear to clump together, rather than
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streaming as wild-type do and also the production of several spore heads from the 
mound structure when left for time in excess of 30 hours. Similarly to the arp8 null 
cells, when a small percentage of the population is made up of wild-type cells the 
developmental arrest can be rescued, with the degree of rescue increasing with wild- 
type:null cell ratio, resulting in chimeric fruiting bodies. This suggested that the cells 
were lacking an external signaling molecule which can be replaced by the wild-type 
cells.
Looking at the expression of several pre-spore and pre-stalk genes these were 
all observed to be severely reduced and delayed in their expression by up to around 20 
hours. This would be consistent with the observation that several spore heads are seen 
to occur after 24 hours of starvation, yet does not explain the developmental arrest. 
Dark field time-lapse movies reveal that cAMP signaling occurs incorrectly in these 
cells, with the nulls showing no cAMP pulses through the population until they enter 
the loose mound stage, where the pulses resonate throughout this structure. Mixing 
with wild-type cells does rescue this, once again dependent on the degree of AX2 
cells mixed into the population, but never returning to wild-type signaling. An 
increase in the expression of the genes encoding phosphodiesterases; pdsA, regA and 
pde7, observed in RNA-seq data, could be responsible for this effect. If the levels of 
secreted phosphodiesterases are too high they will diminish the secreted cAMP pool, 
decreasing the cells ability to signal to one another and guide the aggregation process. 
RNA- and ChlP-sequencing also reveal a large number of genes that may be involved 
in producing the arrested development phenotype observed in the null cells. The most 
instantly interesting of these is the down regulation of the gene yelA, which encodes 
the elongation initiation factor eIF-4. The phenotype associated with this gene almost 
exactly phenocopies the developmental arrest and associated qualities of the chdC
171
null cells. It is therefore possible that the mis-regulation of this gene and subsequent 
down-stream effects results in the phenotype observed when knocking out chdC. 
There are however a number of other candidates all of which could contribute 
significantly.
These results clearly indicate that CHDC plays a pivotal role in regulating 
many genes involved in the regulation of the early stages of Dictyostelium starvation 
induced development and also give some insight into the binding of this factor during 
this time.
7.4 The two CHDC mutants respond oppositely to cAMP gradients and to 
lithium treatment.
Lithium has previously been shown on many occasions to be detrimental to a 
cells ability to chemotax towards a cAMP source. The LisG null mutant had 
previously been identified as being resistant to this effect. However upon closer 
inspection it is revealed that this mutant in fact displays improved chemotaxis 
characteristic making it more efficient than wild-type cells. This effect has previously 
also been reported in cells over-expressing both inol and impAl, two genes which are 
also observed to be up-regulated in LisG REMI. This does not explain the phenotype 
as it has already been indicated that over-expressing these two genes results in an 
inability to perform chemotaxis. There is a possibility that the entire pathway is up- 
regulated in this mutant, however further analysis is required to prove this theory.
Conversely to this result the CHDC null mutants behave extremely poorly 
when placed in a high cAMP gradient, moving erratically and demonstrating a higher 
number of lateral and dorsal pseudopods. Once again this phenotype appears to be 
related to the expression of inositol biosynthetic genes inol and impAl, with a large
172
increase in the expression of impAl during vegetative growth and inol expression 
appearing opposite to that of wild-type, being low during vegetative growth and then 
rising as the cells enter development. This increase in inositol monophosphate could 
flood the IMPase active sites resulting in a decrease in activity due to competitive 
inhibition of the enzyme. This would then serve to reduce the levels of PIP2 in the cell 
leaving the cells insensitive to the cAMP signal and unable to respond effectively. 
RNA-seq data also reveals an increase in the production of Phospholipase C which 
would also serve to reduce the PIP2 in the cells when stimulated with cAMP and a 
down-regulation of one of the 5’ phosphatases which would disrupt recycling of the 
produced I(1,4,5)P3.
Increased pseudopod formation could be a result of the down-regulation of the 
enzyme producing cGMP: guanylyl cyclase, a signaling molecule which has been 
implicated in the correct formation of myosin fibres and repression of pseudopod 
formation at the rear of the cell. Coupled with an increase in the expression of some 
of the SCAR/WAVE and Arp2/3 complex members, both responsible for actin 
polymerization, this may explain this aspect of the phenotype.
The chdC null cells also show disrupted cAMP pulsing during the aggregation 
period of development, not producing any pulsing patterns throughout the population 
indicating that the signal is not being transduced from cell to cell. It has previously 
been suggested that an increase in phosphodiesterase expression would produce such 
a phenotype by breaking down too much of the secreted cAMP and disrupting the 
signal. Three of the major phosphodiesterases are up-regulated in the chdC mutant 
which is likely to produce this effect.
Treating the chdC null cells with lithium also has an opposite effect to treating 
the LisG REMI mutant similarly. These cells are rescued by lithium treatment with an
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improvement in cell chemotaxis. Whilst inhibiting IMPase would not alleviate the 
theorized cause of the chemotactic defects in these mutants, it is possible that lithium 
is affecting IPPase, an enzyme that acts further up the inositol recycling pathway 
serving to reduce the levels of inositol monophosphate entering the system and 
therefore bring the PIP2 levels back to normal again. This would allow the cells to 
start chemotaxing more as wild-type.
The results from the CHDC mutants chemotaxing have opened up the idea of 
what exactly lithium resistance or sensitivity is? It was previously taken as being 
whereby a population of cells could chemotax or develop in the presence of lithium as 
a result of some form of biological change within the cells. This was generally 
considered as being a direct action of lithium on one of its targets which resulted in an 
observable change in behavior. However, in the case of the LisG REMI mutant there 
is a cell line that is exhibiting a newly described form of lithium resistance which 
shall be termed lithium protection. The theoretical explanation for this is that the cells 
aren’t actually lithium resistant. They are affected by lithium treatment, most likely by 
exactly the same mechanism that affects wild-type cells, yet they have an elevated 
signaling pathway which is then reduced to wild type levels through the action of 
lithium.
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7.5 Final conclusions.
To summarize the findings of my research; roles have been identified for two 
ATP-dependent chromatin remodeling factors in the Dictyostelium discoideum in the 
starvation induced development process and chemotaxis towards a cAMP signal. This 
has increased our knowledge of both of these key processes and the roles of these re­
modeling complexes in this organism, which had to this point yet to be fully 
investigated.
Both of these processes, development and chemotaxis, are highly regulated by 
a large number of processes and involve the regulation of a large number of others. 
Knocking out these re-modelers has resulted in a change in the expression of a very 
large number of genes, many of which are involved in the developmental process. 
Experimental evidence has also been introduced for the theory that Dictyostelium is 
responsive to differing concentrations of cAMP with different signaling systems. 
These systems are switched on and off through the expression of genes regulated by 
ATP chromatin remodeling. These data, found in this thesis, indicate that when 
expression of the genes regulating an individual signaling process is removed, the 
range under which the cells can respond is reduced.
Finally, further evidence has been introduced towards the regulation of 
chemotaxis by the mood stabilizing drug; lithium. More data is represented to suggest 
that the drug acts upon the inositol biosynthetic system within the cell effecting the 
production of the signaling molecules PIP2 and PIP3.
This is the first analysis into the role of chromatin re-modeling in 
Dictyostelium discoideum. There are several other factors identified in this organism 
and through a coordinated and combined analysis a pattern of genetic regulation can 
be elucidated for the full development process
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Appendicies
Appendix A 
Gene Ontology (GO) data.
A.l GO analysis of RNA-seq data
The Gene Ontology (GO) project has attempted to provide a unified 
categorization system to try and end potential confusion that arises when you have 
extensive descriptive nomenclature. The use of a consistent terminology allows for 
genes from different species to be analyzed based on their GO annotations. The 
system initially lists all genes within three major categories; molecular function, 
biological process and cellular localization and then these are further divided into 
many other sub-categories describing functions of gene products. The group that was 
most interesteding and have displayed here is that of biological process.
There are many tools available for analyzing GO data, however, as the 
capability for GO analysis is available within the Arraystar software that was opted to 
use this. The genes full gene lists consisting of all genes that have either been up- or 
down-regulated at either OH or 8H are highlighted individually and then subject to the 
Arraystar analysis. This analysis identifies the most significantly affected GO gene 
groups within the listed genes. The significance is represented by the p-value, which 
symbolizes the chance that the test results observed could have also happened through 
random chance. The group that proved most interesting and has been displayed here is 
that of biological process.
Looking at the vegetative cells the groups that are significantly affected are 
mainly those involved in cellular process such as metabolism and catabolism which is 
to be expected in normal growing cells (Table 3.6). The fact that there are no 
significant results for the up-regulated gene group suggests that Arp8 and the INO80 
complex are involved more in activating genes than repressing them at this stage.
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Gene
Ontology
Term ID P-Value
metabolic process 8152 0.0000847
catabolic process 9056 3.37E-12
macromolecule
catabolic process 9057 1.72E-11
biopolymer
catabolic process 43285 4.63E-12
protein catabolic
process 30163 8.3E-12
cellular protein
catabolic process 44257 3.48E-11
proteolysis
involved in cellular
protein catabolic
process 51603 3.16E-11
modification-
dependent protein
catabolic process 19941 3.15E-11
ubiquitin-
dependent protein
catabolic process 6511 4.2E-11
proteolysis 6508 3.8E-11
cellular biopolymer
catabolic process 34962 5.18E-10
cellular
macromolecule
catabolic process 44265 2.31 E-08
modification-
dependent
macromolecule
catabolic process 43632 3.6E-11
cellular catabolic
process 44248
CMooooooo
protein metabolic
process 19538 0.00114
nucleobase,
nucleoside,
nucleotide and
nucleic acid
metabolic process 6139 0.00813
regulation of
developmental
process 50793 0.00687
Z-Score
4.8884054
9.7650458
Selected
160
57
Total
2611
402
%
6.13%
14.18%
9.5300247 44 275 16.00%
10.0816491 43 248 17.34%
9.9918798 39 214 18.22%
10.8966276 22 72 30.56%
10.8966276 22 72 30.56%
10.9981262 22 71 30.99%
10.9981262
9.5387576
22
37
71
208
30.99%
17.79%
9.8630917 23 90 25.56%
8.5774174 24 117 20.51%
10.9981262 22 71 30.99%
7.4046398 33 232 14.22%
4.4793408 74 1043 7.09%
-3.4104801 12 680 1.76%
5.2514246 10 52 19.23%
Table A.l GO term enrichment for genes exhibiting a 2-fold decrease in expression in 
the arp8 null cell line in comparison to wild type cells during vegetative growth. The 
P-value cut off was set at 0.01 and the GO data file used was gene_association.ddb.
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Looking at the genes that are significantly affected at the 8 hour 
developmental stage there are a much larger and varied number of groups identified. 
Those down-regulated include many involved in starvation induced development, 
including developmental processes locomotion, regulation of cAMP biosynthesis and 
several groups involved with the production of spores (Table 3.8). Many of those 
significant GO groupings that are identified in the up-regulated gene list are involved 
in protein synthesis, cellular metabolism and energy production plus a large number 
of other processes you would expect to find in vegetatively growing rather than 
starving cells (Table 3.9). This includes the ribosomal proteins and translational 
machinery which were noticed earlier when simply scanning the gene lists for 
anything that stood out on first inspection. This stands to reason, as if the arp8 null 
cells are delayed in their entry to development then they will still be operating under a 
similar set of processes as if they were growing vegetatively and the switch between 
the two states has not been fully registered.
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Term
Gene
Ontology ID P-Value Z-Score Selected Total %
binding 5488 3.81E-13 8.030697 678 3235 20.96%
ion binding 43167 1.49E-09 7.064406 213 849 25.09%
cation binding 43169 1.78E-09 7.064406 213 849 25.09%
metal ion binding 46872 8.61 E-09 6.730836 202 812 24.88%
transition metal ion 
binding 46914 4.57E-05 4.953982 153 654 23.39%
calcium ion binding 5509 7.18E-05 5.294431 38 108 35.19%
protein binding 5515 2.32E-06 5.596687 201 866 23.21%
adenyl
ribonucleotide
binding 32559 9.59E-05 4.696408 171 759 22.53%
ribonucleotide
binding 32553 0.00014 4.545973 209 967 21.61%
purine ribonucleotide 
binding 32555 0.000134 4.545973 209 967 21.61%
catalytic activity 3824 4.24E-13 8.110028 599 2791 21.46%
hydrolase activity 16787 1.61E-10 7.43908 248 1001 24.78%
peptidase activity 8233 2.51 E-09 7.545738 60 155 38.71%
peptidase activity, 
acting on L-amino 
acid peptides 70011 4.41 E-08 6.980209 55 146 37.67%
endopeptidase
activity 4175 3.46E-07 6.722978 38 89 42.70%
phosphoric ester 
hydrolase activity 42578 4.13E-05 5.487431 39 109 35.78%
phosphotransferase 
activity, alcohol 
group as acceptor 16773 2.78E-07 6.300819 98 339 28.91%
protein kinase 
activity 4672 2.43E-05 5.327163 81 291 27.84%
kinase activity 16301 4.83E-05 4.997692 113 453 24.94%
enzyme regulator 
activity 30234 4.68E-05 5.234347 60 200 30.00%
structural
constituent of 
ribosome 3735 2.96E-06 -4.49436 1 114 0.88%
developmental
process 32502 2.38E-11 7.976119 110 342 32.16%
anatomical structure 
development 48856 4.43E-12 8.493379 85 230 36.96%
culmination during
sorocarp
development 31154 1.49E-05 5.896442 22 45 48.89%
reproductive
structure
development 48608 1.83E-05 5.399134 44 130 33.85%
spore-bearing organ 
development 75259 0.000018 5.399134 44 130 33.85%
fruiting body 
development 30582 1.94E-05 5.399134 44 130 33.85%
fruiting body 
development in 
response to 
starvation 55084 1.98E-05 5.399134 44 130 33.85%
sorocarp
development 30587 2.02E-05 5.399134 44 130 33.85%
aggregation involved 31152 1.92E-05 5.6246 30 74 40.54%
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in sorocarp
development
organ development
reproductive
developmental
48513 2.06E-05 5.399134 44 130 33.85%
process 3006 0.000019 5.399134 44 130 33.85%
metabolic process 8152 1.2E-09 6.698719 542 2611 20.76%
catabolic process 
macromolecule
9056 5.05E-12 8.216212 126 402 31.34%
catabolic process 
biopolymer catabolic
9057 3.93E-12 8.540993 97 275 35.27%
process
protein catabolic
43285 5.27E-12 8.366368 89 248 35.89%
process
cellular protein
30163 3.29E-12 8.729824 82 214 38.32%
catabolic process 
proteolysis involved 
in cellular protein
44257 5.28E-12 8.997811 40 72 55.56%
catabolic process 
modification- 
dependent protein
51603 5.81 E-12 8.997811 40 72 55.56%
catabolic process 
ubiquitin-dependent 
protein catabolic
19941 5.13E-12 9.113313 40 71 56.34%
process 6511 4.4E-12 9.113313 40 71 56.34%
proteolysis 
cellular biopolymer
6508 3.79E-11 8.094917 77 208 37.02%
catabolic process 
cellular
macromolecule
34962 7.05E-11 8.352761 44 90 48.89%
catabolic process 
modification- 
dependent 
macromolecule
44265 7.21 E-11 8.229166 52 117 44.44%
catabolic process 
cellular catabolic
43632 6.16E-12 9.113313 40 71 56.34%
process
primary metabolic
44248 1.15E-08 6.967848 77 232 33.19%
process
protein metabolic
44238 7.82E-10 6.812859 467 2189 21.33%
process
cellular protein
19538 6.93E-14 8.702572 271 1043 25.98%
metabolic process 
protein modification
44267 6.69E-11 7.460349 226 892 25.34%
process
post-translational
6464 8E-09 6.748571 151 566 26.68%
protein modification 
protein amino acid
43687 2.11E-07 6.177743 110 397 27.71%
phosphorylation 6468 2.44E-06 5.683067 83 290 28.62%
translation
carbohydrate
6412 3.5E-07 -4.76686 2 138 1.45%
metabolic process 
ncRNA metabolic
5975 2.62E-07 6.287168 72 227 31.72%
process
macromolecule
34660 2.03E-05 -4.22315 3 124 2.42%
metabolic process 
macromolecule
43170 2.14E-06 5.319727 347 1658 20.93%
biosynthetic process 
biopolymer
9059 2.64E-06 -4.80857 21 320 6.56%
biosynthetic process 43284 1.68E-06 -4.89108 20 316 6.33%
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cellular biopolymer 
biosynthetic process 34961 2.2E-06 -4.83793 20 313 6.39%
cellular
macromolecule 
biosynthetic process 34645 2.26E-06 -4.83793 20 313 6.39%
biopolymer 
metabolic process 43283 7.46E-06 5.032121 336 1620 20.74%
biopolymer
modification 43412 1.66E-07 6.12141 151 592 25.51%
cellular metabolic 
process 44237 3.36E-05 4.593361 411 2072 19.84%
phosphorus 
metabolic process 6793 1.14E-08 6.80941 106 359 29.53%
phosphate metabolic 
process 6796 1.09E-08 6.80941 106 359 29.53%
phosphorylation 16310 3.41 E-07 6.119523 88 300 29.33%
response to stimulus 50896 1.49E-08 6.638139 137 505 27.13%
response to external 
stimulus 9605 4.27E-08 6.692874 74 226 32.74%
response to
extracellular
stimulus 9991 3.6E-07 6.355945 53 149 35.57%
response to nutrient 
levels 31667 2.85E-07 6.413747 53 148 35.81%
response to 
starvation 42594 2.67E-05 5.283637 45 136 33.09%
response to chemical 
stimulus 42221 7.51 E-06 5.631815 49 146 33.56%
response to stress 6950 1.93E-05 5.137101 94 357 26.33%
cellular process 9987 4.59E-08 6.013901 582 2901 20.06%
biological regulation 65007 1.16E-06 5.578086 209 908 23.02%
regulation of 
biological process 50789 2.65E-07 5.917622 203 859 23.63%
regulation of cellular 
process 50794 2.45E-07 5.949848 196 822 23.84%
regulation of 
nucleobase, 
nucleoside, 
nucleotide and 
nucleic acid 
metabolic process 19219 8.72E-05 4.775618 70 256 27.34%
regulation of 
nucleotide metabolic 
process 6140 5.58E-05 5.692346 15 26 57.69%
regulation of 
nucleotide
biosynthetic process 30808 5.49E-05 5.692346 15 26 57.69%
regulation of cyclic 
nucleotide
biosynthetic process 30802 5.76E-05 5.692346 15 26 57.69%
regulation of cAMP 
biosynthetic process 30817 9.74E-05 5.553515 14 24 58.33%
regulation of cyclic 
nucleotide metabolic 
process 30799 5.67E-05 5.692346 15 26 57.69%
regulation of cAMP 
metabolic process 30814 9.89E-05 5.553515 14 24 58.33%
regulation of primary 
metabolic process 80090 0.000176 4.556902 73 276 26.45%
positive regulation of 51349 0.000156 5.508729 12 19 63.16%
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lyase activity 
positive regulation of
cyclase activity 31281 0.000158 5.508729 12 19 63.16%
reproductive process 22414 1.87E-05 5.399134 44 130 33.85%
locomotion 40011 4.17E-05 5.222896 39 113 34.51%
cell part 44464 2.16E-07 5.752175 658 3360 19.58%
membrane part 44425 1.05E-06 5.64611 207 894 23.15%
intrinsic to
membrane 31224 7.5E-08 6.360578 182 732 24.86%
integral to membrane 16021 1.71E-07 6.156684 179 727 24.62%
proteasome core
complex 5839 3.13E-07 7.349175 14 17 82.35%
proteasome
regulatory particle 5838 1.36E-06 7.045158 11 12 91.67%
ribosome 5840 3.24E-05 -4.07787 1 96 1.04%
cytosol 5829 6.44E-10 7.876761 57 139 41.01%
Table A.2 GO term enrichment for genes exhibiting a 2-fold decrease in expression in 
the arp8 null cell line in comparison to wild type cells 8H into starvation induced 
development. The P-value cut off was set at 0.01 and the GO data file used was 
gene_association.ddb.
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Term
G ene
O ntology
ID P-Value Z -Score S elected Total %
molecular_function 3674 6E-79 18.59705 748 6797 11.00%
structural molecule 
activity 5198
2.08E-
71 27.1664 103 175 58.86%
structural
constituent of 
ribosome 3735
2.22E-
78 29.97458 89 114 78.07%
binding 5488
3.14E-
42 14.89447 413 3235 12.77%
nucleoside binding 1882
5.22E-
15 9.442549 121 795 15.22%
purine nucleoside 
binding 1883
5.87E-
15 9.442549 121 795 15.22%
adenyl nucleotide 
binding 30554 4.7E-15 9.442549 121 795 15.22%
adenyl
ribonucleotide
binding 32559
1.27E-
12 8.549365 111 759 14.62%
ATP binding 5524
9.37E-
13 8.620696 110 745 14.77%
nucleotide binding 166
5.47E-
15 9.236232 156 1148 13.59%
purine nucleotide 
binding 17076
1.98E-
14 9.045792 141 1014 13.91%
purine
ribonucleotide
binding 32555
1.51E-
12 8.362667 131 967 13.55%
ribonucleotide
binding 32553
1.61E-
12 8.362667 131 967 13.55%
protein binding 5515
1.31 E- 
14 9.219148 127 866 14.67%
cytoskeletal protein 
binding 8092
3.27E-
16 11.44385 47 156 30.13%
actin binding 3779
3.82E-
12 9.845955 34 111 30.63%
nucleic acid 
binding 3676
2.52E-
08 6.6636 114 924 12.34%
catalytic activity 3824
3.09E-
20 10.26283 317 2791 11.36%
hydrolase activity 16787
1.33E-
08 6.763286 122 1001 12.19%
cellular_com ponent 5575
3.29E-
76 18.80389 661 5566 11.88%
cell part 44464
5.57E-
88 21.68852 511 3360 15.21%
intracellular part 44424
1.27E-
91 23.54145 392 2047 19.15%
cytoplasmic part 44444
7.6E-
102 26.96385 292 1084 26.94%
ribosome 5840
4.92E-
60 25.8988 71 96 73.96%
cytoplasmic vesicle 31410
6.54E-
52 20.71994 115 318 36.16%
cytoplasmic 
m em brane- 
bounded vesicle 16023 2.2E-52 20.86277 115 315 36.51%
endocytic vesicle 30139
4.71 E- 
53 21.12468 114 305 37.38%
184
phagocytic vesicle 45335 1.6E-52 
6.21 E-
20.99606 113 303 37.29%
ribosomal subunit 33279 15 12.97574 17 22 77.27%
small ribosomal
subunit 15935 4.3E-10
3.96E-
10.95008 10 11 90.91%
cytosolic part 44445 08 8.559831 14 30 46.67%
chaperonin-
containing T- 8.25E-
complex 5832 09 10.34829 8 8 100.00%
intracellular 2.69E-
organelle 43229 75 22.06024 289 1346 21.47%
intracellular non­
membrane- 5.71 E-
bounded organelle 43232 58
3.12E-
21.81274 131 370 35.41%
cytoskeleton 5856 11 9.126442 31 105 29.52%
intracellular
membrane- 1.05E-
bounded organelle 43231 38 15.39918 198 1075 18.42%
ribonucleoprotein 4.89E-
complex 30529 38 17.88116 82 219 37.44%
intracellular
organelle part 44446 1.3E-22 11.60608 135 786 17.18%
cytoskeletal part 44430 1.3E-18
2.16E-
11.70072 55 196 28.06%
cytoplasm 5737 15
5.29E-
10.09797 61 273 22.34%
intracellular 5622 32
1.49E-
14.57821 128 582 21.99%
cell leading edge 31252 12
7.73E-
10.5869 23 52 44.23%
cell projection 42995 09
8.91 E-
8.593064 18 46 39.13%
organelle 43226 77 22.32285 292 1351 21.61%
non-membrane- 6.43E-
bounded organelle 43228 58
1.15E-
21.81274 131 370 35.41%
vesicle 31982 52 20.75955 120 341 35.19%
membrane- 9.62E-
bounded vesicle 31988 51 20.33995 116 331 35.05%
membrane- 1.1 IE -
bounded organelle 43227 38 15.39918 198 1075 18.42%
macromolecular 7.83E-
complex 32991 55
9.43E-
19.25985 199 861 23.11%
protein complex 43234 22
1.59E-
11.53808 116 632 18.35%
organelle part 44422 22
7.87E-
11.57218 135 788 17.13%
biological_process 8150 69
3.33E-
17.72266 688 6137 11.21%
cellular process 9987 73 20.19146 447 2901 15.41%
cellular metabolic 1.36E-
process 44237 49 16.88067 324 2072 15.64%
cellular
biosynthetic 3.51 E-
process 44249 53 19.71516 169 644 26.24%
cellular 2.44E-
macromolecule 34645 46 19.61018 109 313 34.82%
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biosynthetic
process
cellular biopolymer
biosynthetic
process 34961
2.17E-
46 19.61018 109 313 34.82%
translation 6412
2.28E-
73 28.38839 94 138 68.12%
nucleotide
biosynthetic
process 9165
1.04E-
11 10.32801 24 58 41.38%
purine nucleotide
biosynthetic
process 6164
1.39E-
10 10.09519 19 40 47.50%
purine
ribonucleotide
biosynthetic
process 9152
6.37E-
08 8.756662 14 29 48.28%
ribonucleotide
biosynthetic
process 9260
2.83E-
08 8.887592 15 32 46.88%
cellular
macromolecule 
metabolic process 44260
4.72E-
26 12.1671 215 1477 14.56%
cellular biopolymer 
metabolic process 34960 5.3E-26 12.16612 212 1448 14.64%
cellular protein 
metabolic process 44267
9.68E-
32 14.15787 166 892 18.61%
cellular nitrogen 
compound 
metabolic process 34641
6.78E-
13 9.489644 52 228 22.81%
cellular amine 
metabolic process 44106
1.64E-
11 9.13975 41 164 25.00%
cellular amino acid 
metabolic process 6520
4.62E-
12 9.489586 40 151 26.49%
cellular ketone 
metabolic process 42180
2.53E-
11 8.60802 56 282 19.86%
oxoacid metabolic 
process 43436
2.53E-
11 8.623713 55 274 20.07%
carboxylic acid 
metabolic process 19752
2.45E-
11 8.623713 55 274 20.07%
organic acid 
metabolic process 6082
2.77E-
11 8.591688 55 275 20.00%
heterocycle 
metabolic process 46483
1.16E-
10 8.93913 34 125 27.20%
purine nucleotide 
metabolic process 6163
8.84E-
09 8.771992 19 49 38.78%
cellular amino acid 
and derivative 
metabolic process 6519
1.83E-
10 8.533089 41 177 23.16%
nucleobase, 
nucleoside and 
nucleotide 
metabolic process 55086
8.23E-
12 9.639485 34 114 29.82%
nucleoside 
phosphate 
metabolic process 6753
6.45E-
10 8.857555 27 87 31.03%
nucleotide 
metabolic process 9117
6.62E-
10 8.857555 27 87 31.03%
ribonucleotide 
metabolic process 9259
7.71 E- 
08 8.528981 15 34 44.12%
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membrane 8.57E-
organization 16044 11
membrane 9.22E-
invagination 10324 09
endocytosis 6897 1.3E-08
vesicle-mediated 5.28E-
transport 16192 10
cytoskeleton 1.32E-
organization 7010 07
5.93E-
metabolic process 8152 48
biosynthetic 1.67E-
process 9058 52
macromolecule
biosynthetic 1.98E-
process 9059 45
biopolymer
biosynthetic 5.23E-
process 43284 46
primary metabolic 3.37E-
process 44238 46
protein metabolic 6.51 E-
process 19538 34
macromolecule 1.55E-
metabolic process 43170 27
biopolymer 8.89E-
metabolic process 43283 28
nitrogen compound 1.18E-
metabolic process 6807 09
amine metabolic 4.89E-
process 9308 10
multi-organism 5.43E-
process 51704 19
response to other 3.98E-
organism 51707 20
response to 1.85E-
bacterium 9617 20
response to 8.43E-
stimulus 50896 15
response to biotic 2.13E-
stimulus 9607 15
cellular component
9.239788 30 98 30.61%
8.242616 25 84 29.76%
8.208555 24 79 30.38%
8.454261 36 146 24.66%
7.306421 28 116 24.14%
16.21857 371 2611 14.21%
19.46025 172 673 25.56%
19.29137 109 320 34.06%
19.4724 109 316 34.49%
16.12814 328 2189 14.98%
14.50192 187 1043 17.93%
12.43778 236 1658 14.23%
12.52556 233 1620 14.38%
7.196168 110 842 13.06%
8.267547 42 190 22.11%
13.71022 32 63 50.79%
14.30793 32 59 54.24%
14.60327 31 54 57.41%
9.605665 89 505 17.62%
11.62638 34 89 38.20%
9.556361 78 418 18.66%organization 16043 2.7E-14
Table A.3 GO term enrichment for genes exhibiting a 2-fold increase in expression in 
the arp8 null cell line in comparison to wild type cells 8H into starvation induced 
development. The P-value cut off was set at 0.01 and the GO data file used was 
gene_association.ddb.
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A.2 GO analysis of chdC null RNA-seq data
Remember to mention no significant GO data for CHDC OH 2-fold up!
Term
G ene
O ntology
ID P-Value Z -Score S elected Total %
molecular_function 3674 2.65E-10 7.150595 365 6797 5.37%
catalytic activity 3824 4.65E-07 6.19923 174 2791 6.23%
hydrolase activity 16787 8.51 E-09 7.487896 87 1001 8.69%
hydrolase activity, 
acting on glycosyl 
bonds 16798 0.000241 6.56776 15 80 18.75%
hydrolase activity, 
hydrolyzing 0 -  
glycosyl 
com pounds 4553 0.000239 6.595434 14 71 19.72%
hydrolase activity, 
acting on ester 
bonds 16788 0.00596 4.540205 26 271 9.59%
nucleic acid 
binding 3676 0.00459 -3.64643 17 924 1.84%
myosin binding 17022 0.00304 6.161973 9 37 24.32%
structural
constituent of 
cytoskeleton 5200 0.00384 6.191134 8 30 26.67%
cellular_com ponent 5575 4.37E-06 5.346908 292 5566 5.25%
extracellular region 5576 0.00346 4.989998 12 78 15.38%
m em brane part 44425 1.08E-05 5.710192 70 894 7.83%
intrinsic to 
m em brane 31224 6.87E-06 6.217431 63 732 8.61%
integral to 
m em brane 16021 6.23E-06 6.086047 62 727 8.53%
vacuole 5773 0.00202 5.340104 12 72 16.67%
lytic vacuole 323 0.000831 6.089317 10 45 22.22%
lysosome 5764 0.000997 6.089317 10 45 22.22%
nucleus 5634 0.00181 -3.54922 7 566 1.24%
biological_process 8150 1.36E-05 5.571043 319 6137 5.20%
cellular
macromolecule
biosynthetic
process 34645 0.00815 -3.43728 1 313 0.32%
cellular biopolymer
biosynthetic
process 34961 0.0068 -3.43728 1 313 0.32%
biopolymer
biosynthetic
process 43284 0.00904 -3.45684 1 316 0.32%
am ine metabolic 
process 9308 0.008 4.805305 21 190 11.05%
Table A.3 GO term enrichment for genes exhibiting a 2-fold decrease in expression in
the chdC null cell line in comparison to wild type cells during vegetative growth. The
P-value cut off was set at 0.01 and the GO data file used was gene_association.ddb.
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Term
G ene
O nto logy
ID P-Value Z -Score S elected Total %
catalytic activity 3824 6.49E-12 7.690488 573 2791 20.53%
transferase activity 16740 6.82E-06 5.292469 216 996 21.69%
transferase activity, 
transferring 
phosphorus- 
containing groups 16772 0.00047 4.281115 132 599 22.04%
kinase activity 16301 0.000021 5.166175 111 453 24.50%
protein kinase 
activity 4672 0.000968 4.228225 72 291 24.74%
phosphotransferase 
activity, alcohol 
group a s  acceptor 16773 0.00186 3.987368 80 339 23.60%
hydrolase activity 16787 3.71 E-05 4.848972 212 1001 21.18%
hydrolase activity, 
acting on acid 
anhydrides 16817 1.59E-06 5.888855 103 388 26.55%
hydrolase activity, 
acting on acid 
anhydrides, in 
phosphorus- 
containing 
anhydrides 16818 1.66E-06 5.918574 103 387 26.61%
pyrophosphatase
activity 16462 1.51E-06 5.918574 103 387 26.61%
nucleoside-
triphosphatase
activity 17111 2.01 E-06 5.813744 101 381 26.51%
microtubule motor 
activity 3777 0.00125 5.124477 10 16 62.50%
DNA-dependent 
A TPase activity 8094 1.24E-05 6.280935 18 32 56.25%
binding 5488 9.2E-12 7.563505 648 3235 20.03%
nucleoside binding 1882 8.41 E-09 6.754549 193 795 24.28%
purine nucleoside 
binding 1883 9.61 E-09 6.754549 193 795 24.28%
adenyl nucleotide 
binding 30554 1.13E-08 6.754549 193 795 24.28%
adenyl ribonucleotide 
binding 32559 7.39E-09 6.871155 187 759 24.64%
ATP binding 5524 8.67E-09 6.746861 183 745 24.56%
nucleotide binding 166 0.000121 4.535641 235 1148 20.47%
ribonucleotide
binding 32553 0.000018 5.052309 208 967 21.51%
purine ribonucleotide 
binding 32555 0.000019 5.052309 208 967 21.51%
purine nucleotide 
binding 17076 2.12E-05 4.994488 216 1014 21.30%
nucleic acid binding 3676 0.000466 4.206077 191 924 20.67%
DNA binding 3677 4.72E-17 10.12345 126 360 35.00%
transcription factor 
activity 3700 0.000328 4.873428 34 102 33.33%
protein binding 5515 0.00078 4.061562 179 866 20.67%
protein dimerization 
activity 46983 0.000431 4.957182 24 62 38.71%
ion binding 43167 0.00186 3.777184 173 849 20.38%
transcription 30528 2.1 E-06 5.993845 66 216 30.56%
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regulator activity 
structural constituent 
of ribosome 3735 5.55E-06 -4.38655 1 114 0.88%
metabolic process 8152 4.59E-06 5.403473 503 2611 19.26%
primary metabolic 
process 44238 5.97E-05 4.617783 418 2189 19.10%
carbohydrate 
metabolic process 5975 2.73E-05 5.34679 65 227 28.63%
cellular carbohydrate 
metabolic process 44262 0.00042 4.699929 36 113 31.86%
polysaccharide 
metabolic process 5976 0.000722 4.98016 15 31 48.39%
translation 6412 1.58E-05 -4.4108 3 138 2.17%
protein modification 
process 6464 0.000277 4.423709 127 566 22.44%
post-translational 
protein modification 43687 0.000106 4.787166 97 397 24.43%
protein amino acid 
phosphorylation 6468 0.000434 4.423807 73 290 25.17%
DNA metabolic 
process 6259 0.000122 4.906445 60 215 27.91%
DNA strand 
elongation 22616 9.22E-06 6.92772 9 9 100.00%
DNA strand 
elongation during 
DNA replication 6271 8.56E-06 6.92772 9 9 100.00%
leading strand 
elongation 6272 3.05E-05 6.531276 8 8 100.00%
DNA replication 
initiation 6270 6.81 E-05 6.112521 11 15 73.33%
DNA repair 6281 0.000416 4.793218 30 87 34.48%
mismatch repair 6298 4.92E-07 7.867725 14 16 87.50%
ncRNA metabolic 
process 34660 0.00106 -3.60894 5 124 4.03%
deoxy ribonucleotide 
metabolic process 9262 0.000161 6.01354 8 9 88.89%
cellular metabolic 
process 44237 0.000533 3.96853 388 2072 18.73%
phosphorus 
metabolic process 6793 8.25E-05 4.880783 90 359 25.07%
phosphate metabolic 
process 6796 8.51 E-05 4.880783 90 359 25.07%
phosphorylation 16310 0.000157 4.738477 77 300 25.67%
macromolecule 
metabolic process 43170 0.00124 3.740984 314 1658 18.94%
biopolymer metabolic 
process 43283 0.00179 3.633647 306 1620 18.89%
biopolymer
modification 43412 0.000759 4.086942 129 592 21.79%
cellular component 
organization 16043 1.97E-05 5.30688 105 418 25.12%
organelle
organization 6996 3.53E-06 6.117856 74 248 29.84%
chromosome
organization 51276 1.09E-06 6.981452 32 69 46.38%
chromatin
organization 6325 3.81 E-05 5.713269 25 58 43.10%
chromatin
modification 16568 0.000357 5.423437 12 20 60.00%
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cellular process 9987 2.79E-05 4.80417 542 2901 18.68%
cell cycle process 22402 3.52E-06 6.786563 23 43 53.49%
microtubule-based
process 7017 6.77E-05 5.819342 16 29 55.17%
cellular response to 
stimulus 51716 0.000234 4.896568 37 114 32.46%
cellular response to 
stress 33554 0.000653 4.562997 35 111 31.53%
cellular response to 
DNA damage 
stimulus 34984 0.000295 4.868855 33 98 33.67%
cell cycle 7049 0.00108 4.825247 15 32 46.88%
response to stimulus 50896 0.000236 4.502888 116 505 22.97%
response to stress 6950 2.68E-05 5.234637 92 357 25.77%
response to DNA 
damage stimulus 6974 0.000416 4.741423 34 104 32.69%
regulation of 
metabolic process 19222 1.76E-05 5.426367 83 308 26.95%
regulation of 
macromolecule 
metabolic process 60255 4.63E-06 5.919053 76 262 29.01%
regulation of gene 
expression 10468 3.03E-06 6.078083 74 249 29.72%
regulation of 
transcription 45449 2.76E-06 6.251205 69 223 30.94%
regulation of 
transcription, DNA- 
dependent 6355 1.65E-05 5.620653 59 194 30.41%
regulation of 
macromolecule 
biosynthetic process 10556 5.39 E-06 5.884761 72 245 29.39%
regulation of RNA 
metabolic process 51252 1.76E-05 5.575188 59 195 30.26%
regulation of nitrogen 
compound metabolic 
process 51171 6.32E-06 5.8055 76 265 28.68%
regulation of 
nucleobase, 
nucleoside, 
nucleotide and 
nucleic acid 
metabolic process 19219 6.11 E-06 5.804665 74 256 28.91%
regulation of 
biosynthetic process 9889 1.87E-05 5.41446 75 271 27.68%
regulation of cellular 
biosynthetic process 31326 1.96E-05 5.41446 75 271 27.68%
regulation of primary 
metabolic process 80090 0.000032 5.234489 75 276 27.17%
regulation of cellular 
metabolic process 31323 4.15E-05 5.143595 77 288 26.74%
cell part 44464 2.31 E-06 5.353356 629 3360 18.72%
intracellular part 44424 0.0017 3.590426 378 2047 18.47%
ribonucleoprotein
complex 30529 8.19E-05 -4.22123 12 219 5.48%
ribosome 5840 7.91 E-05 -3.97834 1 96 1.04%
intracellular organelle 
part 44446 0.000315 4.314283 167 786 21.25%
chromosomal part 44427 2.46E-10 8.407753 38 74 51.35%
nuclear chromosome 44454 6.06E-06 6.61354 16 25 64.00%
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part
nuclear part 44428 4.47E-05 5.129037 83 317 26.18%
nucleoplasm part 44451 0.000306 4.834849 37 115 32.17%
nucleus 5634 8.34E-08 6.425036 144 566 25.44%
chromosome 5694 0.000468 5.141158 14 27 51.85%
organelle part 44422 0.00033 4.277342 167 788 21.19%
protein complex 43234 0.000382 4.26099 138 632 21.84%
Table A.4 GO term enrichment for genes exhibiting a 2-fold decrease in expression in 
the chdC null cell line in comparison to wild type cells 8H into starvation induced 
development. The P-value cut off was set at 0.01 and the GO data file used was 
gene_association.ddb.
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Term
G en e
O nto logy
ID
P-
V alue Z -Score S elec ted Total %
molecular_function 3674
2.87E-
81 18.8843 786 6797 11.56%
structural molecule 
activity 5198
2.25E-
66 25.70577 101 175 57.71%
structural
constituent of 
ribosome 3735
4.77E-
68 27.26351 84 114 73.68%
binding 5488
6.94E-
44 15.16726 434 3235 13.42%
protein binding 5515
3.05E-
21 11.36007 148 866 17.09%
cytoskeletal protein 
binding 8092
2.75E-
24 14.36524 58 156 37.18%
actin binding 3779
6.56E-
17 11.99881 41 111 36.94%
nucleotide binding 166
9.26E-
16 9.420643 164 1148 14.29%
purine nucleotide 
binding 17076
6.66E-
15 9.199619 148 1014 14.60%
adenyl nucleotide 
binding 30554
1.46E-
12 8.490918 119 795 14.97%
adenyl
ribonucleotide
binding 32559
4.42E-
10 7.481237 108 759 14.23%
ATP binding 5524
1.47E-
10 7.695635 108 745 14.50%
purine
ribonucleotide
binding 32555
1.86E-
12 8.309626 136 967 14.06%
ribonucleotide
binding 32553
1.75E-
12 8.309626 136 967 14.06%
nucleoside binding 1882
1.25E-
12 8.490918 119 795 14.97%
purine nucleoside 
binding 1883
1.35E-
12 8.490918 119 795 14.97%
catalytic activity 3824
9.45E-
21 10.33897 332 2791 11.90%
hydrolase activity 16787
1.57E-
12 8.36748 140 1001 13.99%
biological_process 8150
2.91 E- 
66 17.47815 715 6137 11.65%
cellular process 9987
3.3E-
63 18.61598 445 2901 15.34%
cellular metabolic 
process 44237
5. IE - 
37 14.34542 309 2072 14.91%
cellular
biosynthetic
p rocess 44249
1.52E-
33 14.96433 144 644 22.36%
cellular
m acrom olecule
biosynthetic
process 34645
6.73E-
38 17.31816 102 313 32.59%
cellular biopolymer
biosynthetic
process 34961
5.77E-
38 17.31816 102 313 32.59%
193
5.51 E-
translation 6412 60
cellular
macromolecule 3.96E-
metabolic process 44260 23
cellular biopolymer 1.81E-
metabolic process 34960 23
cellular protein 4.83E-
metabolic process 44267 34
cellular component 3.84E-
movement 6928 19
actin filament- 1.26E-
based process 30029 17
actin cytoskeleton 1.8E-
organization 30036 17
actin filament 5.09E-
organization 7015 13
membrane 7.03E-
organization 16044 16
membrane 1.49E-
invagination 10324 16
1.06E-
endocytosis 6897 15
1.19E-
cell division 51301 14
6.87E-
cytokinesis 910 16
vesicle-mediated 5.75E-
transport 16192 12
cytoskeleton 2.03E-
organization 7010 16
cellular component 1.48E-
morphogenesis 32989 11
1.45E-
cell morphogenesis 902 11
1.28E-
metabolic process 8152 38
primary metabolic 7.05E-
process 44238 41
protein metabolic 8.95E-
process 19538 37
biosynthetic 6.38E-
process 9058 32
macromolecule
biosynthetic 4.17E-
process 9059 37
biopolymer
biosynthetic 1.33E-
process 43284 37
macromolecule 1.94E-
metabolic process 43170 25
biopolymer 3.98E-
metabolic process 43283 26
cellular component 1.47E-
organization 16043 16
response to 2.18E-
stimulus 50896 14
1.12E-
behavior 7610 10
locomotory 7626 1.14E-
24.87952 86 138 62.32%
11.3586 216 1477 14.62%
11.47191 214 1448 14.78%
14.66908 176 892 19.73%
13.03142 40 95 42.11%
12.43076 38 93 40.86%
12.41729 37 89 41.57%
11.03881 24 50 48.00%
11.58043 37 98 37.76%
12.0942 35 84 41.67%
11.7626 33 79 41.77%
11.05824 35 95 36.84%
11.86929 33 78 42.31%
9.336917 40 146 27.40%
11.60828 41 116 35.34%
10.53198 20 39 51.28%
10.53198 20 39 51.28%
14.4601 365 2611 13.98%
15.13841 330 2189 15.08%
15.11841 199 1043 19.08%
14.48354 145 673 21.55%
17.02073 102 320 31.88%
17.18963 102 316 32.28%
11.87757 240 1658 14.48%
12.07723 238 1620 14.69%
10.33955 85 418 20.33%
9.370221 91 505 18.02%
9.027137 31 101 30.69%
9.027137 31 101 30.69%
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behavior 10
1.09E-
taxis 42330 10
5.86E-
9.027137 31 101 30.69%
chemotaxis 6935 10 8.748621 28 89 31.46%
response to 4.4E-
external stimulus 9605 10 8.073005 48 226 21.24%
response to biotic 5.98E-
stimulus 9607 10 8.748621 28 89 31.46%
response to other 4.94E-
organism 51707 13 10.835 26 59 44.07%
response to 3.88E-
bacterium 9617 12 10.4701 24 54 44.44%
response to 1.88E-
radiation 9314 10 10.00906 18 35 51.43%
developmental 9.05E-
process 32502 14 9.420941 70 342 20.47%
multi-organism 3.74E-
process 51704 13 10.82875 27 63 42.86%
biological 1.24E-
regulation 65007 12 8.335921 130 908 14.32%
regulation of 5.88E-
biological process 50789 12 8.094288 123 859 14.32%
regulation of 3.35E-
cellular process 50794 12
1.94E-
8.223512 120 822 14.60%
locomotion 40011 11
4.47E-
9.305255 34 113 30.09%
cellular_component 5575 66
2.43E-
17.54635 671 5566 12.06%
cell part 44464 68
9.69E-
19.00112 496 3360 14.76%
intracellular part 44424 64
4.8E-
19.18339 359 2047 17.54%
cytoplasmic part 44444 82
2.99E-
23.71304 275 1084 25.37%
cytoplasmic vesicle 31410 50 20.14994 116 318 36.48%
cytoplasmic
membrane- 1.IE -
bounded vesicle 16023 50
1.35E-
20.29153 116 315 36.83%
endocytic vesicle 30139 50
7.16E-
20.3328 114 305 37.38%
phagocytic vesicle 45335 51
4.36E-
20.43097 114 303 37.62%
phagolysosome 32010 10
1.38E-
9.849226 15 26 57.69%
ribosome 5840 49
5.24E-
22.74975 65 96 67.71%
ribosomal subunit 33279 13
4.61 E-
11.76381 16 22 72.73%
cell cortex part 44448 10 9.665204 16 30 53.33%
cortical 4.91 E-
cytoskeleton 30863 12 11.26463 15 21 71.43%
intracellular 7.14E-
organelle 43229 66 20.37971 284 1346 21.10%
intracellular non­
membrane- 1.78E-
bounded organelle 43232 60 22.18836 137 370 37.03%
cytoskeleton 5856 1.IE - 13.62617 44 105 41.90%
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actin cytoskeleton 15629
21
2.21 E- 
12 10.11507 26 65 40.00%
intracellular 
membrane- 
bounded organelle 43231
1.6E-
32 13.89336 193 1075 17.95%
ribonucleoprotein
complex 30529
4.28E-
30 15.38348 75 219 34.25%
intracellular 
organelle part 44446
4.29E-
16 9.474691 125 786 15.90%
cytoskeletal part 44430
3.36E-
21 12.57625 60 196 30.61%
actin filament 5884
1.52E-
11 11.09113 14 19 73.68%
intracellular 5622
1.38E-
29 13.8447 128 582 21.99%
cell leading edge 31252
7.03E-
20 13.94232 30 52 57.69%
cell projection 42995
3.52E-
18 13.37167 27 46 58.70%
pseudopodium 31143
3.58E-
11 10.647 15 23 65.22%
phagocytic cup 1891
2.48E-
13 11.52536 19 31 61.29%
organelle 43226
1.54E-
66 20.52558 286 1351 21.17%
non-membrane- 
bounded organelle 43228
2.04E-
60 22.18836 137 370 37.03%
vesicle 31982
1.72E-
53 20.8021 124 341 36.36%
membrane- 
bounded vesicle 31988
1.78E-
52 20.6228 121 331 36.56%
membrane- 
bounded organelle 43227
1.7E-
32 13.89336 193 1075 17.95%
macromolecular
complex 32991
5.87E-
32 14.00508 167 861 19.40%
organelle part 44422
5.06E-
16 9.442731 125 788 15.86%
Table A.5 GO term enrichment for genes exhibiting a 2-fold increase in expression in 
the chdC null cell line in comparison to wild type cells 8H into starvation induced 
development. The P-value cut off was set at 0.01 and the GO data file used was 
gene_association.ddb.
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Lithium (Li+) is a com m on trea tm en t for bipolar m ood disorder, a major psychiatric illness with a lifetime prevalence of more 
than  1%. Risk of bipolar disorder is heavily influenced by genetic predisposition, bu t is a complex genetic trait and, to  date, 
genetic studies have provided little insight into its molecular origins. An alternative approach is to  investigate th e  genetics 
of Li+ sensitivity. Using th e  social am oeba Dictyostelium, we previously identified prolyl oligopeptidase (PO) as a m odulator 
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expression. This reveals a novel, g en e  regulatory netw ork th a t m odulates inositol m etabolism and Li+ sensitivity. Among its 
targets is th e  inositol m onophosphatase  gene IMPA2, which has also been associated with risk of bipolar disorder in som e 
family studies, and our observations offer a cellular signalling pathw ay in which PO activity and IMPA2 gene expression 
converge.
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In tro d u c tio n
Bipolar mood disorder is a common psychiatric disorder, which 
is treated using mood stabilizer drugs, such as lithium (Li+). There 
is a strong genetic component to risk of developing bipolar 
disorder, however this is a complex genetic trait and no consensus 
candidate susceptibility genes have yet emerged from those 
identified in individual family studies [1 j. Genetics is not the only 
factor affecting risk, and twin studies demonstrate the presence of 
environmental inputs [2,3]. Environmental risk factors include 
lifetime events and psychosocial stressors, physical illnesses and 
hormonal imbalances [4]. Onset of bipolar disorder is most 
frequent during late adolescence and early adulthood suggesting 
contributions from developmental and physiological mechanisms. 
As in the case o f genetics, the biological mechanisms underlying 
environmental risk are also unclear.
An alternative approach is to investigate the therapeutic 
mechanisms o f the mood stabilizer drugs used to treatment 
bipolar disorder. Li+ is the most widely used mood stabilizer, taken 
by 50% o f bipolar patients. It is an effective prophylactic agent and 
good anti-manic, but a weaker anti-depressant treatment [5]. 
Inositol monophosphatasc (IMPase) and Inositol 1-polyphospha­
tase (1PP) are direct biochemical targets of Li+ [6,7], and Li+ 
treatment leads to reduced inositol synthesis and suppression of 
inositol phosphate (IP) signalling. Consequently, it has been 
proposed that the neurological processes underlying bipolar mood
disorder are susceptible to aberrant IP signalling [8]. Consistent 
with this hypothesis, the structurally unrelated mood stabilizers 
valproic acid (VPA) and carbamazepine also deplete inositol 
[9,10], indicating a wider association between mood stabilizers 
and IP signalling.
To understand why Li+ is an effective therapy, we undertook a 
genetic screen for Li+ resistance in the social amoeba Dictyostelium. 
This identified the serine protease prolyl oligopeptidase (PO) as a 
modulator of Li+ sensitivity [11]. Interestingly, reduced PO 
activity has been associated with bipolar disorder [12,13,14], We 
found that ablation of the PO gene or inhibition of PO enzyme 
activity is accompanied by an increase in inositol(l,4,5)trispho- 
sphate (IP3) production. This inhibitory interaction is conserved in 
mammalian cells as reduced PO activity increases IP3 in 
astroglioma and COS-7 kidney cell lines [10,15]. These effects 
are manifest at the cellular level where PO inhibition both reverses 
the effects of Li+, VPA and carbamazepine on neuronal growth 
cone morphology and stimulates removal of protein aggregates via 
macro-autophagy [9,10,16,17].
The mechanism by which PO controls Li+ sensitivity has not 
been established. Initial Dictyostelium studies showed that PO null 
mutants had unaltered phospholipase C activity but increased 
activity of two inositol phosphate phosphatases. One phosphatase 
activity corresponds to multiple inositol polyphosphate phospha­
tase (Mippl), which dephosphorylates IP6 to IP3. The other is an 
IP3 5-phosphatase activity that dephosphorylates IP3 further to
PLoS ONE | www.plosone.org 1 June 2010 | Volume 5 | Issue 6 | el 1151
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I(1,4)P2 [11]. Here, we report that Mippl is required to mediate 
the effects of PO on Li+ sensitivity. Furthermore, we show that 
these effects do not arise through direct elevation of IP3 production 
as previously assumed, but are due to changes in the expression of 
genes involved in inositol synthesis and metabolism, including 
inositol synthase (inol), IMPase (impAl) and the Dictyostelium IP3 5- 
phosphatase (Dd5P3). Finally, we show that this PO mediated 
regulation of gene expression is conserved in human cells where 
among its targets is IMPA2, a gene associated with risk in some 
bipolar disorder patient family studies. Our observations suggest a 
signalling pathway that could connect altered PO mediated 
signalling to aberrant IMPA2 gene regulation.
Results
Dictyostelium PO, dpoA, reduces the effect of Li+ on 
chemotaxis
Starved Dictyostelium cells aggregate by cAMP-mediated chemo­
taxis to form a multicellular mass of 100,000 cells, which develops 
further into a fruiting body of spore and stalk cells [18]. We found
that PO activity is regulated throughout Dictyostelium development, 
peaking during late aggregation and early multicellular stages 
(Figure 1A), indicative of a regulatory function.
Li+ treatment of wild type cells has a specific effect on 
chemotaxis, causing reduced cell speed and Directionality (a 
measure of the linearity of the cell path) [19]. We found that 
chemotaxis of dpoA mutant cells was less sensitive to Li+, with cells 
exhibiting greater speed and Directionality in the presence of Li+ 
than wild type cells (Figure IB; Table 1). We also noted that dpoA 
mutant cells exhibited increased speed of movement in control 
conditions, treatment with NaCl, suggesting that DpoA suppresses 
this aspect of the chemotaxis response.
Dictyostelium PO acts via Multiple Inositol Polyphosphate 
Phosphatase (Mippl)
Previous results indicated that loss of dpoA is associated with 
increased activity of multiple inositol polyphosphate phosphatase 
(MIPP), an enzyme that dephosphorylates IP6, IP5 and certain 1P4 
species to form IP3 [11]. The Dictyostelium genome contains two 
homologues o f the mammalian MIPP, however only one gene,
PO activity
□
4 8 12 16 20
Development time (h)
0 il
B
WT + Na+
D = 0.72 ± 0.06 
S = 10.02 ± 0 .4 2
WT + Li+
D = 0.59 ± 0.04 
S = 6.09 ± 0.45
dpoA + Li+
D = 0.67 ± 0.02 
S = 8.24 ± 0.82
Figure 1. Loss o f dpoA reduces Li+ sensitivity. A, PO activity peaks at 8 hours of Dictyostelium development, and then declines to levels only 
slightly higher than in growing cells (0 hours of development). Error Bars: mean ± standard error of 3 independent experiments. Peak activity 
corresponds to streaming and mound developmental stages. B, Cell tracks of wild type and mutant cells in 7 mM LiCI (or control of 7 mM NaCl) 
during chemotaxis along a 1 nM/pm cAMP gradient (direction of arrow). D= Directionality, S= cell speed (pm/min). dpoA null mutants have a 
reduced Lf sensitivity, showing higher Directionality and speed than wild type in Li+. 
doi:10.1371/journal.pone.0011151.g001
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Tab le  1. C hem otactic analysis of lithium sensitivity.
Relative lithium  sen sit iv ity
Strain D irectionality  (D) S p eed  (s) (iim/min) D irectionality S p eed
Wild type
dpoA
mippl
mipp UdpoA
mippl0*
lmpAl°*
lmpA1oe:lno1oe
ipkA1°*
ipkET
mippl :ipkA1°* 
mippl :ipkB°*
Na
L i
Na
U
Na
U
Na
Li
Na
Li
Na
L i
Na
U
Na
U
Na
Li
Na
L i
Na
Li
0.72 ±0.06 
0.59±0.04t+ 
0.68 ±0.02 
0.67 ±0.02*“  
0.69 ±0.02 
0.50±0.06m  
0.73 ±0.03 
0.51 ±0.04+++ 
0.68 ±0.03 
0.46 ±  0.04f tt  
0.70 ±0.06 
0.66 ±0.05* 
0.51 ±0.02 
0.41 ±0.03 
0.77 ±0.05 
0.68 ±0.03*** 
0.69 ±0.01 
0.71 ±0.03*** 
0.65 ±0.02 
0.36 ±0.04 
0.62 ±0.11 
0.40±0.01
10.02 ±0.42 
6.09±0.45m  
11.34±0.57* 
8.24±0.82* 
9.65±0.19 
4.69±0.58tt+ 
9.62 ±0.27 
5.46±0.22t+ts
9.02 ±0.79 
2.96 ± 0.12m  
9.80 ±0.60 
7.85±0.43** 
18.89±0.84 
8.48 ±0.46* 
10.03±0.80 
10.07 ±0.65*** 
10.03 ±0.22
9.08 ±0.95***
8.09 ± 0 5 9  
4.64 ±0.60 
8.74±1.79 
5.43 ±0.54
Cells were treated  with 7mM LiCI or NaCl (control treatm ent) for one hour prior to  analysis. Values shown are the m ean ±  standard error of data from at least three 
independent experiments. Directionality is defined as the  total distance moved divided by th e  net distance moved. Statistical analysis: two-tailed t-test. 
tt+ p< 0 .001 ,
ttp < 0 .0 2 , com pared to  NaCl control treatm ent.
***p<0.005,
**p<0.05,
*p<0.1, com pared to  LiCI-treated wild-type cells.
Sp<0X)01, com pared to  NaCl treated  wild type cells.
$ p<0.05, com pared to  LiCI treated  dpoA null cells.
Relative lithium sensitivity
This is based on the  difference betw een the numerical values for lithium treatm ent of wild type and m utant cells, as calculated by (value of m utant in Lithium)/(value for 
WT in Lithium). For Directionality: (- - -) 60-69% of wild type; (- - -) 70-79% of wild type; (- -) 80-89% of wild type; (++) 110-119% of wild type; (+++) 120-129% of wild
type. For speed: (-----) 25-49% of wild type; (- -) 50-74% of wild type; (-) 75-99% of wild type; (++) 125-149% of wild type; (+++) 150-174% of wild type.
doi:10.1371 /joum al.pone.00111511001
denoted mippl, is expressed in growing cells and during 
development (data not shown). We generated null mutant cell 
strains, which lack the mippl gene, and strains that over-expressed 
Dictyostelium M ippl. 'These latter strains were a useful source of 
M ippl enzyme, which was used to show that Mippl rapidly 
converts 1P6 to IP3 (Figure 2A). mippl null mutants completely lack 
Mipp activity and Mippl over-expressors greatly enhanced 
activity (Figure 2B). However, total mass measurement o f all 
inositol phosphates (IPs) showed that loss o f mippl had no 
significant effect on the overall concentrations of IP4, 1P5 and 
IP6 (data not shown) suggesting that Mippl regulates only a small 
proportion o f the cellular IPs. Such robustness in the cellular 
content o f the higher order IPs has been observed previously and 
means that small changes of the IP species involved in signalling 
may be masked behind larger non-dynamic IP populations [20J.
Chemotaxis o f mippl null mutants was hypersensitive to Li‘t‘ 
(Figure 2C), the opposite phenotype of dpoA mutant cells. Double 
dpoAxnippl null mutant cells possess a similar Li+ hypersensitive 
phenotype to mippl null cells (Figure 2C), indicating that M ippl
activity is required for PO mediated signalling. Consistent with this 
we found that elevation o f IP3 following PO inhibition was also 
dependent on M ippl. 'The 1P3 concentration of wild type cells 
doubled within 30 minutes o f addition o f the PO inhibitor Z-pro- 
L-prolinal (Figure 2D). 'This increase was transient and IP3 
returned to basal levels after 60 minutes. PO inhibitors were 
unable to elevate IP3 in mippl null mutants (Figure 2D).
To investigate the interaction between PO and Mippl at the 
biochemical level, we prc-incubated Mippl extracts with bacterially 
produced recombinant DpoA protein, and then monitored Mippl 
activity. Incubation with DpoA enzyme caused an approximate two­
fold decrease in Mippl activity, an effect reversed by treatment with 
PO inhibitor (Figure 2E). However, there was no change in the 
abundance or size of the Mippl protein following PO treatment 
(Figure 2E), arguing against direct proteolysis. Mipp 1 is extracted as a 
membranous particulate fraction and the most likely explanation is 
that PO acts on a yet unidentified, co-purified intermediate protein or 
peptide. TTiese results however do indicate a close association 
between PO activity and Mipp 1 regulation.
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Figure 2. M ippl m ediates the e ffects of PO inhibition. A, Mippl enzyme prepared from Mippl over-expressing cells were incubated with 10 
nmoles lnsP6 for the indicated times and analyzed by HPLC-MDD. I(1,4)P2 was generated by contaminating IP3 5-phosphatase activity, and
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dem onstrates that the  product of Mippl is 1(1,4,5)P3. B, Mippl activity measured as the  rate of IP3 formation in extracts from wild type, mippl null 
m utant and Mippl overexpressingcells. C, Cell tracks of wild type and mippl m utant cells in 7 mM LiCI (or control of 7 mM NaCl) during chemotaxis. 
mipp, mipp:dpoA and Mippl over-expressing m utants (M ipploe) are Lr hypersensitive compared to  wild type. D = Directionality, S= cell speed (pm/ 
min). D, Vegetative wild type and mippl null cells were treated with either 1.2 mM Z-pro-L-prolinal or an equal volume of DMSO carrier as a control. 
Samples were then removed at the times indicated and IP3 concentration measured. Values plotted as mean ±  standard error of 4 independent 
experiments. * P<0.05, paired T-test. E, Mippl protein extracts were incubated with recombinant DpoA with or without the  PO inhibitor Z-pro-L- 
prolinal. Mippl activity is measured by the  production of IP3 from IP6. Values plotted as mean ±  standard error of 3 independent experiments. 
** PC0.01, paired T-test. Samples of Mippl protein are shown on Western (underneath). 
doi:l 0.1371 /joumal.pone.0011151.g002
Over-expression of Mippl causes Li+ hypersensitivity
A simple hypothesis is that decreased PO activity controls Li+ 
sensitivity through Mippl mediated changes in IP3 abundance, 
but a number o f observations show this is not the case. First, 
Mippl over-expression would be expected to increase the IP3 
concentration and reduce Li+ sensitivity, however Mippl over- 
expressing cells are strongly Li+ hypersensitive (Figure 2C). 
Second, in the absence of PO inhibition, we found that neither 
loss nor over-expression o f Mippl altered the cellular concentra­
tion of IP3, despite both causing Li+ hypersensitivity (data not 
shown). This lack o f correlation argues against generation of IP3 as 
a direct mechanism for Li+ resistance. The same lack o f reciprocity 
also argues against a mechanism involving depletion o f the Mipp 1 
substrate 1P6 or its alternative substrate 2,3-bisphosphoglyceratc 
(2,3-BPG) [21]. I(1,3,4,5,6)P5 and I(1,4,5,6)P4/I(1,3,4,5)P4 are 
intermediates in the dephosphorylation of 1P6 to I(1,4,5)P3 by 
M ippl and both have signalling properties within the cell. Mippl 
could therefore play a more complex role by regulating the 
abundance o f these molecules through controlling the balance of 
their synthesis and degradation.
Over-expression of the IP3 kinases IpkAl and IpkB confers 
Li+ resistance
In all but one case, it was not possible to observe direct changes 
in the abundance o f IPs in our mutants, however the exception 
was seen in Mippl over-expressing cells, which exhibited a large 
decrease in the cellular I(1,3,4,5,6)P5 concentration, in addition to
decreased IP6 (Figure 3A). As this correlates with a strong Li+ 
hypersensitive phenotype, it suggested a positive role of 
I(1,3,4 ,5,6)P5 signalling in establishing Li+ sensitivity. To pursue 
this possibility, we over-expressed two structurally distinct IP3 
kinases (IpkAl and IpkB) each capable o f generating I(1,3,4 ,5,6)P5 
[22,23,24]. In the reverse o f that seen for Mippl over-expression, 
chemotaxis o f cells over expressing either IpkAl or IpkB was 
resistant to Li+ (Figure 3B). Interestingly, we found that the Li+ 
resistant phenotype was lost when the IpkAl or IpkB were over­
expressed in a mipp] null mutant background (Figure 3B), arguing 
that Mippl activity may be the key regulator o f this signal 
pathway.
DpoA acts via M ippl-mediated gene regulation
As the yeast homologuc o f ipkAl, Ipk2/Arg82, controls 
expression o f the inositol synthase gene (inol) [25], we investigated 
potential changes in gene expression mediated by PO and Mipp 1. 
Expression o f the Dictyostelium inol gene [9,26] was elevated both in 
dpoA null cells and cells treated with 1*0 inhibitor (Figure 4A,B). 
Furthermore both conditions gave a 60-100% increase in 
expression of the genes encoding IMPase (impAl), IPP (ippA and 
ippB) and Dd5P3, a phosphatase that converts I(1,4,5)P3 to I(1,4)P2 
(see Table SI). Dd5P3 is homologous to the synaptojanin-like IP3 
5-phosphatase conserved from yeast to humans [27] and its 
elevated expression is consistent with the elevated IP3 5- 
phosphatase activity previously observed in dpoA null cells [11). 
No change was seen for mippl, dpoA or ipkAl genes (Figure 4B).
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Figure 3. E levated expression  of M ippl and IP3 k in ases alter lithium  sensitiv ity . A, Comparison of the l(1,3,4,5,6)Ps and IP6 concentration 
of wild type, dpoA null; mippl null and Mippl over-expressing cells. Values plotted (means ± standard error of 3 independent experiments) as 
percentage of the  total IP content relative to wild type (*P<0.05, ** P<0.01 T-test). B, Cell tracks of wild type and mippl null m utant cells over­
expressing IpkAl and IpkB during chemotaxis in 7 mM LiCI. D= Directionality, S= cell speed (nm/min). Over-expression of IpkAl and IpkB in wild 
type cells confers Li4 resistance, whereas Li+ hypersensitivity is m aintained after over-expression in a mippl null mutant. 
doi:10.1371/journal.pone.0011151.g003
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Changes in gene expression were dependent on M ippl, as mippl 
null mutant cells treated with the PO inhibitor exhibited no 
change in the expression of inol or impAl (Figure 4C). Further­
more, in the absence of PO inhibitor, Mippl over-expression 
caused a 50% decrease in expression of impAl, although inol was 
unaffected (Figure 4C). Finally, IpkAl and IpkB over-expression 
elevated inol and impAl gene expression in the absence of PO 
inhibition (Figure 4D), again supporting a signalling role of the 
higher order IPs.
Previously, we demonstrated that elevated expression of impAl 
in Dictyostelium cells reverses Li+ inhibition of chemotaxis [19]. This 
is consistent with the uncompetitive inhibition mechanism of Li+
on IMPase, which unlike other modes o f inhibition is only reversed 
by increased enzyme concentration. This mechanism alone offers 
an explanation for how PO inhibition could confer Li+ resistance, 
however our observations on gene expression suggest a more 
extensive effect of PO on expression o f multiple inositol synthetic 
genes. This could combine to enhance Li+ resistance. We 
investigated cells with elevated expression of both impAl and 
inol and found that they appeared to be Li+ resistant. 
Quantification showed that in terms of cell speed, impAl.mol 
over-expressing cells were Li+ resistant in comparison to wild type 
cells. However, we also observed that these cells exhibited higher 
cell speed compared to wild type cells in the Na+ control treatment
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(Figure 5 A 3)- In contrast, Directionality was reduced in both Na+ 
control and Li+ treated cells, effectively making the cells more 
sensitive than wild type with regard to this parameter. These 
observations demonstrate that whilst mis-regulation o f multiple 
genes may enhance overall Li+ resistance, there is likely to be more 
complexity to the regulation, either involving more genes than inol 
and impAl or perhaps a finer balance in levels o f expression.
PO and Mippl modulate gene expression in HEK293 cells
These results show that PO and Mipp 1 control expression o f the 
Dictyostelium inositol synthetic genes (Figure 6A). A key question is 
whether a similar modulatory pathway exists in human cells. We 
therefore examined the effects o f PO inhibition on HEK293 cells. 
PO inhibition caused a strong elevation o f expression o f the 
human IMPase genes, IMPA1 and IMPA2 (Figure 6B). siRNA to 
knockdown human Mippl expression again demonstrated that 
this increase was dependent on M ipp l. Interestingly, basal IMPA1 
expression was reduced by mippl siRNA (Figure 6B), suggesting 
that in these human cells, IMPA1 expression may be more 
dependent on M ippl function than other co-rcgulatcd genes. PO  
inhibitors also lead to a smaller Mippl-dependent elevation in 
expression o f the human inositol synthase gene ISYNA1.
D iscussion
These results indicate that PO and M ippl are key components 
o f a gene regulatory network that controls expression o f the 
Dictyostelium inositol synthetic genes (Figure 6A). We suggest that 
this may act in Dictyostelium during aggregation stage o f 
development to modulate chemotaxis. It has previously been 
observed that Dictyostelium change their chemotactic response 
during aggregation in order to accommodate changes in cAMP 
signalling as cells approach multicellularity [28]. Little is known 
about the mechanisms that mediate these changes, however we 
observed elevated PO activity during these later stage o f
aggregation, and note that DpoA appears to act as a suppressor 
of cell speed during chemotaxis, suggesting that the PO /M ippl 
signal pathway could be involved with these developmental 
changes.
The rapid elevation of IP3 in response to PO inhibition, suggests 
a series of direct interactions within this signalling pathway, and 
consistent with this we see no change in mippl mRNA following 
PO inhibition. Furthermore, we show that incubation with 
recombinant PO decreases Mippl activity in cell extracts. This 
in vitro effect does not proceed via proteolysis o f M ippl, and 
therefore is likely to involve an unidentified intermediate peptide 
or protein.
In addition, we show that although I(1,4,5)P3 is the Mippl 
product, it is not the modulator of Li+ sensitivity. Instead, we show 
that this occurs via altered expression of the genes that encode the 
myo-inositol synthetic and metabolic genes. 'This fits biochemical 
observations as Li+ is an uncompetitive inhibitor of the IMPase 
and IPP [6,29] and hence targets the enzyme-substrate complex. 
Uncompetitive inhibitors can only be overcome by increasing the 
amount of enzyme, and we have previously shown that increased 
expression of ImpAl reduces Li+ sensitivity o f Dictyostelium cells 
undergoing chemotaxis [19]. We also previously found that in the 
absence o f Li+, elevated ImpAl enhances signalling via PIP3, an 
important mediator o f the chemotaxis in Dictyostelium and 
signalling in other cells. We now show that a combined increase 
in expression o f impAl and inol genes, as occurs in the dpoA null 
mutant, enhances the degree o f Li+ resistance with regard to cell 
speed and also alters the chemotactic response in the absence of 
Li+. A combined up-regulation o f gene expression would be 
expected to have significant effects on PIP3 signalling.
The exact nature of the link between Mipp 1 and gene 
expression requires further study, however genetic evidence 
implicates signalling via changes in the metabolism of the higher 
order inositol phosphates, I(1,3,4,5 ,6)P5 and I(1,4 ,5,6,)P4 [30]. 
I(1,3,4,5,6)P5 is a good candidate for a signalling and has
lno1/lmpA10<
lmpA1oe lno1°e/lmpA1oe
Figure 5. Increased in o l and impAl g en e  ex p ression  confers Li* resistance. A, Cell tracks of wild type cells over-expressing ImpAl alone or 
both ImpAl and inol undergoing chemotaxis in 7 mM NaCl or LiCI. D = Directionality, S= cell speed (^m/min). B, Cells of wild type cells over­
expressing ImpAl alone or both ImpAland inolw ere developed in th e  presence of 10 mM LiCI. Images are taken after 24 hours, bar = 5  mm. 
doi:10.1371 /journal.pone.0011151.g005
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Figure 6. PO regu lates expression  o f hum an IMPA1, IMPA2 and ISYNA1 g en es . A, A diagram to illustrate the gene regulatory network 
through which PO activity regulates expression of the IMPA1, IMPA2 and ISYNA1 genes. The gene regulatory network is separate from ligand- 
stimulated regulation of IP3 signalling via phospholipase C (PLC), but interacts via changes in gene expression or interchange of soluble IP3. * marks 
genes and enzyme activities associated with bipolar mood disorder. B, HEK293 cells were treated with either mippl specific or non-targetting siRNA 
for 24 hours with or without 130 pM Z-pro-L-prolinal (PO inhibitor). Gene expression was quantified by qRT-PCR using expression of B2M as a 
reference. Expression of IMPA1, IMPA2 and ISYNA1 genes was quantified as percentage relative change compared to  control (DMSO carrier treated, 
non-targeted siRNA samples). * p<0.05, ** p<0.02, *** p<0.001. 
doi:10.1371/journal.pone.0011151.g006
previously been observed in the control of inol and pho gene 
expression in yeast [25]. In mammals, recent results indicate the 
I(1,3,4 ,5,6)P5 rapidly accumulates following Wnt3A stimulation 
[31].
To investigate the effects o f PO inhibition in animal cells, we 
examined PO inhibition and siRNA knock down of Mippl in 
HEK293 cells. As found in Dictyostelium, expression of inol 
(ISYNA1), IMPA1 and the IMPase paralogue IMPA2 are 
increased in a Mippl dependent manner following treatment 
with PO inhibitors. Interestingly, basal IMPA1 expression was 
reduced by Mipp 1 siRNA and no subsequent elevation of 
expression was seen with PO inhibition. This suggests that in 
human cells, expression of IMPA1 may have a greater 
requirement for Mippl activity than other genes. We note that 
although the same dependency is not seen in Dictyostelium, we did 
observe a differential inhibitory effect on impAl and inol following 
Mippl over-expression (Figure 4D). It is currently unclear how 
these differences in expression arise between genes, however we 
suggest that they reside in subtle differences in their promoter 
structure.
How might PO mediated signalling be relevant to bipolar mood 
disorder? First, altered PO activity has been observed in bipolar 
disorder patients. In manic phase patients prior to treatment, 
plasma PO activity is elevated, but then reduced to below that of 
control patients following mood stabilizer treatment [13]. In a 
follow up study, PO activity was shown to be below that of control 
groups in euthymic patients [14]. Both sets of measurements were 
made using plasma, however PO is a cytosolic enzyme and plasma 
levels of activity are 1,000-fold less than intracellular activity [14]. 
The relationship between intracellular activity and patients has not 
yet been explored.
The potential causes of altered PO activity are unknown, but as 
single nucleotide polymorphism (SNP) analysis has failed to find a 
genetically significant association of PO with risk of bipolar 
disorder [32], it may arise from environmental or physiological 
effects. High doses o f the cytokine IFN-a in patients undergoing 
immunotherapy are reported to decrease serum PO activity and 
be associated with some symptoms of depression [33], and mood 
disorders in general have previously been associated with an
activation of the inflammatory response. A recent report found 
bipolar disorder patients have altered expression of a subset of 
genes that are associated with the pro-inflammatory response, 
including those involved in cytokine signalling and chemotaxis 
[34]. Furthermore twin studies showed that these changes arise 
through a common environmental factor, not a shared genetic 
component [34]. Altered PO activity may therefore reflect an 
environmental or physiological component for risk of bipolar 
disorder.
Second, genetic studies suggest that the presence of a specific set 
of SNPs within the IMPA2 gene promoter associates with elevated 
risk for bipolar disorder in some family studies [35,36,37]. Some of 
these SNPs have been shown to elevate promoter activity when 
coupled to marker genes and may also associate with elevated 
expression in post-mortem brain samples, although these studies 
may be confounded by differences in brain pH [37]. Global 
differences in brain IMPase activity have not been substantiated 
[38,39], although differences could be missed by sampling 
different populations, or if changes only occur in a small subset 
of cells or brain regions.
Third, we have identified a novel signal pathway, where PO acts 
to suppress gene expression of the inositol synthetic and metabolic 
genes. It seems significant that PO suppresses IMPase gene 
expression, which is a Li+ target. In Dictyostelium, loss o f PO leads to 
reduced Li+ sensitivity. This would seem the opposite case to that 
seen in patients, where Li+ treatment suppresses a clinical state. 
However, the difference may be that Li+ treatment of Dictyostelium 
cells leads to a quantifiable difference in cell behaviour, whereas 
no behavioural difference has been observed in human non­
patient controls. Our Dictyostelium experiments can be viewed from 
an alternative perspective, where our mutant Dictyostelium cells 
possess aberrant signalling  and in some cases exhibit altered 
chemotaxis behaviour. Li+ treatment suppresses this aberrant 
signalling behaviour so that it now falls into the behavioural 
parameters measured in wild type cells prior to Li treatment. For 
example in the case of both the dpoA null mutant and inol.impal 
over-expressors we observed differences in chemotactic behaviour 
that were reversed by Li+ treatment. Similarly we have previously 
observed elevated PIP3 signalling in wild type cells over-expressing
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impal in the absence o f Li+, which is suppressed by Li+ treatment 
[19].
We therefore envisage that treatment o f patients may fit a 
general model, where elevated signalling activity is suppressed by 
mood stabilizer treatment. We propose that altered transcriptional 
control o f inositol synthetic and metabolic genes, particularly 
IMPA2, could contribute to elevated risk o f bipolar disorder. This 
risk could be heightened through changes in PO activity. In the 
simplest scenario, a genetic predisposition for elevated IMPA2 
expression could be enhanced though an environmentally 
mediated decrease in PO activity leading to overactive cell 
signalling. Long-term Li+ treatment would in turn suppress 
elevated cell signalling to compensate for elevated gene expression. 
Although this will be difficult to direcdy demonstrate in patient 
studies, further genetic analysis and development o f model systems 
will be useful to probe the clinical relevance of PO-mediated 
signalling.
Materials and Methods
Analysis of Cell movement
All Dictyostelium mutants and over-expressing strains were 
generated in the AX2 parental background (Materials and 
Methods SI) and grown using standard methods [40]. Cells were 
shaken at 106 cells/m l for 5 hours in KK2 with 6-minute pulses of 
100 nM cAMP every 6 minutes. Lithium was added for the final 
hour o f pulsing. Cells were placed in 1 pM gradient o f cAMP[41] 
and images collected every 10 seconds on a DIC inverted 
microscope. Data was analysed using DIAS 3.4.1 analytical 
software (Soli Technologies Inc; [42]). Data sets were analysed for 
statistical significance using a Mann-Whitney U-test, and based on 
200 300 cells per experiment.
Biochemical analysis. PO activity was measured as 
described by Williams et al (1999) [11]. For MIPP activity, cell 
extracts were prepared as described by Van Dijken et al (1995)
[43] and incubated with an equal volume of TEE [20 mM  
triethanolamine pH 6.5, 5.9 mM EGTA, 0.5 mM EDTAj 
supplemented with 20 mM CaCl2, 50 mM LiCI and 200 |lM  
IPg. Production of IP3 was measured by an isotope dilution assay 
(Perkin Elmer). For HPLC-MDD analysis, IP were prepared from 
109 cells and resuspended in 400 |il 0.1 M NaCl, 15 mM NaF, 
0.5 mM EDTA pH 6.0, and quantified by hplc analysis using 
Tricorn Mini 0 ,4 .6 /5 0  PE columns (GE healthcare) with solutions 
A: (21 pM YCI3) and B (0.8 M HC1, 25 pM YC13 (Merck). Post­
column detection used (2.13 M triethanolamine, 500 pM 4-(2'-
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Glycogen synthase kinase-3 (GSK3) is a highly conserved protein kinase that is involved in several important cell 
signaling pathways and is associated with a range of medical conditions. Previous studies indicated a major role of the 
Dictyostelium  homologue of GSK3 (gskA) in cell fate determination during morphogenesis of the fruiting body; however, 
transcriptomic and proteomic studies have suggested that GSK3 regulates gene expression much earlier during Dictyo­
stelium development To investigate a potential earlier role of GskA, we examined the effects of loss of gskA on cell 
aggregation. We find that cells lacking gskA exhibit poor chemotaxis toward cAMP and folate. Mutants fail to activate two 
important regulatory signaling pathways, mediated by phosphatidylinositol 3,4,5-trisphosphate (PIP3) and target of 
rapamycin complex 2 (TORC2), which in combination are required for chemotaxis and cAMP signaling. These results 
indicate that GskA is required during early stages of Dictyostelium development, in which it is necessary for both 
chemotaxis and cell signaling.
INTRODUCTION
G lycogen  syn thase k inase-3 (GSK3) is a m ultifunctional pro­
tein  k inase that is h igh ly  conserved  throughout the eu ­
karyotes. In anim als, includ ing  hum ans, it is associated w ith  
im portant em bryological and physio log ica l signaling  pro­
cesses, such  as W nt and insu lin  signaling  (Cross et al., 1995; 
Papkoff and A ikaw a, 1998). A s a consequence it is linked to  
major clinical conditions, includ ing  cancer, d iabetes, and  
A lzheim er's d isease. A t the cellu lar level GSK3 m ed iates  
processes, such  as regulation o f gen e  expression , control o f  
p roteo lysis, m etabolism , and control o f the cytoskeleton  
(H arw ood , 2001; Kim et al., 2002). T he question  o f h ow  GSK3 
exerts its effects on  these m ultip le processes is im portant for 
u n d erstan d in g  the integration o f cell signaling  w ith in  the  
cellu lar context.
T he socia l am oeba D ictyostelium  g row s and d iv id es in  the 
p resence o f  n u trients in a unicellular form, but w h en  starved  
it u n d erg o es a d evelop m en ta l program  to form  a m ulticel­
lular and d ifferentiated structure, term ed the fruiting b od y  
(H arw ood , 2001). D ictyostelium  d evelop m en t com prises of 
tw o  major ph ases. First, du ring  aggregation  phase, cells 
m igrate together b y  chem otaxis in  a process m ediated  by  
cA M P p u lses . Second, the m ulticellu lar aggregate, or 
m ou n d , undertak es a series o f differentiation even ts and  
m orp h ogen etic  m ovem en ts to  u ltim ately  form  a fruiting
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b ody, w hich  com p rises spore cells w ith in  a spherical head, 
supported  by a sta lk  o f  vacuolated , cellu lose encased stalk  
cells.
D ictyostelium  p o sse sse s  a single hom ologu e o f GSK3, gskA  
(H arw ood et al., 1995). It w as d iscovered  previously  that 
G skA  regulates the p rocesses that control cell fate (H arw ood  
et al., 1995). This in itia lly  occurs during early stages o f m u l­
ticellular d ev e lo p m en t, w h en  cells first com e together to  
form  a m ulticellu lar m ound. A t this point, cells differentiate 
into three basic ce ll types; prespore cells that eventually  
form  spores, and prestalk  cells (pst) com prising pstA  cells  
that g ive  rise to  the stalk and the majority o f  its associated  
structures and pstB cells that form the basal d isk  that an­
chors the stalk to the substratum  (W illiam s et al., 1989). In 
w ild -typ e  cells, 80% o f the cells form prespore cells and the  
rem ainder form  p st cells, o f w hich  the majority are pstA . 
H ow ever, in a gskA  null m utant, the pstB population  ex­
p an d s at the exp en se  o f the prespore population , so  that the 
final fruiting b od y  o f the basal d isk is greatly enlarged and  
the spore head reduced (H arw ood et al., 1995). D uring later 
stages o f fruiting b od y  form ation, G skA  regulates a second  
cell fate d ecision  b y  controlling the differentiation from pstA  
cells to  pstAB cells (Schilde et al., 2004), w h ich  progress to  
form  the m ain structural elem ent o f the stalk.
In the m ound, activation o f G skA  is m ediated  b y  h igh  
concentrations o f cAM P via the cAM P receptors carC and  
carD, w hich  control tyrosine phosphorylation  of G skA  b y  
the kinase ZakA (Kim et al., 1999) and an unidentified  ty­
rosine phosphatase (Kim et al., 2002). D ow nstream  of G skA  
lies a /3-catenin hom ologue, Aardvark (Aar; G rim son et al., 
2000), and a signal transducer and activator o f transcription  
(STAT) transcription factor, STATa (G inger et al., 2000), al­
though  the full role o f these proteins is currently unclear.
A lthough the phenotypes described for gskA  null m utants  
occur during m ulticellular stages, G skA  expression  and ac-
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tiv ity  is p resent throughout D ictyostelium  d eve lop m en t  
(P lyte et al., 1999). A  proteom ic and m icroarray an alysis o f  
cells  at 5 h  o f  develop m en t, several hou rs before the first 
m ulticellu lar d evelop m en ta l stages, revea led  = 1 5 0  gen es  
w ith  altered patterns o f expression  (Strm ecki et ah, 2007). 
C uriously , o f th ose  gen es identified  that had been  charac­
terized  p rev iou sly , all are associated  w ith  grow th  and ag­
gregation  p h ase  rather than m ulticellu lar d eve lop m en t. T his  
raises the q u estion  o f additional roles o f  G skA  du ring  these  
earlier stages o f  Dictyostelium  d eve lop m en t.
H ere, w e  report an in-depth  in vestigation  o f  aggregation  
and  ch em otax is o f gskA  null m utants. W e find that g skA  null 
m utan t ce lls  h a v e  defective chem otaxis tow ard  cA M P and  
folate, a grow th  ph ase chem oattractant. T he ch em otaxis d e­
fect is accom pan ied  by supp ression  o f  p h osp h atid y lin osito l 
3,4 ,5-trisphosphate (PIP3) levels. H ow ever , w e  observe that 
lo ss  o f  gskA  cau ses a m uch greater effect on  cA M P-m ediated  
ch em otaxis than can b e  accounted for b y  lo ss  o f  PIP3 sign a l­
in g  a lon e (Lee et al., 2005; H oeller and Kay, 2007; T akeda et 
al., 2007). W e find  that p rote in  k in a se  B (PK B)R l is  n ot 
p h o sp h o ry la ted  in  g skA  m u tants, a p ro te in  k in ase  related  
to  PKB b u t reg u la ted  in  a PIP3-in d ep en d en t m anner. L oss  
o f  b o th  PIP3 s ig n a lin g  and  PKBR1 p h o sp h o ry la tio n  h as a 
stro n g  effect o n  ch em o ta x is . F in ally , w e  sh o w  that gskA  
n u ll m u tan t c e lls  d o  n o t g en era te  cA M P p u lse s  d u r in g  
ag g reg a tio n , d em o n stra tin g  that G skA  p la y s  a m ajor role  
in  th e  reg u la tio n  o f  ch em o ta x is  and  early  D ictyostelium  
d e v e lo p m e n t.
MATERIALS AND METHODS 
Strains
The gskA  null strain (ID Strain: DBS0236114) was obtained from the Dicty 
Stock Centre (http://dictybase.org/) and was originally generated in the 
Dictyostelium discoideum strain AX2 background. The wild-type strain refers to 
AX2 and is the same strain denoted in Bloomfield et al. (2008). Cells were 
cultured axenically on plates in HL5 with glucose medium (Formedium 
HLG0102) before experiment. gskA null mutants were grown in media sup­
plemented with 10 fig/ml blasticidin, and gskA null transformants carrying 
GskA-green fluorescent protein (GFP) (gskA-GSKA) and immobilized metal 
assay of phosphorylation (IMPA)-GFP (gsJcA-IMPA) were grown in medium 
supplemented with 40 jxg/ml G418 (catalog no. 11811-023; Invitrogen). All 
cells were maintained at 22°C.
Plasmids
The GskA-GFP2 rescue protein for gskA was constructed by inserting the 
coding regions of GskA into pDXA GFP2 at the Kpnl and Nsil restriction 
sites, such that the fusion protein was expressed under the control of a 
constitutive Actinl5 promoter. By introducing point mutations into the cod­
ing region of the pDXA GskA-GFP2, the kinase-dead construct pDXA GskA- 
GFP2 K85R was made with the QuikChange site-directed mutagenesis kit 
(Strategene , La Jolla, CA) as per the manufacturer's direction. The coding 
sequence of the IMPA  gene was amplified from the cDNA clone FCBP15, 
obtained form the Japanese D. discoideum cDNA project (Morio et al., 1998). 
The insert was subsequently ligated into the pTX-GFP vector.
Cell Signaling Assays
cAMP was measured as described previously (Snaar-Jagalska and Van Haas­
tert, 1994) by using isotope dilution assay kits (GE Healthcare, Little Chalfont, 
Buckinghamnshire, United Kingdom). Cells were starved in KK2 buffer (6.5 
mM KH2P04, 3.8 mM K2HP04, pH 6.2) for 5 h in shaking culture at a 
concentration of 1 x 107 cells/ml. To determine cAMP levels, cells were 
resuspended at 5 x 107 cells/ml, and 100 /d of cells was stimulated with 5 #aM 
2'-deoxy-cAMP in the presence of 5 mM dithiothreitol. Reactions were ter­
minated by the addition of 100 p i of 3.5% (vol/vol) perchloric acid on ice. 
Samples were neutralized with 50 fil of KHC03 (50% saturated), followed by 
centrifugation for 2 min at 14,000 x g  at 4°C. Finally, 50 p i of each sample was 
added to the cyclic AMP 3H assay system (GE Healthcare).
Wild-type cells transformed with the plasmid WF38 (PHCRAC-GFP; Parent 
et al., 1998) were pulsed with cAMP for 5 h with an end concentration of 100 
nM. Cells were subsequently stimulated by the addition of 1 jtM cAMP, and 
protein translocation was recorded by fluorescence videomicroscope with a 
60 x objective.
Time-Lapse Analysis
For chemotaxis to folate, cells were grown axenically to a density of 1 X 106, 
and 4 x 105/cm2 cells were washed twice in 20% media/KK2 and replated in 
a LabTek coverglass chambered well (Nunc 155379; Nalge Nunc Interna­
tional, Rochester, NY) with 2 ml of 20% media/KK2. Folate (25 mM) was 
delivered via a Femtotip (5242 952.008; Eppendorf, Hamburg, Germany), and 
images were recorded for every 20 s under 10X phase objective. For aggre­
gation, 5 x 106 cells were washed and plated on KK2 agar. Images were taken 
every 30 s for cAMP pulse movies under 4X objective for at least 24 h. 
Postprocessing was carried out with ImageJ (National Institutes of Health, 
Bethesda, MD). For chemotaxis, 5 X 107 cells were shaken in KK2 buffer 
(Formedium KK29907) for 5 h while being pulsed every 6 min with cAMP to 
an end concentration of 10-7 M. The chemotaxis-competent cells were placed 
in a Zigmond chamber (2102; Neuro Probe, Gaithersburg, MD) in a cAMP 
gradient (source at 10-6 M cAMP, sink with no cAMP). Differential interfer­
ence contrast images of cells were captured with a 20x objective at 6-s 
intervals for 15 min. Cell movement was analyzed using Dynamic Image 
Analysis System (DIAS), version 3.4.1 (Soil Technologies, Iowa City, IA; 
Curreli et al., 2001). Statistical analysis was carried out using the nonparamet- 
ric Kruskal-Wallis test, with a post hoc Dunn's multiple comparison test 
using Prism 4 (GraphPad Software, San Diego, CA).
Phospholipid Radiolabeling and Thin Layer 
Chromatography (TLC) Analysis
Cells (1 x 108) were starved and pulsed for 4 h with 100 nM cAMP. At the 
fourth hour, cells were pelleted and resuspended in 600 #*1 of KK2. Radioac­
tive [y-32P]ATP was added (1.2 MBq), and the cells were pulsed with cAMP 
for a further hour (100 nM/6 min).
Phospholipids were extracted as described in Konig et al. (2008): cells were 
added to 750 jri of acidified A (chloroform/methanol/HCl (1M) ratio: 40:80:1) 
and sonicated. A further 250 /il of chloroform and 450 p i of 1 M HC1 were 
added to the cells, and then the cells were vortexed and spun, and the lower 
phase was collected. The process was repeated two more times, once with 
chloroform/methanol/HCl (1M) (ratio: 10:10:4) and the second time with 
methanol/EDTA (100 mM) (ratio: 1:0.9) and subsequently dried. Samples 
were then resuspended in chloroform/methanol (ratio: 2:1) and spotted onto 
a TLC plate (Cole-Parmer Instrument, Vernon Hills, IL). Plates were devel­
oped with a chloroform/acetone/methanol/acetic add/double-distilled H20  
solvent system (ratio 46:17:15:14:8), and phospholipids were visualized by 
spraying with molybdenum Blue spray reagent (Sigma Chemical, Poole, 
Dorset, United Kingdom). Radiolabeled lipid spots were imaged by exposing 
the plate to Hyperfilm (GE Healthcare) for 3 d. PIP3 measurements were 
carried out according to manufacturer's instructions (K-2500s PIP3 Mass 
ELISA kit; Echelon Biosdences, Salt Lake City, UT). Anti-phospho protein 
kinase C (PKC; pan) antibody used for detection of PKBA and PKBR1 was 
purchased from Cell Signaling Technology (190D10; Danvers, MA) and ana­
lyzed as described previously (King et al., 2009).
Quantitative Reverse Transcription-Polymerase Chain 
Reaction (qRT-PCR)
Dictyostelium cells were starved and shaken with pulses of 100 nM cAMP for 
5 h. Cells (2 x 106) were then harvested and pellets were snap-frozen. RNA 
was isolated using an illustra RNA spin mini kit (25-0500-72; GE Healthcare), 
and its integrity was checked on a 1% formaldehyde agarose gel. Genomic 
DNA contamination was checked by PCR using existing primers for a known 
gene. cDNA was prepared using the First-Strand cDNA kit (11483188001; 
Roche Diagnostics, Mannheim, Germany) using 1 p g  of RNA and random 
primers. A minus-reverse transcriptase control was also set up. qRT-PCR was 
carried out on a Chromo4 machine (Bio-Rad laboratories, Hercules, CA) with 
the Opticon2 detection software. The fluorophore used for detection was 
SYBR Green, iq SYBR Green master mix (170-8884; Bio-Rad Laboratories) 
was used for the reactions with 100 p g  of cDNA. Housekeeping genes 
incorporated for quantification were lg7 (www.dictybase.com; ID Strain: 
DDB_G0294034), impkl, and impk2. The genes of interest were carA-1 
(DDB_G0273397), acaA (DDB_G0281545), and pdsA (DDB_G0285995). Data 
analysis was carried out using the qbase software Jo VandeSomple and Jan 
Hellemans (Hellemans et al., 2007). Standard curves were created for all genes 
by using a 3-point 10-fold dilution series of Ax2 0 h cDNA, and all samples 
also were normalized to the Ax2 0 h cDNA. Primer sequences are as follows: 
ig7 forward, TCCAAGAGGAAGAGGAGAACTGC and ig7 reverse, TGGG- 
GAGGTCGTT AC ACC ATTC; ipmkl forward, GCAGGTTCAACACCATTCA- 
AAAAATC and ipmkl reverse, TCCA AC ACT ATCCATTCCTT ACCATC; 
tpmk2 forward, TGGTAGTTTTTTGAGTGTCAGCCC and ipm kl reverse, TGAT- 
GATGTTGTTGTTGTTG TTGTAGTG; carA-1 forward, ATGTTGGGTTGTAT- 
GGCAGTG and carA-1 reverse, AGGGAAACCACCATTGACAG; acaA for­
ward, CATTCTAGAGGCGGTATTGGC and acaA reverse, GGAGAAAATG- 
TCTG ATTTCGCTT; and pdsA forward, CC ATTGGGT AC AACTGGTGG A and 
pdsA reverse, AACTGCCCATGATGGATAGGT.
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Figure 1. Analysis of Dictyostelium development. (A) 
Wild-type cells form streams ~ 8  h after starvation, but 
gskA null mutants bypass this stage and form small 
m ounds that are unstable. (B) Mounds of gskA null 
m utant cells are constantly disaggregating and reaggre- 
gating. Arrows indicate mounds exhibiting this process. 
(C) gskA null mutant cells carrying a rescue plasmid 
proceed normally through development (bottom left), 
but a kinase-dead version (GskAK85R) in the gskA null 
m utant had similar development to the original null, 
indicating a requirement for kinase activity for normal 
development.
RESULTS
g skA  N u ll M u ta n ts  H ave A b erra n t Aggregation
We observed previously that gskA  null mutant cells had 
unusual aggregation, form ing sm all m ounds ~ 2  h  before 
w ild-type strains. This w as independent of parental back­
ground, bein g  seen  in m utants created from both DH1 and 
AX2 parental w ild -type strains (H arwood et al., 1995; Schilde 
et al., 2004). Small m ounds also w ere seen in cells treated 
w ith  lithium , an inhibitor o f GSK3 (W illiams et al., 1999). 
This prom pted a m ore in depth  investigation o f gskA  null 
mutants.
To investigate the role o f G skA during aggregation, w ild - 
type and g skA  null mutant cells w ere plated for develop­
ment and recorded using tim e-lapse videom icroscopy. A s 
seen previously , gskA  null m utant cells form ed small 
m ounds *=2 h earlier than w ild -typ e cells (Supplemental 
M ovie 1). These sm all m ounds form ed w ithout the m ulticel­
lular stream s seen  in  w ild -type cells (Figure 1A). Further­
more, the sm all m ounds w ere unstable, and they often dis­
aggregated before reaggregating in different positions on  the 
substratum (Figure IB). Restoring GskA activity via expres­
sion o f the w ild -type g skA  cD N A  in gskA  null mutants, 
rescued aggregation to that seen  in the w ild  type (Figure 
1C). H ow ever, no phenotypic rescue w as seen  after expres­
sion o f a mutant gene that lacks kinase activity (GskAK85R), 
indicating a requirement for kinase activity to m ediate GskA  
function (Figure 1C).
GSK3 Is  R equired  fo r  C h em o tax is  to  cA M P  an d  F olate
W e tested the ability o f gskA  null cells to undergo chem o­
taxis to cAMP. C ells w ere pulsed  w ith  cAM P for 5 h  and  
then placed in a gradient form ed from a 1 /xM cAMP source. 
gskA  null m utant cells had a com plete loss o f chem otaxis. 
C ell chem otaxis can be m easured  as the chem otactic index  
(Cl), w h ere  +1 represents m axim ally  accurate chem otaxis 
tow ard the cAM P source, - 1  represents chem otaxis aw ay  
from the cAM P source, and 0 is random  m ovem en t n ei­
ther tow ard nor aw ay from  the cA M P source. W e also  
have calcu lated  the percentage o f ce lls  that respond p o s­
it iv e ly  tow ard cAM P (% cells  respond), and th is repre­
sen ts the proportion  o f ce lls  that h ave Cl v a lu es  o f ^ 0 .7 , 
w ith  c o s -1 (0.7) =  45° and c o s -1 (1.0) =  0°. H ence, cells  
w ith  C l =  1.0, chem otax in  a straight line to cAM P, 
w h ereas any cell that d ev ia tes  45° on  either sid e  o f this 
w o u ld  exh ib it a va lu e  o f 0.7.
W ild-type cells possessed  a m ean Cl of 0.9, w ith  88.7% of 
w ild -type cells exhibiting chem otaxis toward cAM P com ­
pared w ith  31.5% of gskA  m utant cells. This is a slightly  
higher percentage (25%) than expected from cells w h en  they  
random ly m ove. The gskA  null m utant cells have a strongly  
decreased m ean Cl value o f 0.18 and in addition exhibited  
an approxim ate 50% decrease in cell speed and directional­
ity, a measure o f cell turning as they migrate toward the 
cAMP source. Re-expression o f GskA in  the gskA  null m u­
tant restores Cl, cell speed, and directionality to that o f the
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% cells respond to cAMP Cl
Speed (pm/min) 
Directionality
Wild type
88.7 
0.90 ±0.17  
9.6 ± 4.4 
0.81 ±0.17
gskA null
31.5 
0.18 ± 0 .7 ' 
5.4 ± 2.8 
0.34 ± 0.2
gskA null + 
GskA
80.4 
0.90 ±0.17 
9.9 ± 5 .3  
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B
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D
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Figure 2. Chemotaxis of gskA null m utant cells. (A) Chemotaxis parameters for wild-type, gskA null mutant, and gskA null cells expressing 
GskA (gskA-GskA). "% cells respond to cAMP" indicates the proportion of cells that have a Cl values of >0.7, w ith cos- 1  (0.7) = 45° and cos- 1  
(1.0) = 0°. Values are means and SDs based on at least 140 cells, compiled from three independent experiments. Dunn's multiple comparison's 
test between wild type and gskA null m utant showed a significant difference at p <  0.001 for all three parameters. (B) qRT-PCR showed gene 
induction for car A, pdsA, and aca are to similar levels to that observed in the earlier microarray study (Strmecki et al., 2007). The y-axes denote 
fold induction. (C) gskA null m utant cells are able to cause PTEN-GFP relocalization within 10 s of cAMP stimulation. (D) Chemotaxis to 25 
mM folate. Wild-type cells take on average 140 min to show clustering at the micropipette compared with gskA null mutants, taking an 
average of 270 min. Figures here show a representative of one replicate experiment. Control, buffer used to dissolve folate.
w ild-type cells. These results indicate a strong chem otaxis 
defect toward cAMP in the gsk A  null m utant (Figure 2A).
To exclude the possibility that the cells could not sense  
cAM P, w e exam ined expression o f gen es involved  in che­
m otaxis and cell signaling. The earlier microarray w as car­
ried out in cells that had been starved for 5 h and m atched  
the developm ental state of those used  in our chem otaxis 
experim ents (Strmecki et al., 2007). W e reexamined the results 
of the microarray but failed to detect differences in gene ex­
pression of the cAMP receptor genes, car A  is the major receptor 
expressed during aggregation (Sun and Devreotes, 1991), and 
w e used  qRT-PCR to confirm that there w as no difference in 
car A  gene expression between w ild-type and gskA  null mutant 
cells (Figure 2B). The microarray show ed altered expression of 
pdsA  and pdiA  genes, all which play a role in aggregation and 
w e confirm ed that induction of pdsA , w hich  encodes a cAMP  
phosphodiesterase, is indeed substantially reduced in gskA  null 
cells (Figure 2B). Finally, a survey o f major genes expressed  
during aggregation showed that the expression of the adenylyl 
cyclase acaA gene w as induced to on ly  30% of the w ild  tjq^e. 
This m ay have been below the threshold to detect on the 
microarray (Figure 2B).
To confirm that gskA  null cells can sense and respond to 
cAMP, w e examined the response o f phosphatase and tensin 
hom ologue (PTEN) to cAMP stimulation. In w ild-type cells, an 
accumulation of PTEN protein w as seen on the cell membrane 
but w as lost to the cytosol within seconds of cAM P accumu­
lation. This relocalization w as still present in gskA  null cells 
(Figure 2C), demonstrating that the loss of gskA  did not block 
cAMP sensing and som e downstream events.
To exam ine chem otaxis in a context independent o f cAM P  
signaling, w e  investigated the ability o f the gskA  null m utant 
to chem otax toward folate. This occurs during grow th o f  
D ictyostelium  w here cells are attracted to folic acid and  
pterins (Pan et al., 1972, 1975), substances that are secreted  
by bacteria, the D ictyostelium  food source. W e recorded the 
chem otaxis response o f grow th phase cells to 25 mM folic 
acid, delivered via a m icropipette. W e again observed a 
substantial chem otaxis defect in gskA  null cells com pared  
w ith  w ild  type (Figure 2D). Together, these results indicate 
a requirement of GskA in D ictyostelium  chem otaxis.
GSK3 Is R eq u ired  f o r  P IP 3 S ig n a lin g
To investigate the chem otaxis deficit in gskA  null m utant 
cells during early developm ent, w e  exam ined PIP3, a d o w n ­
stream effector of cAM P and m ediator o f the chem otaxis  
response. To d o  this, w e m onitored phosphorylation  of  
PKBA, the D ictyostelium  hom ologue of PKB. A s in its anim al 
hom ologues, PKBA contains a pleckstrin homoO logy (PH)- 
dom ain that m ediates translocation to the plasm a m em brane  
via PIP3 binding, w here the protein is subsequently  phos- 
phorylated (Kamimura et al., 2008). It therefore is a good  
monitor for PIP3 synthesis after cAM P stim ulation. In w ild -  
type cells, PKBA phosphorylation occurred w ithin secon ds  
of cAMP stimulation, w ith  a peak betw een 10 and 20 s, and 
then declined to basal levels by 60 s. N o  cA M P stim ulated  
elevation of PKBA occurred in gskA  null m utant cells (Figure 
3A). W e can exclude a failure to express the PKBA  gene  
because no difference in expression b etw een  m utant and
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Figure 3. PKB phosphorylation is lost in gskA null m utant cells. 
(A) Phosphorylation of PKBA on T278, indicative of PIP3 synthesis 
(bottom arrow) peaks at 10 s post cAMP stimulation in the wild type 
and gskA-GskA but not the gskA null mutant. Phosphorylation of 
PKBR1 on T309 (top arrow) showed kinetics similar to that for T278 
for both wild type and gskA-G skA and again is not observed for the 
gskA null mutant. (B) PHcrac-GFP translocation to the membrane is 
not observed in the gskA null mutant; however, relative fluorescence 
profiles post-cAMP stimulation showed small cytosolic fluorescence 
loss but not to the extent that observed for the wild type (C).
w ild-type cells w as observed either in the microarray 
(Strmecki e t al., 2007) or b y  qRT-PCR (data not show n).
To pu rsue this further, w e  m onitored PIP3 synthesis in 
living cells b y  expression of the PIP3-specific binding protein  
PH crac'G F P  (Parent et a l ,  1998). When cells are stimulated 
with a global cAMP signal, PIP3 is generated on the entire 
plasma membrane, causing translocation of P H q^ c-G F P  from 
the cytosol to the membrane. In w ild-type cells, PHCRAC-GFP 
w as recruited to the m em brane w ith in  10 s of cAMP addi­
tion and is subsequently lost after 30 s. N o  PHCRAC-GFP 
membrane translocation w as observed in the gskA  null cells 
(Figure 3B) and w h en  levels of fluorescence w ere quantified, 
P H cra c“GFP w as suppressed to on ly  10% of that seen in 
w ild-type cells (Figure 3C).
Increasing P IP 3 Levels R escues C hem otaxis in  the g sk A  
N u ll M u ta n t
W e previously show ed  that overexpression of the inositol 
m onophosphatase gene IMPA in w ild -type cell elevates PIP3
Wild type gskA null gskA null 
+ GSKA
t = 0 t = 10s
1.05
by increased synthesis of the phosphatidylinositol 3-kinase 
(PI3-kinase) substrate phosphatidylinositol 4 ,5-bisphosphate 
(PIP2; King e t al., 2009). W e used IMPA overexpression to 
elevate PIP3 in gskA  null cells and exam ined its effects. 
O verexpression o f IMPA in gskA  null m utant cells not only  
rescued chem otaxis, restoring m ean cell speed , directional­
ity, and C l values o f gskA  null m utant cells to w ild-type  
control values (Figure 4A), it also restored PKBA phosphor­
ylation (Figure 4B). This not on ly  indicated that GskA plays 
a major role in PIP3 signaling, it again dem onstrated that 
gskA  null m utant cells could sense sufficient cAMP to restore 
chem otaxis w hen this dow nstream  effector is restored.
W e used IMPA overexpression to probe h ow  loss o f gskA  
affects PIP3 signaling. One possib ility  is that GskA regulates 
IMPA activity or other targets on  the inositol-PIP2 pathw ay. 
A lack o f PIP2 w ould  then lead to a decrease in PIP3 syn­
thesis, in a similar m echanism  to that seen w ith  lithium  
treatment (King et al., 2009). In contrast, elevation o f PIP3 
m ay bypass a block in an alternative pathw ay, such as 
activation of PI3-kinase. W e m easured synthesis of phos­
phatidyl inositol phosphates (PIPs) in w ild-type, gskA  null 
mutant, and gskA  null m utant IM PA-overexpressing cells. 
W e observed no difference in phosphatidylinositol (PI), 
phosphatidylinositol phosphate (PIP), and PIP2 synthesis 
betw een w ild -type and gskA  null m utant cells (Figure 4C). 
This argued against a requirem ent for GskA for PIP2 syn­
thesis. In contrast, w e  saw  an increase in PIP2 in gskA  null 
m utant IM PA-overexpressing cells (Figure 4C). This sug­
gested that IMPA overexpression bypasses a deficit in PIP3 
signaling by elevating PIP2 and hence PIP3 synthesis.
Finally, w e  m easured PIP3 directly and found that in 
response to cAM P, gskA  null m utant cells did not synthesize  
PIP3 but seem ed to lose it. This response is the opposite to 
that observed in either w ild -typ e or gskA  null m utant IMPA- 
overexpressing cells (Figure 4D), w hich  rapidly synthesize  
new  PIP3 under these conditions. Overall, the data show ed  
that very little PIP3 is form ed in gskA  null m utant cells.
G skA  Is R equired  fo r  Target o f  R a p a m yc in  C om plex 2 
(T O R C 2)-m edia ted  S igna ling
W e noted that the cAMP chem otaxis p henotype seen  in the 
gskA  null m utant w as m uch stronger than that observed for 
loss o f PIP3 signaling alone (H oeller and Kay, 2007; Takeda 
et al., 2007; King et al., 2009), and sought evidence for a 
further m olecular defect in the gskA  null mutant. Previously, 
it has been found that signaling via the kinase target of 
rapamycin (TOR) acting in the TORC2 com plex w as capable 
of m ediating cAMP chem otaxis w hen  PIP3 synthesis w as  
inhibited (Kamimura et al., 2008). This alternative chem o­
taxis m echanism  acts via a second PKB hom ologue, know n  
as PkgB, or PKBR1 (Meili et al., 2000). This kinase protein is 
associated w ith  the plasm a m em brane via m yristoylation  
and not via a PH dom ain-PIP3 interaction (Meili et al., 1999) 
and is activated by phosphorylation from TORC2 (Lee et al., 
2005). W e exam ined PKBR1 phosphorylation in gskA  null 
m utant cells after cAMP stim ulation, and found that as seen  
for PKBA, PKBR1 phosphorylation w as also lost (Figure 4B). 
W e could detect PKBR1 expression (data not show n), su g­
gesting a signaling failure upstream  of PKBR1. In contrast to 
PKBA phosphorylation, PKBR1 phosphorylation w as not 
restored b y  overexpression o f IMPA (Figure 4B), indicating  
that this second m olecular m echanism  is independent of 
PIP3 signaling. These results indicated that GskA is required  
for tw o intracellular signaling processes, explaining w h y  it 
possesses a very strong chem otaxis defect.
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Figure 4. IMPA overexpression restores chemotaxis to 
gskA  null m utant cells. (A) Comparison of wild-type 
cells and gskA  null m utant cells overexpressing IMPA 
(gskA + IMPA) demonstrates rescued chemotaxis in the 
gsJL4-IMPA. (B) gskA-lMPA  shows similar PKBA T278 
phosphorylation kinetics to that observed in wild-type 
cells. However, T309 phosphorylation of PKBR1 is still 
absent after IMPA overexpression. (C) PI, PIP, and PIP2 
synthesis between fourth to fifth hour of early develop­
ment show gskA m utant cells are still capable of pro­
ducing phosphoinositides at levels similar to that of the 
wild type. (D) gskA m utant cells show higher basal PIP3 
levels compared with wild type; however, kinetics of 
PIP3 synthesis do not reflect that shown in wild type 
and gs/cA-IMPA, post-cAMP stimulation.
Wild type gskA null gskA null + IMPA
% cells respond to cAMP 88.7 
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A lth o u g h  it restored chem otaxis, IM PA overexpression  d id  
n ot rescu e aggregation or any other aspect o f m orphogenesis  
(F igure 5A  and Supplem ental M ovie 2). This indicated that 
the aggregation  defect w as not a sim ple consequence o f loss 
o f ch em otax is, and m ay arise from an additional sign alin g  
d efic ien cy . To test w hether these cells can generate cAM P  
sign a ls , ce lls w ere developed for 5 h  in susp en sion  and 
stim u lated  w ith  the cAM P analogue 2 -d eoxyadenosine 3,5- 
m on op h osp h ate  (dcAM P), and cA M P syn th esis w as m ea­
su red . There w as alm ost undetectable cA M P synthesis in 
g skA  null- and gskA  null-expressing IM PA cells (Figure 5B).
D ark-field  optics w as used to exam ine the cell signaling  
activ ity  during aggregation. W hen v iew ed  under these con ­
d ition s, changes in cell shape in response to cA M P p u lses  
can be seen  as a change in light scattering (Tom chik and  
D evreotes, 1981). In w ild -type cells, w a v es  o f light scattering  
propagate from  the center of the aggregation  field pass 
through the d ev e lo p in g  cell field as spiral w a v es (Figure 5C 
and Su pplem ental M ovie 3A). In contrast to w ild -typ e  cells, 
n o light scattering w a v es w ere observed in gskA  null m utant 
cells or gskA  m utants overexpressing IMPA (Figure 5C and
Supplem ental M ovie 3B). T hese observations su ggested  that 
although PIP3 signaling is sufficient to rescue chem otaxis, it 
w as unable to restore cAM P signaling and fu lly  rescue ag­
gregation.
D ISC U SSIO N
Here, w e  report that lo ss o f G skA  has substantial effects on  
Dictyostelium  aggregation, causing a major defect in ch em o­
taxis and cAMP signaling. This ph en otyp e correlates w ith  
the presence o f G skA activity during early stages o f d ev e l­
opm ent and the results o f prev ious m icroarray and pro- 
teom ic analysis (Plyte et al., 1999; Strm ecki et a l ,  2007). T hese  
results reveal an un expected ly  strong chem otaxis p h en o­
type, w hich has been p rev iously  m issed , and ind icates that 
the terminal developm ental p henotype o f D ictyostelium  m u­
tants may not be a good  indicator o f d efective chem otaxis.
Loss of gskA  has a substantial effect on ch em otaxis toward  
both cAM P and folate. These tw o  chem otactic resp on ses are 
m ediated by different receptors and G proteins (K um agai et 
al., 1989; H adw iger et al., 1994; Kim et al., 1998). Together  
w ith  the expression o f the cA M P receptor carA  and the
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presence o f the PTEN response, these observations argue 
that the requirem ent for G skA lies at the level of effector 
activation rather than w ith  signal sensing. We do not know  
exactly how  loss o f GskA inhibits folate chemotaxis, and our 
further conclusions are based on  our investigation of the 
better characterized cAMP chem otaxis response.
W e found that loss of gskA  caused a major decrease in PIP3 
signaling, w h ich  could be bypassed by elevation o f PIP3 
after overexpression of IMPA. Previous observations have 
show n that PIP3 signaling is able to elicit the chem otaxis 
response (Kortholt et al., 2007), explaining h ow  this restores 
chem otaxis to gskA  null m utant cells. A lthough PIP3 signal­
ing is sufficient for chem otaxis, it is not essential and a 
sim ple loss o f PIP3 cannot totally explain the severe chem o­
taxis phenotype observed for the gskA  null m utant cells. 
Loss or inhibition o f PI3K or PIP3 synthesis reduces speed  
and directionality in  chem otaxing cells; how ever, it has only  
a m inor effect on the Cl value (H oeller and Kay, 2007; King 
et al., 2009). In contrast, although w e  also saw  reduced speed  
and directionality in the gskA  null m utant, w e  also measured  
a large drop in the Cl value. W e found that loss o f gskA
GskA ^
/  \
IMPA --------------- ►PIP3  ►PKBA-^-----  T0RC2--------►PKBR1
F ig u re  6. Proposed mechanism of GskA action on both PIP3 and 
PKBR1. Phosphorylation of PKBA probably relies on both the action 
of TORC2 and another kinase, most likely PDK (Kamimura and 
Devreotes 2010, Liao et al, 2010), whereas GskA also acts upstream 
of TORC2, hence affecting subsequent phosphorylation of PKBR1.
blocks phosphorylation of PKBR1, a PIP3-independent com ­
ponent of a parallel signaling pathw ay that also m ediates 
chem otaxis to cAMP (Kolsch et al., 2008). We conclude that 
GskA acts upstream of both PIP3- and PKBR1-mediated 
signaling (Figure 6).
In our experim ents, w e  m onitored PKBA and PKBR1 ac­
tivation through antibodies specific to m otifs phosphory- 
lated by the protein kinase PDK-1 (Kamimura and D ev­
reotes, 2010). This in turn is dependent on phosphorylation  
by TOR kinase as part of the TORC2 com plex after cAMP  
stim ulation. These events occur at the plasma mem brane so  
that PKBR1 is dependent so lely  on TORC2 activation, 
w hereas PKBA phosphorylation requires sim ultaneous  
TORC2 activation and PIP3 synthesis. This presents a para­
dox: if TORC2 activation is required for both PKBA and 
PKBR1, how  can overexpression of IMPA restore PKBA 
phosphorylation w ithout an effect on PKBR1? W e noted  
how ever that a sm all am ount o f PKBA phosphorylation  
occurs in the absence of TORC2. This is evident in the report 
from (Kamimura et al., 2008; Liao et al., 2010) w here PKBA 
phosphorylation is observed in pia m utant cells, w hich  lacks 
the D ictyostelium  hom ologue o f  TORC2 com ponent Rictor. 
W e also observed PKBA phosphorylation in a rip3  null 
mutant, lacking a second com ponent o f TORC2 (Supplem en­
tal Figure 1, top), but an absence of PKBR1 phosphorylation. 
W e propose that elevation o f PIPj, as a consequence of 
IMPA overexpression, brings m ore PKBA to the mem brane 
w here it is phosphorylated through a TO RC2-independent 
kinase. The identity of this kinase is not know n, but a 
possible candidate could be the PDK1 hom ologue PdkA  
(Kamimura and Devreotes, 2010, Liao et al., 2010). A lth ou gh  
both  P dkA  and its paralogue can function  in  the cytoso l, 
PdkA  can translocate to the plasm a m em brane in  re­
sp on se  to cAM P through b in d in g  to PIP3 (K am im ura and  
D evreotes, 2010), and so  IMPA overexpression could en­
hance PKBA phosphorylation by  increasing the concentra­
tion o f both PKBA and PdkA on the membrane. Further­
more, PKBR1 null cells undergo normal chem otaxis (Meili et 
al., 2000), indicating that PKBA phosphorylation alone is 
sufficient for chemotaxis.
Further apparent com plexity relates to earlier results con­
cerning the effects of lithium  on  D ictyostelium  chem otaxis. 
Lithium inhibits both GSK3 and IMPA (Van Lookeren Cam- 
pagne et a l ,  1988; Van Dijken et al., 1996; R yves et al., 1998; 
R yves and H arw ood, 2001) and therefore w ou ld  be expected  
to produce the strong chem otaxis effect seen in the gskA  null 
mutant. H ow ever, previously w e  found that lithium  treat­
ment of aggregation com petent w ild -type cells suppressed  
PIP3 signaling, but left PKBR1 phosphorylation and cAMP  
synthesis unaffected (King et al., 2009). W e dem onstrated  
that this result arose from inhibition o f IMPA, leading to a 
decrease in PIP2 and subsequent PIP3 synthesis. A rguing
gskA null + GFP gskA null + IMPA
F igu re  5. (A) Overexpression of IMPA in the gskA null back­
ground does not rescue aggregation and multicellular development. 
(B) cAMP production is impaired in both gskA null m utants and 
gsfcA-IMPA cell lines. (C) Dark-field images of aggregating wild- 
type cells at h shows spirals of dark, stationary cells alternating 
with lighter areas of moving cells (top left). All gskA null m utant cell 
lines (null, gskA-GFP, and gsfcA-IMPA) do not show such patterning 
or light scattering waves. Bar, 50 /um.
Time (min)
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against the possibility that GskA becom es in sen sitive to  
lithium, w e  found that nuclear export o f Dd-STATa (Ginger 
et al., 2000), w hich  is mediated by GskA p hosphorylation , is 
suppressed by  lithium  in aggregation com petent cells (Sup­
plem ental Figure 1, bottom left). W e therefore prop ose  that 
these differences arise through the tim ing o f G skA  action. 
A cute inhibition of GskA in aggregation com petent cells, 
practically defined as cells pulsed  w ith  cA M P for 4 h  before 
addition of lithium  for 1 h, has n o  effect on  chem otaxis or 
cAMP synthesis. In contrast, loss o f G skA  activity at the 
beginning of developm ent or in  grow th  ph ase  cells causes 
the block to chem otaxis and signaling. In support of this 
hypothesis, w e  found that long-term  treatm ent w ith  lithium  
present from the initiation of cell d evelop m en t caused a 
substantial suppression  of cAM P syn th esis (Supplem ental 
Figure 1, bottom  right). T his su g g e s ts  that G skA  activ ity  
acts as a perm issive  sign a l to  in itia te  or se t up  chem otaxis  
but is not required co n tin u o u sly  eith er  as a d irect require­
m ent w ith in  the ch em otax is resp o n se  or for m aintenance  
of a chem otactic com p eten t state. H o w  G skA  m ay ach ieve  
this is unclear; h o w ev er , p o ss ib ilit ie s  cou ld  range from  
con stitu tive p h osp h ory la tion  o f  a prote in  that acts up ­
stream  of PIP3 and  TORC2 s ig n a lin g  to regu lation  o f gene  
exp ress ion  o f a com p on en t, or com p on en ts, required for 
ch em otax is and sign a lin g .
W hat is clear is that G skA  is required in  the regulation of 
som e aggregation-specific gene expression. Here, w e  have  
sh o w n  decreased expression  in  both pdsA , a cAM P phospho­
diesterase, and acaA, the adenylyl cyclase required for gen­
eration o f cAM P during aggregation. Loss o f expression of 
these gen es cou ld  account for loss o f cAM P signaling during  
aggregation, but not the GskA requirem ent for chem otaxis. 
The earlier proteom ic and microarray analysis o f gskA  null 
m utant cells (Strmecki et al., 2007) indicates several genes  
that m ay contribute to the chem otaxis phenotype. Loss of 
gskA  reduces expression  o f sodC, a superoxide dism utase, 
w hich has been sh ow n  to be required for chem otaxis tow ard  
cAMP (Veeranki et al., 2008). The sodC  m utant causes an 
increase in RasG activity even  in  the absence o f cAM P  
stim ulation, a know n upstream  activator o f PI3-kinase 
(Sasaki et al., 2004), and could contribute to the higher basal 
levels o f PKBA phosphorylation before cAM P stim ulation  
(Figure 3). The microarray also sh ow ed  that expression of 
the gen e  air A  is reduced in  gskA  null m utant cells. The AlrA, 
protein encod es an aldehyde reductase, w h ich  w h en  d is­
rupted a lso  suppresses cell m otility, although  the m echa­
nism  is unclear (Ehrenman et al., 2004). C uriously, both  
GskA and A lrA  have the capacity to alter g lucose m etabo­
lism w ith in  the cell, but the significance of this is not know n. 
In contrast, lo ss o f gskA  elevates expression  o f am pA . The 
product o f th is g en e  is antiadhesion protein that accum u­
lates during aggregation  (Varney et al., 2002), and elevated  
levels o f A m p A  cou ld  explain the instability of the sm all 
m ounds observed  during the aggregation o f the gskA  null.
T ogether, th is  s tu d y  ind icates that G skA  is an im portant 
regulator o f th e  aggrega tion  p rocess and is  essen tia l for 
cell chem otaxis. O ur observation s h o w ev er  also indicate  
that the role o f  G sk A  is probably com p lex , acting through  
a com bination  o f  m ech an ism s that are required  at a m in­
im um  for ch em o ta x is  and sign a lin g  b ut that a lso  m ay  
include m etab o lism  and  cell ad hesion . T hese m ay inte­
grate to d u r in g  ear ly  d ev e lo p m en t to a llow  aggregation  
proceed to  th e  m u ltice llu lar  stage, in  w h ich  G skA  m ed i­
ates cell fate d eterm in ation .
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